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Abstract 
     Dorsal root ganglion (DRG) neurons transmit sensory information to the central nervous 
system through glutamatergic synaptic transmission that can be modulated by diverse 
neuropeptides packaged in large dense core vesicles (LDCVs). LDCVs fuse at the cell somata and 
in afferent terminals along with synaptic vesicles, in response to a specific stimulus. Cultured DRG 
neurons are an appropriate system to investigate the role of Calcium-dependent Activator Protein 
for Secretion (CAPS) in the release machinery of these two different types of vesicles. CAPS has 
two isoforms that are known to be localized to different neurons in brain and DRGs. Hence DRG 
neurons are a good model to assess any possible differential roles of CAPS isoforms in LDCV and 
SV release. LDCV secretion can be studied in isolation or simultaneously with SV secretion once 
the DRG neurons are co-cultured with the spinal neurons. 
Using RT-PCR, western blot and immunocytochemistry, we verified that both CAPS 
isoforms are expressed in DRGs. CAPS1 is expressed in all neurons while CAPS2 is present in 
half of the population. We visualized NPY-Venus labeled LDCVs in real time using total internal 
fluorescence reflection microscopy. LDCV release was stimulated by a field electrode inducing 
secretion in fifty percent of neurons. Double gene deletion of CAPS1 and 2 strongly reduced the 
number of secreting cells and significantly reduced the amount of exocytosed LDCVs per 
responding cell in comparison to control. Furthermore, CAPS1 or 2b overexpression raised the 
number of WT secreting neurons by 20%, and the responding cells released more than twice as 
many LDCVs in comparison to wild type (WT) controls. Since the density of LDCVs at the plasma 
membrane was not affected by CAPS expression level, our results indicate that CAPS is a priming 
factor for LDCVs in DRG neurons. Further investigation of secreting WT cells revealed that only 
peptidergic neurons secrete LDCV upon stimulation. Interestingly, Isolectin GS-IB4 (iB4) staining 
together with anti-CAPS2 antibody staining showed that eighty percent of peptidergic neurons 
express CAPS2. Overexpressing CAPS2b in non-peptidergic neurons induced secretion while 
CAPS2 KO neurons didn’t secrete LDCVs. This strongly suggest that CAPS2 is the priming factor 
for LDCV release in WT DRG neurons. To address a possible role of CAPS in synaptic 
transmission we established DRG neurons co-cultured with spinal neurons (DRG/S neuron) to 
allow synapse formation. SypHy Lentivirus-based transfection was used to specifically label SVs 
 XIII 
 
and visualize their exocytosis. We found that CAPS1 but not CAPS2 promotes synaptic 
transmission. Upon CAPS1 but not CAPS2 deletion, synaptic transmission is dramatically 
decreased. Surprisingly, in-depth analysis of the synaptic transmission suggested that CAPS2 
indirectly affects synaptic transmission through peptide release. CAPS2 induced an 
unsynchronized secretion phenotype, while its absence synchronized synaptic transmission. 
Interestingly, blocking the receptors for the three major peptides, calcitonin gene-related peptide 
(CGRP), substance P (SP) and brain-derived neurotrophic factor (BDNF), led to the silencing of 
the majority of active synapses and induced synchronized synaptic transmission in the remaining 
active synapses. This suggests that the peptide antagonism might induce long-term depression, 
possibly by altering presynaptic calcium.  
Taken together, these findings indicate that CAPS isoforms play differential roles due to their 
differential localization. CAPS2 is localized to DRG cell bodies and primes LDCV secretion, while 
CAPS1 is localized to synapses and primes SV secretion. Additionally, CAPS2 affects synaptic 
transmission by promoting the release of peptides which modulate SV fusion. We conclude that 
CAPS is an indispensable protein with multiple functions that regulate both LDCV secretion and 
synaptic transmission in dorsal root ganglions. 
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Zusammenfassung 
   Spinalganglion (Eng: Dorsal Root Ganglion (DRG)) -Neurone übertragen sensorische 
Informationen an das zentrale Nervensystem durch eine glutamaterge synaptische Transmission, 
die durch verschiedene Neuropeptide moduliert werden kann und in großen dichten Kernvesikeln 
(Eng: Large Dense Core Vesicles (LDCVs)) verpackt sind. LDCVs werden als Reaktion auf einen 
spezifischen Stimulus an den Soma und in afferenten Termini zusammen mit synaptischen 
Vesikeln exocytiert. Die Spinalganglion Kultur ist ein geeignetes System, um die Rolle des 
Calcium-dependent Activator Protein for Secretion (CAPS) in der Freisetzung  zweier 
unterschiedlichen Arten von Vesikeln zu untersuchen. CAPS hat zwei Isoformen, die 
bekanntermaßen auf verschiedene Neuronen im Gehirn, und in DRGs lokalisiert sind. Daher sind 
DRG Neurone ein perfektes Modell, um mögliche Rollen der CAPS Isoformen in der LDCV und 
SV (Synaptic vesicle) Freisetzung zu bewerten. Die LDCV-Sekretion kann isoliert oder gleichzeitig 
mit der SV-Sekretion untersucht werden, sobald die DRG-Neuronen mit den Spinalneuronen co-
kultiviert werden. 
Unter Verwendung von RT-PCR, Western-Blot und Immunzytochemie konnten wir 
nachweisen, dass beide CAPS Isoformen in DRGs exprimiert werden. CAPS1 wird in allen 
Neuronen exprimiert, während CAPS2 nur in der Hälfte der Population vor liegt. Mit Hilfe des 
Total Internal Reflection Fluorescence Mikroskopie konnten  NPY-Venus (Eng: NeuropeptideY 
(NPY)) markierte LDCVs in Echtzeit visualisiert werden. Die Freisetzung wurde durch eine 
Feldelektrode stimuliert, die eine Sekretion in fünfzig Prozent der Neurone induzierte. Die doppelte 
Gendeletion von CAPS1 und 2 verminderte die Anzahl der sekretierenden Zellen stark und 
verringerte signifikant die Menge der exocytosierten LDCVs pro Reaktionszelle im Vergleich zur 
Kontrolle. Darüber hinaus erhöhte CAPS1 oder 2b Überexpression die Anzahl der WT (Wildtyp) 
sezernierenden Neurone um 20%, und die reagierenden Zellen setzten mehr als doppelt so viele 
LDCVs frei im Vergleich zu WT Kontrolle. Da die Dichte der LDCVs an der Plasmamembran nicht 
durch das Expressionsniveau von CAPS beeinflusst wurde, legen unsere Ergebnisse nahe, dass 
CAPS ein Priming faktor für LDCVs in DRG Neuronen ist. Eine weitere Untersuchung des 
Prozentsatzes an sekretierenden WT Zellen ergab, dass nur peptiderge Neurone nach Stimulation 
LDCV sekretieren. Interessanterweise zeigte eine Antikörperfärbung von Isolectin GS-IB4 (iB4) 
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zusammen mit anti-CAPS2-Antikörperfärbung, dass achtzig Prozent peptiderger Neurone CAPS2 
exprimieren. Überexpression von CAPS2b in nicht-peptidergen Neuronen induzierte Sekretion, 
während CAPS2 KO (Knockout) Neurone keine LDCVs sekretierten. Dies deutet stark darauf hin, 
dass CAPS2 der Priming faktor für die LDCV Freisetzung in WT DRG Neuronen ist. Um eine 
mögliche Rolle von CAPS bei der synaptischen Übertragung zu untersuchen, haben wir DRG 
Neurone mit spinalen Neuronen (DRG/S Neuron) co-kultiviert, und somit Synapsenbildungen 
ermöglich. Eine SypHy (Synaptophysin Phluorin) Lenti-Virus basierte Transfektion wurde 
verwendet, um Synaptische Vesikel spezifisch zu markieren und ihre Exocytose zu visualisieren. 
Wir konnten zeigen, dass CAPS1, aber nicht CAPS2 die synaptische Übertragung fördert. Bei 
CAPS1, aber nicht CAPS2 deletion, wird die synaptische Übertragung drastisch verringert. 
Überraschenderweise zeigte eine eingehende Analyse der synaptischen 
Transmissionsexperimente, dass CAPS2 indirekt die synaptische Transmission durch 
Peptidfreisetzung beeinflusst. CAPS2 induzierte einen asynchronen Sekretions Phänotyp, während 
dessen Abwesenheit zu einer synchronisierten synaptische Übertragung führte. Interessanterweise 
führte die Blockierung von drei Hauptpeptiden, einschließlich Calcitonin Gene-Related Peptide 
(CGRP), Substance P (SP), und Brain-Derived Neurotrophic Factor (BDNF), zum silencing der 
Mehrheit der aktiven Synapsen und induzierte synchronische synaptische Übertragung in den 
verbleibenden aktiven Synapsen. Dies deutet darauf hin, dass die Peptidblockade eine Langzeit-
Depression induzieren könnte, indem sie wahrscheinlich präsynaptisches Calcium verändert. 
Zusammengenommen zeigen diese Befunde, dass CAPS Isoformen aufgrund ihrer differentiellen 
Lokalisation differentielle Rollen spielen. CAPS2 ist in DRG Zellkörpern lokalisiert und ist für das 
Priming und die Sekretion von LDCV verantwortlich, während CAPS1 sich in Synapsen befinded 
und das Priming und Sekretion von SVs durchführt. Zusätzlich beeinflusst CAPS2 die synaptische 
Transmission durch die Förderung der Freisetzung von Peptiden, die an ihren präsynaptischen 
Rezeptor binden, wodurch die SV Exozytose induziert wird.  
Wir fassen zusammen, dass CAPS ein leistungsfähiges unentbehrliches Protein mit 
Multifunktionen ist, das sowohl die LDCV Sekretion als auch die synaptische Transmission auf 
unterschiedliche Weise regulieren. 
.
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I. Introduction 
It is vital for living organisms to sense the external world. The brain, through the anterior 
insular cortex, provides us with awareness of the feelings originating outside and inside the 
body  (Craig, 2009). There are countless experiences that can be sensed in our world from the hugs 
of beloved people, to the rain drops splashing on your skin and the feeling of cool breath. 
Incredibly, we are able to differentiate and comprehend these inputs and substantialize them 
through our perception to make things matter for us. Information needed from our environment to 
maintain our awareness of events happening around us are conveyed by different nerve endings 
that innervate our skin and organs. These nerves collectively transfer the sum of information to the 
nervous system. The nervous system serves different major functions, some of which are the 
exteroreceptive and interoceptive functions, then responds to stimuli originating outside or inside 
the body. Another function that is also needed for our perception is proprioception. It helps the 
nervous system keep good command over perception and control of body position and balance 
(Abraira and Ginty, 2013). These functions altogether involve the activation of primary neurons 
whose cell bodies are located in the dorsal root ganglion (DRG). DRG neurons act like a 
“primitive brain”; they can detect information from the periphery and send it to the central nervous 
system in order to be processed (Ibanez and Ernfors, 2007). The information is transmitted to the 
central nervous system via glutamatergic synaptic transmission that is subject to modulation via 
secretion of peptides contained in large dense core vesicles (LDCVs). The vesicular secretion of 
peptides and neurotransmitters is important in many neural and endocrine functions (Zhang and 
Zhou, 2002). Sensory inputs generate action potentials along the DRG axons which induce Ca2+-
dependent vesicle secretion (Huang and Neher, 1996; Zhang and Zhou, 2002). Secretion is 
controlled by a well-orchestrated exocytosis machinery and involves different vesicle pools and 
several fusion steps. Prior to fusion, vesicles undergo the membrane related maturation steps, 
docking, priming and a final fusion step that is calcium dependent. Fusion of the vesicle with the 
plasma membrane marks the release of the vesicular cargo, transmitting the chemical signal from 
the presynapse to the postsynapse (Becherer and Rettig, 2006). The exocytosis machinery has been 
examined in great detail for synaptic vesicles and to some extent for LDCV secretion in brain. 
However, it remains poorly understood in DRG neurons. Particularly, we are interested in the role 
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of CAPS in these neurons. It is widely accepted that CAPS regulates synaptic transmission and 
LDCV secretion in brain neurons (Eckenstaler et al., 2016; Farina et al., 2015; Fujita et al., 2007; 
Klenchin and Martin, 2000; Speidel et al., 2005; Speidel et al., 2003) and mutations in CAPS are 
associated with cerebellar disorders and autism (Okamoto et al., 2011; Sadakata et al., 2012; 
Sadakata et al., 2007a; Sadakata et al., 2007b) but its role in DRG neurons remains unknown. It is 
of great interest to understand how these sensory neurons transmit information and communicate 
with their surroundings and especially how pain is produced (Gu et al., 2010). Discovering how 
these sensory neurons work would help in providing potential treatment for sensory symptoms 
often associated to ataxia and pain. 
I.1 Spinal Cord 
The spinal cord is defined 
by Cambridge dictionary as the set 
of nerves inside the spine that 
connect the brain to other nerves in 
the body. It is a very important 
structure that links the body to the 
foramen magnum part of the 
brainstem where it becomes 
continuous with the medulla 
oblongata (Ibanez and Ernfors, 
2007). In humans, the spinal cord 
is divided into 31 segments that 
includes the cervical, thoracic, 
lumbar and sacral regions 
(Figure 1). The nervous tissue is 
composed of white and gray 
matter, together with supporting 
cells of the spinal cord. These 
tissues begin at the occipital bone 
Figure 1 Cross section of 4 of the spinal cord’s 31 segments.  
Source: Pearson Education Inc. © 2011 
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and extends to the second lumbar vertebrae reaching a length of around 45 cm in men and 43 cm 
in women. Its width varies from 13 mm thick in the cervical and lumbar regions to 6.4 mm thick 
in the thoracic part. In mice, the spinal cord is a white cylindrical slim structure that extends to a 
similar extent as in humans from the foramen magnum to the lower side of the vertebral colum 
(Yaksh et al., 1999). Between the carnium and the sacrum end, there exist about 25 to 30 vertebrae 
(Green, 1941; MJ., 1965). The sensory information travels from the extremities of the body and 
goes through the spinal cord to the central nervous system (CNS) via afferent fibers. The CNS in 
return, can send motor orders via motor neurons located in the ventral horn. These neurons project 
their axons to the body parts, mediating CNS voluntary and involuntary reflexes through muscle 
innervation. The spinal cord connects the brain with the peripheral nervous system, controlling and 
tuning the flow of information. The spinal cord segments are associated with a pair of dorsal root 
ganglia that host the cell bodies of the primary sensory neurons. The central axons of these cells 
project into the spinal cord carrying the information into the CNS second order neurons. 
I.2 DRG Neurons 
DRG neurons are pseudo-unipolar cells, with one axonal branch that extends all the way to 
the periphery and associates with peripheral sites. The second branch, which enters the spinal cord, 
forms synapses with second order neurons in the gray matter of the spinal cord, though few of these 
reach the dorsal column nuclei of the brainstem (Abraira and Ginty, 2013). A single DRG neuron 
nerve ending covers a receptive field of less than a 1 mm in diameter on the skin surface that often 
senses a range of different stimuli (Patapoutian et al., 2003). These neurons are very diverse and 
encompass different subsets that are distinct with respect to their cell body sizes, axonal 
morphologies, physiological properties, and expression of molecular markers. Some subsets 
respond to either thermal, tactile, proprioceptive, or nociceptive stimuli and are classified as 
thermoreceptors, mechanoreceptors, proprioceptors, and nociceptors, respectively (Ryan et al., 
2007). The diversity of the receptive functions is extensive, for example somatosensory subset can 
be further divided into several modalities of somatic sensation that can be further divided into sub-
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modalities. They are basically classified into four main categories that are presented in Table 1. A 
more general and easier classification is to group these neurons as peptidergic and non-peptidergic 
neurons that can be distinguished via isolectin labeling. The isolectin protein (iB4) isolated from 
an African shrub, binds to α-D-galactose carbohydrate residues on small and medium sized neurons 
(Fullmer et al., 2004; Silverman and Kruger, 1990). The iB4 can only bind the unmyelinated non-
peptidergic or “peptide poor” primary neurons hence the name iB4+ neurons (Wang et al., 1994), 
Additionally this substance has been used to label the non-peptidergic neurons expressing the 
exposed isolectin P2X3 receptors (Bradbury et al., 1998; Guo et al., 1999). By default, the 
“peptide rich” myelinated neurons were given the name iB4- neurons. It is now widely accepted 
that these chemical differences on the surface of these neurons represent functionally distinct 
groups of DRG neurons (Snider and McMahon, 1998; Stucky and Lewin, 1999). DRG neurons 
carry out their functions with the help and maintenance provided to them by astrocytes (Fang et 
al., 2006). 
Table 1 The sensory modalities represented by the somatosensory systems.  
DRG neurons are categorized into different somatic modalities that are further divided into sub-modalities (aka 
different types of sensation) and sub-sub-modalities. Each of these sensations are modality specific. For example, 
the somatosensry cold-sensation submodality is naturally stimulated by cold, the perceived sensation is then 
processed by a specific neuron which can not respond to warm or touch signals. Sensory receptors and their 
connections determine the modality specificy by which the responsible neuron will process the information and 
send it to the higher order of central nervous system neurons.  
Source: Modified from Patrick Dougherty, Ph.D., Department of Anesthesiology and Pain Medicine, MD Anderson 
Cancer Center. Content available on: The University of Texas Health Science Center at Houston (UTHealth) website. 
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I.3 Astrocytes 
Michael von Lenhossek introduced the term 
Astrocyte which translates literally into ‘Star-like cell’. 
They can be identified by staining against GFAP1 
(Figure 2). Astrocytes are highly heterogeneous in their 
morphology and the surface markers they express. 
Astrocytes are the most numerous and diverse glial 
cells in the nervous system (Nedergaard and 
Verkhratsky, 2012; Parpura and Verkhratsky, 2012). 
They create the micro-architecture allowing brain 
neurons to thrive and perform their functions. They 
store and distribute energy substrates, control 
development, synaptogenesis and maintenance of 
synapses and synaptic structures. (Kettenmann and 
Verkhratsky, 2011). These cells perform their 
supportive functions by establishing highly organized 
anatomical domains that are extensively connected into networks, dramatically modulating the 
state of neurons (Belanger and Magistretti, 2009). While astrocytes maintain CNS integrity, they 
also do so for the PNS (Guenard et al., 1994). Astrocytes surround the pre- and postsynaptic 
structures in the PNS and stabilize them (Heikkinen et al., 2014). The idea of the functionality and 
participation of astrocytes at synapses became interesting when Alfonso Araque showed, using 
transmission electron microscopy, that astrocytes processes are in the direct proximity of synapses 
(Araque et al., 1999a; Araque et al., 1999b). Further studies revealed that astrocytes release 
molecules that are essential to sustain the maturation, structure and functionality of active synapses 
(Beattie et al., 2002; Pfrieger and Barres, 1997; Slezak and Pfrieger, 2003). The influence of 
astrocytes on synaptic survival, activity and plasticity can be exerted by glial-derived 
neurotrophins, cytokines and metabolites (Faissner et al., 2010). Astrocytes have proven to be 
essential for successful physiological studies involving CNS and PNS neurons. For this reason, we 
                                                 
1 Glial fibrillary acidic protein, a common marker for astrocytes. 
Figure 2 Astrocyte cells.  
Astrocytes fixed with 4% and stained against 
rabbit GFAP and Alexa 488 secondary antibody. 
The displayed image is a bright field overlaid with 
488 confocal acquisition. 
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monitored and controlled the astrocyte numbers in such a way that there were adequate astrocytes 
for healthy DRG culture but not so many that imaging was impaired.  
I.4 Spinal Neurons 
The primary afferents of different DRG subtypes that innervate the skin and body tissues, 
terminate in the spinal cord. The distribution pattern of this termination is determined by the 
sensory modality and the body region these afferents innervate (Sivilotti and Woolf, 1994). It is an 
orchestrated process that drives the modality specific terminations to the proper position inside the 
spinal cord grey matter. For instance, nociceptive neurons terminate in dorsal horn, 
mechanoreceptors neurons terminate in deeper laminae, while proprioceptive neurons terminate in 
the intermediate zone and in the ventral spinal cord horn (Figure 3).  The grey matter encompasses 
the cell bodies of spinal neurons2 that constitute a part of the CNS and is divided into several 
sections that include dorsal horn, intermediate column, lateral horn and ventral horn column. Spinal 
                                                 
2 In addition to spinal neurons, the grey matter encompass glial cells as well as astroglial and oligodendrocytes. These 
cells provide physical support and regulate the internal environment inside the grey matter 
Figure 3 DRG neuronal connections to spinal neurons. 
Modified from: Marmigère and Ernfors. Nature Reviews Neuroscience 8, 114–127 (February 2007), 
doi:10.1038/nrn2057. 
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neurons process the information from 
DRG neurons through complex 
inhibitory and excitatory circuits 
(Todd, 2010). The information is 
then transmitted from spinal neurons 
to higher order neurons in the brain to 
be further processed. It was 
important for us to study synapses 
formed between DRG neurons and 
spinal neurons in order to assess the 
possible role of CAPS isoforms in 
synaptic transmission and for this 
reason we characterized these cells 
according to morphology. We 
noticed that spinal neurons were 
much smaller in size in comparison 
to DRG neurons and that they were 
morphologically different in terms of 
cell body shape (being more round) and having longer and thicker processes (Figure 4). It was 
relatively easy for us to distinguish both types of neurons once co-cultured. During the course of 
this PhD thesis we will present a detailed characterization of these cells and we will describe the 
time course of synapse formation and function.  
I.5 Exocytosis 
The term exocytosis was conceived by the Belgian Nobel prize winner Christian de Duve 
by combing the Greek words Έξω, meaning "external" and κύτος, meaning "cell" (Blaschko; De 
Duve, 1963). As the meaning of the word implies, it is a process by which a vesicle fuses with the 
membrane of the cell, releasing its cargo to the outside (aka secretion). It is an essential mechanism 
for cells to accomplish their functions and maintain homeostasis (Alberts, 1989) For instance, the 
secretion of neurotransmitter serotonin is essential for brain function and mood regulation, the 
Figure 4 Spinal neurons in culture.  
(A) Confocal bright field acquisition of dorsal horn neurons 6 DIV. 
(B) DRG/S neuron co-culture 6 DIV. S neuron can be distinguished 
from DRG neurons with their relatively smaller size. The white 
arrows point to DRG neurons while the yellow arrow points to 
S neuron. 
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secretion of peptides (for example NPY) and hormones (for example oxytocin) are important for 
regulating food intake/obesity and mental state (De-Miguel and Trueta, 2005; de Kock et al., 2003; 
Gehlert, 1999; Piekut, 1985). There are two modes of exocytosis, the constitutive pathway and 
regulated pathway of secretion (Frick et al., 2001). The first mode provides a continuous way of 
secretion of proteins that are packaged inside vesicles of which undergo direct secretion, delivering 
proteins to the extracellular matrix. Fusion of membrane organelles is also used to deliver proteins 
to the plasma membrane of the cell (Alberts B, 2002; Lacor et al., 2000; Lodish H, 2000). The 
second pathway occurs in specialized cells and is important for regulating peptide, neurotransmitter 
and hormone release. Regulated exocytosis is coupled to transient calcium increase in the cytosol 
which induces the fusion of secretory vesicles with the cell membrane, see figure 5 for more details 
(Alberts, 1989; Robert D. Burgoyne, 1993; Vitale et al., 2002). Exocytosis is a firmly regulated 
mechanism that involves vesicle trafficking, tethering, docking, priming and a final fusion step. 
Vesicle trafficking involves translocation of vesicles, often over long distances, from the Golgi 
apparatus to their destined site. Such translocation requires motor proteins and actin and/or 
microtubule cytoskeletal tracks (Johnson et al., 2012; Kuznetsov et al., 1992; Lang et al., 2000; 
Manneville et al., 2003). Once the vesicles are recruited to the intended site, they are tethered. A 
process known to happen before the interaction of vesicular Soluble N-Ethylmaleimide-sensitive 
factor attachment receptor (v-SNAREs) and transmembrane SNARES (t-SNAREs). Tethering is 
defined as the first attachment of the vesicle with its target membrane and usually covers a distance 
half of the vesicle width (> 25 mm). Tethering factors are known to share common characteristics, 
being either multi-subunit complexes or elongated coiled-coil proteins (Lowe, 2000) that stabilize 
the position of the vesicle long enough ensuring a successful docking for fusion (Toonen et al., 
2006). Once the vesicles are strongly-tethered, they are subjected to tighter membrane positioning 
Figure 5 The constitutive and regulated secretory 
pathways. 
The constitutive secretory pathway ensures the 
renewal of proteins located in the plasma membrane 
and the disposal of metabolites. The regulated 
secretory pathway takes place only in specialized cells 
whereby proteins in the trans-Golgi network are 
sorted into secretory vesicles, waiting a proper signal 
to drive their exocytosis.  
Adapted from: Molecular Biology of the Cell. 4th 
edition. Alberts B, Johnson A, Lewis J, et al. New 
York. Garland Science; 2002. 
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bringing the vesicles in a 
proximity of 5 to 10 nm 
from the plasma 
membrane, a process 
called docking. Docking 
involves the integral 
vesicular proteins, 
synaptotagmin which 
interacts with two 
membrane proteins, 
syntaxin and SNAP-25 
(Bennett and Scheller, 
1994; Jahn and Sudhof, 
1993; Pevsner et al., 
1994). Tethering and 
docking establish physical 
proximity of membranes 
but are not enough to 
initiate vesicle fusion-
competence. Prior to 
fusion, an additional 
biochemical process is 
needed that requires a set of proteins interacting with both the vesicle and the plasma membrane in 
an ATP-dependent fashion, rendering the vesicles fusion competent. This process is called priming 
whereby vesicles are now fusion competent and awaiting the calcium trigger to fuse (Klenchin and 
Martin, 2000; Martin and Kowalchyk, 1997). Fused vesicles are endocytosed and recycled for 
further rounds of fusion (Figure 6). 
I.5.1 SV Exocytosis 
Synaptic vesicles are loaded with neurotransmitters, transferred to the active zones of pre-
synaptic axonal terminal, docked then primed and await calcium signal to trigger fusion, a process 
called SV exocytosis. It takes about 100 µs from the arrival of an action potential to the fusion of 
Figure 6 The synaptic vesicle cycle. 
Synaptic vesicle exocytosis can be divided into several stages. 1: Synaptic 
vesicles are loaded with neurotransmitters by active transport. 2: Newly filled 
synaptic vesicles are then transported to the active zones of synapses, a 
process known as tethering. 3: The synaptic vesicles are then docked to the 
presynaptic membrane. 4: Synaptic vesicles status becomes fusion competent 
after a priming step awaiting calcium signal. 5: Calcium signal triggers fusion 
process. 6: Fused synaptic vesicles are then coated with Clathrin and are 
prepared for endocytosis. 7: Endocytosed synaptic vesicles shed the Clathrin 
coat and are acidified via proton pumps. 8: The synaptic vesicles later fuse with 
early endosomes. 9: Once ready, synaptic vesicles bud from endosomes. It is 
reported that some synaptic vesicles can skip the endosomal intermediate step 
and can go directly from step 7 to step 1. 
Modified from: The Synaptic Vesicle Cycle in the Nerve Terminal. Basic 
Neurochemistry: Molecular, Cellular and Medical Aspects. 6th edition. Siegel 
GJ, Agranoff BW, Albers RW, et al., editors. Philadelphia: Lippincott-Raven; 
1999. 
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SVs at the presynapse (Rizo and Rosenmund, 2008; Sudhof, 2004). Twenty years of accumulating 
research investigating neurotransmitter release shows that neuronal SNAREs that mediate 
exocytosis are the vesicular Synaptobrevin and the plasma membrane proteins SNAP-25 and 
Syntaxin. Synaptobrevin and Syntaxin-1 each have one SNARE motif before the C-terminal 
transmembrane domain while SNAP-25 has two SNARE motifs. The assembly of the four 
SNAREs motifs into a tight SNARE complex consisting of a four-helix bundle (Lin and Scheller, 
1997; Poirier et al., 1998; Rizo and Xu, 2015; Sutton et al., 1998) is required for the primed 
state (Sollner et al., 1993). The energy released by this assembly would trigger membrane 
fusion (Hanson et al., 1997) whereby Synaptobrevin binds to SNAP-25 and Syntaxin, drawing the 
vesicular and cell membranes into close proximity (Figure 7). The SNARE complex is 
disassembled right after fusion with the help of NSF and SNAPs (Sollner et al., 1993). 
 
Figure 7 SV exocytosis.  
SNARE proteins, complexins and synaptotagmin 1 and 2 interaction model during exocytosis. While vesicles are 
docked (panel A). There is no direct interaction of SNARES and synaptotagmins while vesicles are docked (panel A). 
Upon priming (panel B), Complexins (green) bind to fully associated SNARE complexes, followed by association of 
synaptotagmins to the formed SNARE complex. Assembled SNARE complexes force the synaptic vesicle membrane 
and the plasma membrane into close proximity, resulting in an unstable intermediate as shown in the hypothetical 
fusion diagram. Calcium influx would trigger synaptotagmin C2 domains to partly insert into the phospholipids (panel 
C), destabilizing the fusion intermediate state. This causes mechanical perturbation that opens the fusion pore 
ending in full vesicle fusion. 
Adapted from: Thomas C. Sudhof. The Synaptic Vesicle Cycle. Annu. Rev. Neurosci. 2004. 27:509–47. 
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I.5.2 LDCV Exocytosis 
Neurons and neuroendocrine cells secrete transmitters such as neuropeptides, neurohormones and 
amines that are contained in LDCVs (Bauerfeind et al., 1994; Liu et al., 1994; Park and Kim, 2009). 
Unlike, small EM clear core SVs (of about 50 nm in diameter), LDCVs are larger and have electron 
dense cores with vesicles of diameters from 100 to 300 nm. Whereas, neurotransmitters in SVs 
primarily bind to ligand gated ion channels to transmit the signal to the postsynapse in rapid way, 
neuropeptides contained in LDCVs target G protein-coupled receptors (GPCRs), hence modulating 
synaptic activity (Park and Kim, 2009) (see Table 2). LDCVs are secreted at the soma as well as 
near active zones of synapses (Zhao-Wen, 2008). The production of LDCVs can be quite a complex 
process for cells. Unlike SVs that can be locally produced at synapses to ensure fast recycling, 
immature LDCVs are de novo produced at the trans-Golgi network (Yang et al., 2001). Once 
formed, LDCVs undergo maturation steps allowing the transportation to the destined location and 
eventual docking at the plasma membrane, a process coordinated via Rab proteins (Grosshans et 
al., 2006) (Figure 8). Despite, the differences between the morphology and function of both SVs 
and LDCVs, they share common mechanisms of exocytosis whereby calcium is essential to trigger 
their release. In similar fashion to SV exocytosis, a synaptotagmin is required for calcium sensing 
in LDCV exocytosis (Schonn et al., 2008). In a very similar way to what was described in SV 
exocytosis section, the priming of vesicles into a fusion competent state involves the assembly of 
Table 2 Comparison between SSV and LDCV.  
Adapted from: Yongsoo Park and Kyong-Tai Kim. hort-term plasticity of small synaptic vesicle (SSV) and large dense-
core vesicle (LDCV) exocytosis. Volume 21, Issue 10, October 2009, Pages 1465–1470. 
 SVs LDCVs 
Size (nm) ~ 50 100–300 
Location Mainly CNS and clustered in nerve 
terminals 
Mainly PNS and homogeneously 
distributed 
Endocytosis Local recycling by endocytosis Slow endocytosis 
Morphology in EM Clear particle Dense particle 
Neurotransmitters 
contained 
Classical neurotransmitters and 
ATP 
Amines (catecholamine, 
serotonin, and histamine), 
peptide, and ATP 
Receptors stimulated Mainly ligand-gated channel 
(generating postsynaptic 
potential) 
Mainly GPCR (modulating synaptic 
activity) 
Time delay between 
calcium influx and fusion 
~ 0.2 ms after single action 
potential 
> 50 ms, longer latency after 
strong stimulation 
Distance from calcium 
channel to fused vesicle 
~ 20 nm ~ 300 nm 
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trans-SNARE complexes. This process that is further regulated with priming factors such as 
Munc13s. Interestingly, it was shown that Munc-13 does not play an essential role in LDCV 
exocytosis in contrast to the case of SV exocytosis (van de Bospoort et al., 2012). Exogenous 
Munc-13 facilitates LDCV secretion but its absence does not impair the ready releasable pool 
(RRP) (Figure 8) (Sieburth et al., 2007). Another important priming factor CAPS, a highly 
conserved protein through evolution with two isoforms that has been proven to play an important 
role in LDCV secretion (Walent et al., 1992). Most studies however focused on CAPS1, knowing 
that CAPS2 is expressed at eight fold higher than CAPS1 in endocrine cells (Sieburth et al., 2007; 
Speese et al., 2007; Zhou et al., 2007). Understanding the differences between CAPS isoforms 
should provide key insights to understand the differences in priming of SV and LDCV exocytosis. 
Through this thesis, we intended to decipher the role of CAPS isoforms in both SV and LDCV 
exocytosis. 
 
 
 
Figure 8 LDCV exocytosis.  
Molecules that are involved in calcium-dependent exocytosis. Several molecular reactions occurs before calcium-
dependent exocytosis. The transfering of vesicles from the depot pool (DP) to the unprimed pool (UPP) defines the 
docking step. Munc18 stabilize docked state of vesicles.  Docking is followed by a priming step which corresponds to 
the transfer of vesicles from the UPP to the slowly releasable pool (SRP) because of the (partial) formation of the 
SNARE complex from the individual SNAREs SNAP-25, syntaxin, and synaptobrevin. Munc13 functions as a priming 
factor. Complexin modulates the equilibrium between SRP and RRP. The final fusion of vesicles is initiated by the 
binding of Ca2+ to synaptotagmin which acts as a calcium censor.  
Adapted from: Ute Becherer and Jens Rettig, 2006. Vesicle pools, docking, priming, and release. 
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I.6 CAPS 
In 1992, a novel brain protein first named p145 was identified by Thomas Martin’s group. 
The protein was described as a dimer of 145 kd subunits that exhibited Ca2+-dependent interaction 
with a hydrophobic matrix. It was suggested that p145 has a membrane-associated function because 
of its ability to bind phospholipids vesicles. The authors also proposed that the restricted expression 
of p145 suggests that this protein has a key role in the transduction of Ca2+ signals into vectorial 
membrane fusion events (Walent et al., 1992). It took the authors five years to give p145 the current 
name, CAPS (Ca2+-binding protein) and they reported that Ca2+-dependent triggering of vesicle 
fusion required CAPS as an additional cytosolic factor (Ann et al., 1997). A year later, CAPS got 
its final submitted name3 which had a better descriptive meaning of its function. It was directly 
understood how important this novel protein is. CAPS was shown as a functional component of 
the exocytotic machinery that localizes selectively to LDCVs, and probably confers distinct 
regulatory features on neuropeptide and biogenic amine transmitter secretion (Berwin et al., 1998). 
As the attention towards CAPS further grew, more groups started studying it in different cell 
systems. The first study of CAPS effect on LDCV release was performed in calf chromaffin cells 
and showed that CAPS is critical for fusion of LDCVs with the membrane (Elhamdani et al., 1999). 
A second mammalian CAPS isoform was identified by Brose group; the localisation of both 
isoforms in the CNS as well as in other organs was then studied (Speidel et al., 2003). These studies 
reported among other findings that CAPS is expressed in DRG neurons but while CAPS1 was 
found in all DRG neurons, CAPS2 was found in an undefined subpopulation (Sadakata et al., 2006; 
Sadakata et al., 2007b). Later, CAPS4 was studied in Caenorhabditis elegans where it was shown 
that it is required for LDCV but not SV exocytosis (Speese et al., 2007). In 2011, CAPS2 isoform 
was shown to promote BDNF release in the GABAergic interneuron network of the hippocampus 
and to be critical for the development of GABAergic interneuron network (Shinoda et al., 2011). 
CAPS2 was also shown to be essential for regulating LDCV trafficking by interacting with Class 
II ARF small GTPases (Sadakata et al., 2012). Rettig’s group showed in 2014 that CAPS primes 
through its Pleckstrin homology domain and not through the Mun domain and that it doesn’t 
interact with Syntaxin and surprisingly, that its function is not redundant with Munc13 (Nguyen 
                                                 
3 Calcium-dependent Activator Protein for Secretion. 
4 CAPS homolog in C. elegans is named UNC-31. 
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Truong et al., 2014). Recently, it was shown that CAPS1 primes LDCV fusion at synapses in 
mammalian neurons and both CAPS1 and CAPS2 primes SVs (Jockusch et al., 2007). A more 
recent study showed that deletion of CAPS2 does not affect SV release (Farina et al., 2015), 
introducing some  controversy to the field. CAPS isoforms play different roles in LDCV vs SV 
secretion among different species and cell types within species. It is not necessarily the case that 
CAPS acts as a priming factor in one cell type if CAPS does for another. For instance, the two 
powerful priming factors Munc13 and CAPS are not required for the molecular regulation of SV 
secretion in cochlear inner hair cells (Vogl et al., 2015). 
The diverse effects of CAPS 
on LDCV and SV release 
among different species is 
illustrated in table 2. It is 
difficult to predict how CAPS 
would act in DRG neurons 
due to its unorthodox role as 
described in the literature. It 
was very interesting for us to 
investigate both isoforms in 
DRG and DRG/S neuron 
system as its roles remain yet unclear in these cells. 
I.6.1 CAPS Isoforms 
The CAPS protein family is 
encoded by two CADPS genes that 
produce two isoforms, CAPS1 and 
CAPS2. The CADPS1 gene is located on 
chromosome 3 while CADPS2 gene is 
located on chromosome 7 (Figure 9). 
CAPS proteins are widely expressed in all adult and fetal tissues examined, with the strongest 
expression in kidney and pancreas. In brain, it is expressed at high levels in cerebellum, to a lesser 
degree in cerebral cortex, occipital pole, and frontal and temporal lobes. CAPS is weakly expressed 
Species LDCVs SVs 
C. elegans Yes  
(Speese et al., 2007) 
No  
(Speese et al., 2007) 
Drosophila Yes 
(Renden et al., 2001) 
Yes 
(Renden et al., 2001) 
Chromaffin cells Yes 
(Elhamdani et al., 1999) 
- 
Hippocampal 
neurons 
Yes 
(Shinoda et al., 2010) 
Controversial 
(Jockusch et al., 2014) 
(Farina et al., 2015) 
Hair cochlear 
cells 
No 
(Vogl et al., 2015) 
No 
(Vogl et al., 2015) 
DRG neurons ? ? 
Table 3 Role of CAPS in LDCV and SV release across the different studied 
species in the literature. 
Figure 9 CADPS gene map region. 
Source: Modified from GeneLoc Genome Locator. 
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in medulla, spinal cord and putamen (Cisternas et al., 2003). CAPS1 isoform is very important for 
neurons and is abundant among almost all neurons (Figure 10).  
Figure 10 Estimated protein expression level of CAPS1. 
Source: GeneReport for Unigene cluster for CADPS1 Gene Hs.654933. 
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CAPS1 deficiency affects the secretion of catecholamines, neuropeptides and peptide hormones 
(Berwin et al., 1998; Fujita et al., 2007; Speidel et al., 2008; Tandon et al., 1998). In the course of 
my thesis, I will study the effect of CAPS1 - as well as CAPS2 - on LDCV and SV release in DRG 
neuronal culture and DRG/S neurons co-culture, respectively.  
Unlike CAPS1 where there are no known splice variants, CAPS2 isoform has 6 known splice 
variants 2b, 2a, 2c, 2d, 2e and 2f ranging from the longest to the shortest, respectively (Figure 11). 
CAPS2 isoforms are expressed right after birth with an expression peak around the first or second 
postnatal week. In several tissues the estimated expression level of CAPS2 is less important than 
CAPS1 (Figure 12). CAPS2 protein is concentrated in parallel fiber terminals5 of the cerebellum 
                                                 
5 CAPS1 is enriched in Glomeruli and Climbing Fibers (Sadakata et al., 2007a). 
Figure 11 CAPS2 splice variants are 
present in adrenal glands.  
(A) Domain structure of CAPS2 splice 
variants (Sadakata et al., 2007). 
Domains are as follows: DID, C2 domain, 
PH domain, MUN domain. Numbers 
refer to the amino acids defining the 
respective domains. Alternatively 
spliced exons are indicated underneath. 
(B) RT-PCR of adrenal gland (AG) and 
cerebellum (Cb) using primers specific 
for CAPS2 splice variants. Lysates from 
adrenal glands obtained from mouse 
embryos at E18 and postnatal days 1, 
10, and 21 were used as templates for 
lanes 1–4, and for lane 5, cerebellar 
lysate from postnatal day 7 mice was 
used as template. The outer lanes 
contain size markers. 
Source: Nguyen Truong et al., 2014, 
Prof. Jens Rettig lab. Cell Reports 9, 
902–909, November 6, 2014. 
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where it is associated with vesicles containing BDNF. CAPS2 enhances release of BDNF, which 
is essential for normal cerebellar development (Sadakata and Furuichi, 2009). 
Figure 12 Estimated protein expression level of CAPS2.  
Source: GeneReport for Unigene cluster for CADPS2 Gene Hs.649459 
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CAPS2 deficient mice exhibited autistic-like behavioral phenotypes such as impaired social 
interaction, hyperactivity and increased anxiety in an unfamiliar environment (Sadakata et al., 
2007a).  
I.7 Aim of the Thesis 
The secretion machinery that permits the release of both LDCVs and SVs in DRG neurons has 
not been studied. It is not clear which priming factors are involved. A quarter of a century time 
worth of CAPS studies made us understand that this protein plays different and sometimes opposite 
roles among mammalian and invertebrate systems. Due to the diverse and controversial roles of 
CAPS, it was of great interest to investigate whether it primes LDCV secretion or not. If CAPS 
does prime, the second question to address is which isoform is involved? According to (Sadakata 
et al., 2006; Sadakata et al., 2007b), CAPS1 is found in all DRG neurons while CAPS2 is localized 
to an unknown subpopulation. To which subpopulation does CAPS2 localize to and what role does 
it play? Since, DRG neurons are very diverse, this different localization might imply different roles 
of CAPS isoforms. To study whether CAPS primes SV release, it was necessary to establish DRG/S 
neuron co-culture in order to achieve functional synapses (Joseph et al., 2010) in-vitro and test at 
what time these synapses start to form and if they are functionally interconnected or not. We 
hypothesized that CAPS1 might be responsible for SV release because of its presence in all DRG 
neurons and it is known that all these cells form synapses with higher order CNS neurons. Would 
CAPS2 prime SV release as well? What would be the effect of absence of both isoforms on SV 
release? Another question was whether CAPS plays a role in synapses between DRG neurons and 
spinal neurons. The main aim of my thesis was to identify the role of CAPS isoforms in murine 
DRG neurons and to look deeper at the localization and investigate the idea of differential 
regulation at different levels. Unraveling the molecular exocytosis machinery of DRG neurons is 
relevant for controlling pain which is important in medicine.
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II. Materials and Methods 
The used materials were mainly available at the department of Univ.-Prof. Dr. Jens Rettig and 
to lesser extent at the department of Univ.-Prof. Dr. Dieter Bruns. 
II.1 Materials: 
II.1.1 Chemicals 
Product Company 
Agar Roth 
B27-Supplement Life Technologies 
BSA Sigma-Aldrich 
CaCl2 x 2H2O Merck 
Chloroform Sigma-Aldrich 
Cyclotraxin B Tocris 
DMEM Life Technologies 
dNTP-Mix Fermentas 
DPBS Life Technologies 
Ethanol 100% Roth 
EtBr Life Technologies 
EDTA Sigma-Aldrich 
EGTA Sigma-Aldrich 
FCS Life Technologies 
Formaldehyde PolyScience 
Fura-2 AM Life Technologies 
FUDR Sigma-Aldrich 
Glucose Merck 
Glutamax Life Technologies 
Glycerol Roth 
Glycin Roth 
HEPES Sigma-Aldrich 
HEPES-buffer Sigma-Aldrich 
HPLC water Life Technologies 
Isopropanol Roth 
Kanamycin K-1377 Sigma-Aldrich 
KCl Merck 
λ Marker Roche 
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Product Company 
MgATP Sigma-Aldrich 
NaCl Merck 
NaCHO3 Merck 
Na2HPO4 x 2H2O Merck 
NaH2PO4 x H2O Merck 
NEAA Life Technologies 
Neurobasal A Life Technologies 
NGS Panbiotech 
Olcegepant MedChem Express 
Optimem  Life Technologies 
PCR-buffer Sigma-Aldrich 
Penicillin Life Technologies 
Pepton Roth 
pfu-Polymerase Buffer Fermentas 
PDL Sigma-Aldrich 
Phenol Sigma-Aldrich 
RPMI Sigma-Aldrich 
Sodium pyruvate Life Technologies 
Streptomycin Life Technologies 
Sucrose Merck 
Trishydrochlorid Roth 
Triton X-100 Roth 
Uridin Sigma-Aldrich 
Water Sigma-Aldrich 
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II.1.2 Solutions 
II.1.2.1  Base- 10x (Tobias) + 40 mM NH4Cl 
NH4Cl, 40 mM, (0.427 g/l) 
NaCl, 1480 mM, (1.309 g/l) 
KCl, 24 mM, (0.035 g/l) 
HEPES, 100 mM, (0.0476 g/l) 
MgCl2 x 6H2O, 12 mM, (0.0487 g/l) 
CaCl2 x 2H2O, 25 mM, (0.0735 g/l) 
II.1.2.2 Blocking Solution (50 ml) 
NGS, 1.25 ml 
PBS, 48.75 ml 
II.1.2.3 S neurons Cell Culture Medium (50 ml) 
NBA, 45 ml 
FCS, 2.5ml 
Horse serum, 2.5 ml 
NGF, 100 µl 
FUDR, 500 µl 
II.1.2.4 DRG Intracellular Patch-Clamp Solution 
L-Aspartat, 135 mM 
MgCl2 x 6H2O, 1 mM 
HEPES, 10 mM 
CaCl2 x 2H2O, 3 mM 
Cs-EGTA, 5 mM 
MgATP, 2mM 
Na2GTP 0.3 mM 
pH: 7.2 
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Osmolarity: 300~315 mOsm 
II.1.2.5 DRG Extracellular Patch-Clamp Solution 
NaCl, 131 mM 
NaHCO3, 25 mM 
KCl, 2.5 mM 
NaH2PO4 x H2O, 1.25 mM 
MgCl2 x 6H2O, 1 mM 
CaCl2 x 2H2O, 2 mM 
Glucose, 10 mM 
pH: 7.4 (5% CO2 + 95% O2) 
Osmolarity, ~300 mOsm (with glucose) 
II.1.2.6 DRG Extracellular Solution 
NaCl, 147 mM 
KCl, 2.4 mM 
CaCl2 x 2H2O, 2.5 mM 
MgCl2 x 6H2O, 1.2 mM 
HEPES, 10 mM 
Glucose, 10 mM 
pH: 7.4 
Temperature: 34 °C 
Osmolarity: 300 mOsm (with glucose) 
II.1.2.7 DRG Cell Culture Medium 
NBA medium 
FCS 5% 
FUDR 10 µl/ml 
II.1.2.8 FUDR 
FUDR, 8.1 mM 
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Uridin, 20.5 mM 
DMEM 
II.1.2.9 HBS 2X Solution (100 ml) 
HEPES, 50 mM (1.19 g) 
NaCl, 280 mM (1.64 g) 
NaH2PO4, 1.5 mM (0.02 g) 
II.1.2.10 HEPES pH-Buffer Physiological Solution 
NaCl, 30 mM 
KCl, 100 mM 
MgCl2, 2 mM 
Glucose, 10 mM 
HEPES, 20 mM 
II.1.2.11 HEK Cell Culture Complete-Medium (100 ml) 
DMEM + 4.5 g/l Glutamax, 100 ml 
Sodium pyruvate, 1.1 ml 
NEAA, 1.1 ml 
FCS, 10 ml 
Penicillin/Streptomycin, 0.1 ml 
II.1.2.12 iB4 Staining Solution 
iB4 conjugated to Alexa-568, 1 mg/ml (5µl) 
Extra cellular solution, 2 ml 
II.1.2.13 LB-Medium 
Pepton, 8g 
Hefextrakt, 4g 
NaCl, 4 g 
H2O, 800 ml 
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II.1.2.14 Loading Buffer 
Sucrose, 4g 
Bromphenol blue 
Sigma H2O, 10 ml 
II.1.2.15 Liberase S neurons Digestion Solution 
Liberase DH, 2.3 U 
NBA, 1 ml 
II.1.2.16 Locke’s 10x Solution 
NaCl, 1.54 M 
KCl, 56 mM 
NaH2PO4 x H2O, 8.5 mM 
Na2HPO4 x 2H2O, 21.5 mM 
D-Glucose H2O, 100 mM 
II.1.2.17 MES pH-Buffer Physiological Solution 
NaCl, 30 mM 
KCl, 100 mM 
MgCl2, 2 mM 
Glucose, 10 mM 
HEPES, 20 mM 
II.1.2.18 Mounting Medium 
Mowiol 4-88, 2.4 g 
Glycerol, 6 g 
H2O double distilled, 6 ml 
Tris-Buffer, 12 ml 
pH: 8.5 
II.1.2.19 Neurobasal A-Medium 
NBA, 500 ml 
MATERIALS AND METHODS 
 
25 
 
B27, 5 ml 
Glutamax, 5 ml 
(This solution is either prepared with 1 ml of Penicillin/streptomycin or without antibiotics) 
II.1.2.20 Optimem 
Optimem, 44 ml 
Tryptosephosphate, 5 ml 
HEPES buffer, 1 ml 
Penicillin/Streptomycin, 50 µl 
BSA, 0.1 g 
II.1.2.21 Paraformaldehyde (15% PFA, 10 ml) 
PFA, 1.5 g 
Sigma H2O, 10 ml 
NaOH, 15 µl 
pH: 7.4 
II.1.2.22 PBS (1 l) 
Na2HPO4, 58 mM (10.3234 g/l) 
NaH2PO4, 17 mM (2.345 g/l) 
NaCl, 83 mM (4.850 g/l) 
II.1.2.23 Peptides-Blocking Solution 
L-70,606 oxalate salt hydrate (10 µM) 
BIBN 4096BS Olcegepant (10 nM) 
Cyclotraxin B (1 µM) 
NH4Cl, 40 mM, (0.427 g/l) 
NaCl, 1480 mM, (1.309 g/l) 
KCl, 24 mM, (0.035 g/l) 
HEPES, 100 mM, (0.0476 g/l) 
MgCl2 x 6H2O, 12 mM, (0.0487 g/l) 
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CaCl2 x 2H2O, 25 mM, (0.0735 g/l) 
II.1.2.24 Permeabilization Solution (50 ml) 
Triton x-100, 50 µl 
NGS, 1.25 ml 
PBS 1x, 48.25 ml 
II.1.2.25 PDL 
Poly-D-Lysin Hydrobromid, 0.5 mg/ml 
Sigma H2O 
II.1.2.26 Quenching Solution (50 mM Glycin) 
Glycin, 0.187 g 
PBS, 50 ml 
II.1.2.27 RPMI 
RPMI, 500 ml 
FCS, 50 ml 
Pen/Strep, 5.5 ml 
HEPES, 5.5 ml 
II.1.3 Enzymes 
Liberase DH Research Grade, Sigma-Aldrich from Roche 
Papain, Cellsystems, Worthington Biochemical Corporation 
TrypLEE Express, Gibco from Life Technologies 
Trypsin-EDTA, Invitrogen 
II.1.4  Antibiotics 
Ampicillin Na-Salz, Zchl/Roth Carl, K029.1. 
Pen/Strep, fisher scientific, 10452882. 
Nigericin sodium salt, Zchl/Sigma Aldrich, N7143-10 mg. 
Vancomycin, Zchl/Life Technologies, V-1644. 
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II.1.5  Bacteria and Cell Lines 
II.1.5.1 Bacteria 
DH5α: F– endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG purB20 φ80dlacZΔM15 
Δ(lacZYA-argF) U169, hsdR17 (rK–mK+), λ–. Invitrogen, Life Technologies. 
Stbl3: F- glnV44 recA13 mcrB mrr hsdS20 (rB-, mB-) ara-14 galK2 lacY1 proA2 rpsL20 xyl-5 
leu mtl-1. Invitrogen, Life Technologies. 
II.1.5.2 Cell Lines 
HEK 293FT. Life Technologies. 
II.1.6  Mouse Strains 
C57Bl/6N (Black 6), Stock No: 005304, The Jackson Laboratory 
129/svj, Stock No: 000691 | 129X1. The Jackson Laboratory 
II.1.7  Kits 
EndotFree Plasmid Maxi Kit, Qiagen 
EndoFree Plasmid Mini Kit, Qiagen 
QIAprep Spin Miniprep Kit, Qiagen 
QIAquick Gel Extraction Kit, Qiagen 
QIAquick PCR Purification Kit, Qiagen 
II.1.8  Cell Culture Products 
Product Lot # Company Size 
NBA (1x) 10888022 Gibco 500 ml 
B27 serum-free supplement (50x) 17504044 Gibco 10 ml 
Pen/Strep 15070-063 Gibco 100 ml 
FCS 10500-064 Gibco 500 ml 
HS P30-0701 PAN Biotech 100 ml 
NGF N-245 Alomone Labs 25 mg 
FUDR F0503 Sigma 100 mg 
PDL P0899 Sigma 50 mg 
BSA A8022 Sigma 1 g 
EBSS (+Ca +Mg) 24010043 Gibco 1 g 
Needle-Long (20 Gx23/4:0.9x70 mm) NN2070S Stoss Medica  
Needle-Thick (20Gx1 1/2 09x40 mm) NN2038R Stoss Medica  
Filter small-white (Acrodisc 13 mm 0.2 µm) PN4427T Life Sciences  
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Filter blue-green (32 mm 0.8/0.2 µm) 514-4136 VWR  
Filter white (0.2 µm) 514-0061 VWR  
Petri dish (150x20 mm) 821473 Sarstdet  
Petri dish (92x16 mm) 821473 Sarstdet  
 
 
 
 
II.1.9 Microscope Facilities 
II.1.9.1  Total Internal Reflection Fluorescence Microscope 
 Conventional epifluorescence microscopes are widely used to observe fluorescent samples. 
This technique comes at the cost of spatial resolution as the signal is highly affected by the sample 
brightness and the background fluorescence, which generates a fuzzy image. Meanwhile, confocal 
microscopes employ a Pinhole to limit the diffraction from backgrounds and foregrounds, it 
basically enables one to get specific emitted signals at specific depth but at the cost of speed. On 
the contrary, total internal reflection fluorescence microscopes (TIRFM) takes advantages of the 
properties of totally internally reflected lights which generates electromagnetic evanescent waves 
that illuminate fluorescent probes within a close proximity of the glass/water interface. With 
TIRFM, it is possible to achieve high spatial resolution with fast acquisition rates which enables 
high time resolution recordings, such as LDCV release from DRG neurons as well as synaptic 
transmission from DRG/S neurons co-cultures or any membrane-associated processes.  
TIRFM concept: 
TIRFM technique was initially developed by Danial Axelrod at the University of Michigan in 
beginning of 1980s (Axelrod, 1981). Whenever light passes through interface of two transparent 
media with different refractive indices it will be partially diffracted. Above a certain critical angle 
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of incidence, there will be 
total internal reflection 
inducing an 
electromagnetic field that 
pass through the interface 
forming and evanescent 
waves that decays 
exponentially with depth 
(Axelrod, 1981). Hence it 
excites fluorescent probes 
within the evanescent field 
and keeping the rest of the 
sample dark. The acquired 
images are therefore sharp 
and are not affected less by 
the fluorescence of other cell components or the background (Figure 13).  
Microscope general information: 
 The Olympus TIRFM IX70 microscope setup is custom made with several enhancements that 
enable a wide set of electrophysiological experiments to be performed. For instance it is provided 
with two perfusion systems, one being automated and the other is manual; the manual was heated 
while the other was controlled via a Warner Instruments valve control (model VC-6 VALVE). The 
microscope is equipped with an 100x objective featuring a high numerical aperture (1.45 NA) that 
is equipped with a correction collar to adjust for the thickness of the coverslip. The laser light 
passes through the objective, the immersion oil (n = 1.52), and is reflected at the interface between 
the glass coverslip and the extracellular solution (n ~ 1.33, Temp. 34 °C), achieving TIRF and an 
evanescent field that fades away exponentially with depth of 230 nm (Quintana et al., 2007). 
Excitation can be applied by two laser systems from Spectra-Physics (450, 488 and 514 nm – model 
285-FA11) and a second red (561 nm) laser from Melles Riot (model 85-YCA-615); as well as 
through a high speed visichrome polychromator (model 2261). The laser wave length is modulated 
by an Acousto Optical Tunable Filter (AOTF) from Visitron Systems (model VS AOTF-2). The 
setup is equipped with different AHF filter sets (green/red, UV, mTFP and yellow/red) and a 
Figure 13 Total internal reflection fluorescence microscopy concept.  
Unlike epifluorescence microscopes which covers the entire sample, Olympus 
TIRFM generates an evanescent field that penetrates to a restricted depth into 
the sample enabling to sharply visualize all the vesicles lying within this range. 
Graphical illustration: Abed Shaib. 
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QuantEM 512SC camera from Andor Technology Plc with Dual-View (565dcxr). The setup has 3 
sets of objectives, the 10x, 40x and 100x NA 1.45 Apochromat TIRF objective. The setup is 
operated by VisiView version 2.1.2 software from Visitron Systems. 
Electrical stimulation components: 
 Electrical stimulus was applied via a Stimulator from AM Systems. The Stimulator is connected 
to a custom-made bipolar field electrode that is supported by a micro-manipulator model SM-8 
from Luigs & Neumann Company. The original field electrode was purchased from MicroProbes 
(#PI2ST30.5B10) for Life Sciences, and was later subjected to manual enhancement by eroding 
the heated tapered end. Initially, the company produced only Heat Tappered field electrodes (H in 
Figure 14) that were not stable and air bubbles were generated whenever the applied stimulating 
voltage exceeds 2.5 V. At high voltage applied to a small surface area, the tip of the electrode heats 
which generates air bubbles that erode the tip. To counter this, I trimmed the tip of the electrode to 
approximately 60 µm in diameter and then applied 4 V to induce maximum DRG cells response. 
The electrode was stable enough to handle up to 10 V at 100 Hz without generating air bubbles6. 
The impedance of the field electrode was 0.1 Ω. The company later reported that they added a more 
                                                 
6 My findings were supported by a study of A. Petrossians presented in SFN Chicago, 2015. Talk citation: 
Nanosymposium – Electrodes Arrays III: N227 (talk 565.08: In-vivo characterization of Platinum-Iridium 
electroplated dbs electrodes). 
Figure 14 MicroProbes commercial field electrodes. 
A - Standard tip profile (25:1 Taper). Tungsten - Platinum/Iridium - Pure Iridium - Stainless Steel. 
H - Heat treated tapered tip profile (25:1 Taper). Tungsten - Platinum/Iridium - Pure Iridium Stainless Steel. 
F - Extra fine tip profile (40:1 Taper). Tungsten only. 
B - Blunted tip profile (25:1 Taper). Tungsten - Platinum/Iridium - Pure Iridium - Stainless Steel. 
Source: MicroProbes for Life Technologies. Link: www.science-products.com /Products/CatalogG/MPI-
Electrodes/MPI.html 
MATERIALS AND METHODS 
 
31 
 
recent bullet-shaped electrode product to their inventory as a result of the numerous feedback from 
many scientists. The exposed length of the wider tip would be less than the sharp long electrode 
that makes it with almost same impedance. Hence isolation can be improved since the blunt pointed 
structure is more stable and less subject to fractures compared to the Heat Tappered end electrode; 
claiming that this provides greater selectivity and more stability of the field electrodes upon high 
voltage vigorous stimuli. The composed material in the selected field electrode was an alloy of 
Platinum and Iridium. Platinum is one of the best highly-unreactive precious conductors of 
electricity but it has a disadvantage that it is malleable. To overcome the malleability of Platinum, 
it was mixed with Iridium, the latter is well known for its high density, it is the second densest 
element after Osmium. Iridium is corrosion-resistant and it can handle temperatures as high as 2000 
°C thus providing a good support to the good conductor Platinum, ensuring a stable break-resistant 
electrodes. The electrode was fixed to metal support exposing its tip and was eroded under 40x 
magnification using a sharp razor (Figure 15). The parylene layer was also removed from the tip 
to make sure it is well exposed so that the electricity is conducted to nearby cells. To test the 
electrode, a glass pipette with metal electrode connected to an oscilloscope was placed between the 
two field electrodes in a good conductor solution and 4 V stimulus was applied. Nearly, four volts 
Figure 15 Magnified image of the original Tappered electrode compared to the custom eroded one. 
In the first panel, the two tips of the field electrode are usually apart from each other with a distance ranging from 
250 to 300 µm. In the second panel, the tip is manually eroded using a sharp razor to make it wider and the 
parylene insulating paint is removed away from the eroded part. 
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were detected by the 
oscilloscope hence 
confirming the effectiveness 
of the stimulus (Figure 16). 
However, the applied voltage 
decays over distance as it 
moves away from the 
electrode poles. In ideal 
condition, if the voltage is 
fixed, the surface area of the 
pointed tip of the electrode 
stays the same and 
considering the material as 
excellent conductor, the 
electric field E would equal to 
voltage divided by distance: 
E=V/d 
E =
4
150
= 0.0267 V/µm  
  0.0267 =
V
50
→ V = 1. 33̅̅̅̅  V  for every 50 µm ∓1. 33̅̅̅̅   V 
As a second way of confirming the functionality of the field electrode, a more physiological test 
was used, whereby DRG neurons were loaded with a calcium dye Fluo-4 AM and 4 V stimulus 
was conducted. Upon depolarization, voltage-dependent calcium channels open, allowing the entry 
of Ca2+. Intracellular calcium concentration increase affecting the fluorescence intensity of Fluo-4. 
Cells in which the fluorescence intensity increased upon stimulation would be marked as 
responding cells to the electrical stimulus. The percentage of depolarized responding cells was 
measured (data is shown in Results chapter). A wider range of voltages were tested starting at 2.5 V 
to 7 V with 4 V having the highest number of responding cells.  
Recording of LDCV evoked release from DRG cultures: 
DRG neurons were transfected with a Lentivirus encoding for NPY-Venus 6 days prior to 
physiological measurements. NPY-Venus is semi-pH sensitive protein that fluoresces weakly at 
Figure 16 Bright field image captured at 100x magnification of DRG 
neuron culture showing field electrode adjustment.  
The real image was edited for display purpose to present the place of the 
pipette that was used to measure the voltage between the two poles of the 
electrode. In the real settings the glass pipette is outside the camera 
detection field. 
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the acidic pH of the vesicle lumen. Upon fusion of the vesicle with the plasma membrane the pH 
lumen neutralises thereby dequenching the fluorescence of Venus. This fluorescence "flash" helped 
me to identify fusion events. A mild stimulus of 4 V at frequency of 10 Hz was applied to the cells 
for 30 s followed by a stronger stimulus of 4 V at 100 Hz to effectively evoke LDCV release 
(Figure 17). Fusion events were recorded in TIRF mode at 514 nm (2% laser) with EM Gain of 
600 for 3 minutes. Exocytosis was essentially recognized by fast disappearance (>200 ms) of NPY-
Venus fluorescence. The number of fusion events were exclusively counted from DRG cell bodies. 
Fusion events may be underestimated as unclear fusion events were dropped in all measured sets. 
To assure the functionality of the field electrode, it was regularly tested every 3 to 4 months with 
calcium imaging and it was replaced with a new electrode every 8 to 9 months as it erodes 
with time. 
 
 
Figure 17 Stimulation protocol to induce LDCV release. 
DRG neurons were transfected with NPY-Venus to visualize exocytosis using 100X objective and excited at514 nm. 
TIRF movies were recorded for 3 minutes. Transfected DRG neurons were stimulated with bipolar field electrode to 
elicit LDCV secretion. The stimulation starts at 10 Hz for 30 sec and followed by 100 Hz, both of which are at 4 V 
intensity, having bipolar pulse width of 3 ms and inter-bipolar pulse duration of 10 ms. The recordings were made 
at 37 °C. 
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SV evoked release recordings from DRG/S neuron co-cultures: 
DRG/S neuron co-cultures were necessary for establishing functional synapses, more 
details would be provided in the Results and Discussion chapters. 24 hrs after taking the DRG 
neurons in culture, we added a Lentivirus encoding for Synaptophysin pHluorin (SypHy) BL-47 
purchased from Viral Core Facility in Berlin. The superecliptic pHluorin was fused to the second 
intravesicular loop of synaptophysin (Granseth et al., 2006). On the third DIV, SypHy was removed 
Figure 18 Synaptic transmission stimulus protocol. 
(A) Graphical illustration of DRG/S neuron co-cultures. DRG neurons extend processes towards S neurons and form 
synapses on their cell bodies as well as on the processes. Upon applying 4 V at 10 Hz stimulus, synaptic vesicles fuse, 
SypHy is exposed to the neutral pH and hence the fluorescence signal increases. Single ROI (red circle) marks 
individual synapses to measure the mean gray value and plot their fluorescence over time. (B) Bright field image of 
DRG/S neuron co-culture acquired at 100x. (C) Snapshot from DRG/S neuron movie acquired at 488 nm in TIRFM. 
(D) Average fluorescent intensity graph of all the synapses displayed with SEM plotted against time. 4 V stimulus at 
10 Hz was applied after 30 seconds of recording for 1 min, then the synapses were left to recover. After 4 min of 
recording, NH4Cl was applied to deprotonate the vesicles at synapses and induce the maximum increase in 
fluorescence signal. Error bars in (D) are SEM. 
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and S neurons were added, thus ensuring that only synapses formed from DRG neurons onto 
S neurons were marked with SypHy, excluding the S neurons/S neurons synapses. DRG/S neurons 
were maintained 9 DIV together before any measurements were carried out. Five minutes 
recording in semi-TIRF mode (a border state between epifluorescence and TIRF acquisition, 
achieving higher signal to noise ratio) was performed. Semi-TIRF acquisitions were necessary to 
include processes and synapses outside the TIRF field. Thirty seconds were recorded prior to a 4 
V at 10 Hz stimulus that was applied for 1 min. Then the synapses were allowed to recover for 3 
min before NH4Cl was applied manually to deprotonate all the vesicles and highlight all synapses 
with maximum intensity. The maximum synapse fluorescence signal after NH4Cl application was 
used to normalize individual synapse response to the stimulus. A ten Hertz stimulus was previously 
in rat hippocampal neurons and cat superior cervical ganglion cells (Applegate and Landfield, 
1988; Pysh and Wiley, 1974). The first reported usage of an external field electrode to stimulate 
DRG/S neuron co-cultures with 10 Hz stimulus date back to mid-80s whereby (Jahr and Jessell, 
1985) showed that glutamate, or a glutamate-like compound is the excitatory transmitter that 
mediates fast excitatory postsynaptic potentials in these types of synapses. For carrying out the 
synaptic transmission experiments, I tested several stimuli, 5 Hz, 10 Hz, 20 Hz and 100 Hz in 
hippocampal and DRG/S neuron. I found that the best stimulus is 4 V at 10 Hz, as I had the 
maximum response with the smallest possible stimulus. 
 
II.1.9.2  Confocal Laser Scanning Microscope   
Laser scanning microscopes (LSM) are able to scan samples either sequentially point by 
point, or multiple points at once whereby the information contained in electrical signals is digitized 
and is integrated into an acquired high optical resolution image. The microscope that I used is 
driven by Zeiss Efficient Navigation (ZEN) 2011 SP27 software that helps in setting the desired 
acquisition parameters to visualize samples. 
LSM concept: 
Sixty years ago, Hiroto Naora was the first to practically use confocal optics by direct 
supervision of Zyun Koana (Naora, 1951). They didn’t generate images but rather used it in high 
                                                 
7 Black edition, version 8.0 
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resolution micro-spectrophotometry. Ten years later, Marvin Minsky took advantage of that and 
added a scanning stage, building a microscope that can acquire images and filed a patent in 1957 
without any scientific publications. LSM improved over time, but it took 30 years to become widely 
available as tool for obtaining High resolution optical images with depth selection, acquiring 
images focused to certain depth, a process called optical sectioning. Obtaining the data at different 
z-levels allows 3-D reconstructions of complex samples. The depth of scanning depends on the 
amount of light that can penetrate the tissues at a given time. Confocal LSMs send a laser beam 
that passes through aperture and then is focused by an objective lens within the surface of the 
fluorescent sample. The reflected laser and fluorescent light from the sample goes back through 
the objective lens and then into the beam splitter that sends part of the signal to a detection system. 
The original excitation wavelength is blocked and only the emitted signal is detected after passing 
through a Pinhole with desired Airy Units and finally to the photomultiplier tube (PMT); changing 
the emitted light signal into digital electrical one and hence digitizing an acquired data into high 
resolution image8. 
LSM 780 microscope general info: 
The microscope is provided with several sets of objectives: 
- 10x dry objective, NA 0.3, EC Plan-Neofluar, M279, Yellow ring color. 
- 20x multi-immersion objective, NA 0.8, Plan-Apochromat, M27, Red/Green ring color. 
- 40x water immersion objective, NA 1.2, C-Apochromat, M27, Blue ring color. 
- 63x oil immersion objective, NA 1.4, Plan-Apochromat, M27, Black ring color. 
- 100x oil immersion objective, NA 1.45, Alpha Plan-Fluar, M27, White ring color. 
- APO Calibration LSM. 
Stage control: 
Controlling the loading and navigation through the sample can be done by an X-Y joystick. The 
focus can be adjusted through a side wheel and the desired focal plane can be saved so that it is 
possible to be loaded automatically for the next sample.  
                                                 
8 Technical information was revised according to “Confocal Basic Concepts” lecture from Nikon by: Stephen W. 
Paddock - Laboratory of Molecular Biology, University of Wisconsin, Madison, Wisconsin 53706 and Thomas J. 
Fellers and Michael W. Davidson - National High Magnetic Field Laboratory, 1800 East Paul Dirac Dr., The Florida 
State University, Tallahassee, Florida, 32310. 
9 Thread type.  
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Fluorescence lamp and bright field: 
It is possible to choose between bright field and fluorescence view at the eyepieces while in 
‘Locate’ configuration mode simply by turning on the X-Cite lamp 120PC Q and setting the desired 
filter. Open the lamp shutter with minimal lamp power of 12% to maximum 100% and the sample 
is ready for inspection. Once the intended area of acquisition is defined, hit the light-off to avoid 
photobleaching and switch the configuration mode into ‘Acquisition’. 
Acquisition configuration: 
It is possible through ZEN to devise acquisition parameters from scratch, reuse existing 
configuration or select ‘Smart Setup’ rather than using your own dyes mix with manual 
excitation/emission cut. Live scan settings provides the possibility to acquire at different 
wavelength excitations: Diode 405, Argon 458, HR Diode 488, HR Diode 514, HR DPSS10 561, 
HeNe 633 and HR Diode 642 nm lasers. For every laser, ‘Gain Master’, ‘Digital Offset’ and 
‘Digital Gain’ can be defined as well as the addition of a bright field image (T-PMT) for every 
wave length while a uniform ‘Pinhole’ Airy Units is selected for all channels. Once the channels 
set, Zen also enables to define the ‘Scan Mode’, ‘Frame Size’, ‘Line Step’, ‘Speed’ and/or ‘Pixel 
Dwell’ time, ‘Bit Depth’ and the ‘Averaging Number, Mode and Method’. The size of the scanned 
area can be defined by ‘Scan Area’ panel, a smaller area means lesser acquisition time, a feature 
than can be useful for fast acquisition purposes. There are four scanning possibilities: ‘Live’ as fast 
and continuous scan, ‘Continuous’ for high quality continuous scan but with lesser speed compared 
to ‘Live’, ‘Snap’ to acquire an image with the desired parameters and ‘Do Experiment’ to start the 
acquisition with the selected parameters for a defined number of cycles. While ZEN enables to 
acquire several cycles, it is also possible to do a Z-stack at several positions as a Tile scan at 
different selected positions with the option of correcting focus via infra-red adjustments of the focal 
plane. A slow feature (~ 17 sec) but recommended for long acquisition time to maintain the focal 
plane of interest during the recording. The ‘Z-series’ panel encompasses several options that 
enables the user to select the number of slices at which interval as well the last and first slice to be 
acquired. ‘Tile’ scan panel have several options to determine the regions of interest to be scanned 
as well the possibility of ‘Live stitching’ the acquired tiles with a certain percentage of image 
overlap. The acquired data can be represented in various ways and real time channel and color edit 
                                                 
10 High Repetition rate Diode Pumped solid State Laser. 
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can be applied by stretching collective or individual channel stretch. Areas can be cropped and 
ROIs can be defined and pixel intensities can be measured and displayed in graphs while Live 
acquisition. 2-D or 3-D displays are available and there is a special panel for the metadata. Confocal 
imaging was mainly used during my study for ICC experiments, pH study experiments and real 
time long recording of growth cones movement analysis and synapse formation between DRG and 
S neurons. 
LSM perfusion/suction system: 
The perfusion system was built by Dr. Elmar Krause and myself. The system was optimized in 
such a way to provide six solutions delivered sequentially or simultaneously. Four are automated 
and controlled with an electronic valve that can be switched on and off sequentially or 
simultaneously by a controller and two that are switched on manually by turning a knob 
independently. The perfusion is delivered to the specimen in glass pipette with a tilt angle that can 
be adjusted. The suction system end point is a glass pipette designed in such a way that keeps 
solution at its spherical bottom and sucks the extra solution out from a hole that is situated above 
the spherical bottom by 2 mm. This was necessary to eliminate desiccation of the sample due to 
surface tension and to reduce volume variation in the chamber which alter the focal plane and affect 
the recordings. The perfusion system specifications are as follows: 
- Automated perfusion speed: 144 ± 5 µl/s 
- Manual perfusion speed: 140  ± 5 µl/s 
- Suction speed: 404.4 µl/s 
- Dead-volume: ~ 241 µl 
Perfusion mixing was simulated in similar conditions of the built LSM perfusion system using 
water and Brilliant Black dye to ensure that the mixing covers the entire chamber and not just the 
surface as well as to test whether bubbles are generated or not. 
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II.1.9.3  Structured Illumination Microscope 
Hundred years ago, (Abbe, 1873) showed that 
optical microscopes have limited lateral resolution 
because of the finite wavelength of light. Unlike 
confocal microscopy, the super-resolution structured 
illuminated microscopy (SIM) can achieve a lateral 
resolution well beyond the classical limit without 
discarding light emission through a pinhole (Gustafsson, 
1997; Heintzmann, 1998). 
SIM concept: 
SIM works in a very similar fashion to moiré effect. 
When two or more patterns are slightly tilted in angle 
and superimposed above each other, moiré fringes are 
formed (Figure 8). Similarly, in probes with fluorescent 
signal, SIM applies structured illumination locally at the 
place of interest. This generates a pattern that contains 
moiré fringes proportional to the original pattern but 
much coarser in size because of the limit of light point spread function. But these fringes contain 
information about these structures that can resolve out high resolution information after processing 
the acquired raw data. Specialized algorithms, extract information thereby increasing the axial 
resolution - theoretically - up to 100 nm that is twice the light diffraction limit11. Images of Zeiss 
SIM microscopes can be acquired with up to 5 individual subsets (Grating 1 to 5) with a 60° rotation 
between every captured image set. The higher the grating the sharper the image one can get. As a 
consequence of higher grating, the acquisition speed is dramatically prolonged. SIM importance 
lies in its ability to generate high resolution images by its practical power in resolving signal to 
noise ratio. Starting with a wide-field microscope with inexpensive lasers and saturated structured-
illuminated scanning, SIM microscopes in ideal world can surpass the diffraction limit and go up 
                                                 
11 Superresolution Structured Illumination Microscopy. Contributing authors: Tony B. Gines and Michael W. 
Davidson, National High Magnetic Field Laboratory, 1800 East Paul Dirac Dr., The Florida State University, 
Tallahassee, Florida, 32310. 
Figure 19 Moiré pattern. 
Two sets of parallel lines with one set being 
slightly inclined and superimposed above the 
other creating a Moiré effect. 
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to 50 nm in resolution whenever there is bright fluorescence and photostable probes (Gustafsson, 
2000, 2005). 
PALM12/ELYRA PS.1 microscope general info: 
The microscope is provided by 3 objectives: 
- 63x oil immersion objective, NA 1.4, Plan-Apochromat, DIC13 M27, Black ring color. 
- 100x oil immersion objective, NA 1.46, alpha Plan-Apochromat, DIC M27 Elyra. 
- 100x oil immersion objective, NA 1.57, alpha Plan-Apochromat, DIC Korr14 M27 Elyra. 
The setup is provided by ZEN 2011 SP315 to operate the microscope, the navigation is very much 
similar to the installed Zen on LSM 780. There are 4 different excitation wave lengths possible on 
ELYRA: HR Diode 405, 488 and 642 nm lasers as well as HR DPSS 561 nm laser. ‘Z-Stack’, 
‘Time Series’, ‘Tile Scan’, ‘Positions’ and ‘Regions’ are adjustable very similarly as in ZEN SP2. 
Image ‘Bit Depth’ can go up to 16 Bit and ‘Averaging’ ranges from 2 till 16 and ‘Continuous’. 
‘Grating’ is possible with 1, 2, 3, 4 or 5 rotations. Experiment acquisition is possible with 4 
channels at a time, each having its ‘EMCCD16 gain’, ‘Digital gain’ and laser wavelength and power. 
The previously mentioned LSM 780 setup is also equipped with ELYRA SIM; just by selecting 
the SIM panel in ZEN, the microscope is ready to acquire data in SIM mode. 
II.1.10  Devices 
The devices were mostly used in Prof. Jens Rettig lab, otherwise it is stated.  
Device Company 
Axiovert 200 microscope Zeiss 
Balance BP 1215 Sartorius 
Bath incubator Memmert 
Centrifuge mini 3-1810 NeoLab 
Centrifuge 5415 C Eppendorf 
Centrifuge 5415 D Eppendorf 
                                                 
12 Superresolution Photoactivated Localization Microscopy. 
13 Differential Interference Contrast. 
14 Correction Ring. 
15 Black edition version 8.1.5. 
16 EMCCD is a quantitative digital camera technology that is capable of detecting single photon events whilst 
maintaining high Quantum Efficiency, from Andor Technology Plc. 
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Centrifuge 5415 R Fast cool Eppendorf 
Centrifuge 5424 Eppendorf 
Centrifuge 5702 R Eppendorf 
Centrifuge 5804 R Eppendorf 
Centrifuge Fresco 17 Thermo Scientific 
Centrifuge Heraeus Labofuge 400 R Thermo Scientific 
Centrifuge mini spin plus Eppendorf 
Centrifuge small Eppendorf 
Combimag RCT IKA 
Eclipse TS 100 microscope Nikon 
Fluor chem M revelation machine ProteinSimple 
FT-14 UV screen Fisher brand 
Fridge 4 °C/-20 °C Liebherr premium 
Hera cell 150i CO2 incubator Thermo Scientific 
Hera Freeze Heraeus -80 °C freezer Thermo Scientific 
Hera Freeze HFUB -80 °C freezer Thermo Scientific 
Hera guard eco Thermo Scientific 
Hera safe cell culture hood Thermo Scientific 
KL 1500 light source Schott 
Master cycler personal Eppendorf 
Master cycler gradient Eppendorf 
Micro-Forge World Precision Instruments Inc. 
Microwave Sererin 
MS2 minishaker IKA 
MSC-Advantage hood Thermo Scientific 
Peq Power PeqLab 
Peq Star PeqLab 
pH meter Scaott 
Power Pac BioRAD 
P-touch 2420 PC Brother 
Puller P-97 Shutter instruments 
RCT basic IKA 
UV-chamber Lab custom-built 
Vortex mixer 7-2020 NeoLab 
Wescor osmometer Kreienbaum 
Wild M3Z dissection microscope Heerbrugg Switzerland 
II.1.11 Consumables 
Product Company 
6-well plate Becton Dickinson (BD) 
6-well plate 3506 Corning Incorporated 
Amicon Ultra-15 centrifugal  filters (100,000 NMWL) Merck Millipore 
Cell-culture flask Becton Dickinson (BD) 
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Coverslip (25 mm) Fiser Scientific 
Coverslip (25 mm) High Precision Marienfled 
Eppendorf 1 ml tube Eppendorf 
Eppendorf safe-lock 2 ml tube Eppendorf  
Multiply µstrip 0.2 ml chain PCR tubes Sarstedt 
One-way pipette 2 ml and 25 ml Falcon 
One-way pipette 5 ml and 10 ml Greine bio-one 
Petri dish (35 mm)  Becton Dickinson (BD) 
Petri dish (92 mm, 150 mm) Sarstedt 
Plastic Pasteur Pipette (0.5, 2, 3 & 5 ml) Ratiolab 
Pipette tips (10 µl) FilterTips Clear Line 
Pipette tips (2-20 µl) Biosphere filter tips Sarstedt 
Pipette tips (1-200 µl) Top-Lipe-Filter-Tips Micro pore filter technology 
Pipette tips (100-1000 µl) Quality pipette tips Sarstedt 
Pipette tips 5 ml Eppendorf 
 
II.1.12 Companies 
Abcam: Cambridge, United Kingdom. Adobe: San Jose, California, United States. AHF: 
Tübingen, Germany. Becton Dickinson: Hidelberg, Germany. Corel: Ottawa, Canada. Cell 
Signaling Technolgies: Danvers, United States. Eppendorf: Hambur, Germany. Fermentas: St. 
Leon-Rot, Germany. Fisher Scientific: Schwerte, Germany. Greiner Bio-One: Frickenhausen, 
Germany. HEKA: Lambercht, Germany. Life Technologies: Darmstadt, Germany. MedChem 
Express: New Jersy, United States. Merck: Mannheim, Germany. Microsoft: Berlin, Germany. 
New England Biolabs: Frankfurt, Germany. Olympus: Hamburg, Germany. Panbiotech: 
Aidenbach, Germany. Photometrics: Tucson, United States. QIAGEN: Hilden, Germany. Roche: 
Grenzach Wyhlen, Germany. Roth: Karlsruhe, Germany. Sarstedt: Nümbrecht, Germany. 
Sartorius: Göttingen, Germany. Schott: Mainz, Germany. Sigma Aldrich: Steinheim, Germany. 
Systat Software Inc.: San Jose, California, United States. Spectraphysics: Darmstadt, Germany. 
The Jackson Laboratory: Bar, Harbor, Maine, United States. Thermo Fisher Scientific: 
Schwerte, Germany. Thomson Reuters: Toronto, Canada. Tocris: Bristol, United Kingdom. 
Visitron Systems: Puchheim, Germany. Warner Instruments: Hamden, United States. 
Wavemetrics: Lake Oswego, United States. Wescor: Logan, United States. World Precision 
Instruments: Berlin, Germany. Zeiss: Jena, Germany. 
 
II.1.13 Software 
 
Adobe Bridge CS5, version 4.0.0529, Adobe Systems Incorporated. 
 
Adobe Photoshop CS5, Adobe Systems Incorporated. 
 
A plasmid Editor (ApE), version 1.17, M. Wayne Davis. 
 CorelDRAW, version 16.1.0.843, Corel Corporation. 
 EasyTrack 2014, Detlef Hof. 
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ImageJ, National Institutes of Health, Federal Government of USA. 
 Igor, version 6.0.4.0, WaveMetrics Inc. 
 
Metamorph, Molecular Devices. 
 
Office 2013, Microsoft. 
 
VisiView, Visitron Systems GmbH. 
 
Pulse, HEKA Elektronik. 
 SigmaPlot Version 13, Systat Software, Inc. 
 SnapGene Viewer 2.8, GSL Biotech LLC 
 Zeiss Efficient Navigator (Zen) 2012, Carl Zeiss. 
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II.2 Methods 
II.2.1 Adult DRG Cell-Culture 
DRG neuronal cell culture is an excellent 
model to study the pathogenic mechanisms of the 
peripheral nervous system and establish new 
therapeutic compounds. These cultures provide a 
powerful tools to study neurodevelopment, neurite 
and axon formation, neuropeptides and 
neurotrophic factors release, neurotransmitter 
release, synapse formation, electrical signaling 
and exocytosis(Melli and Hoke, 2009). Adult 
DRG neurons are superior to embryonic and 
postnatal DRG neurons in terms of survival where 
they survive for 6 DIV and starts gradually to age 
and die while embryonic DRG neurons die much 
faster (Horie and Kim, 1984; Scott, 1977). Our 
group optimized mouse DRG neuronal culture 
whereby the adult cells can live up to 35 DIV, 
consistent with the results of others (Malin et al., 
2007) and embryonic/postnatal DRG neurons can 
survive up to 15 DIV. We performed experiments 
with DRG neurons that were maintained for not 
more than 11 DIV (data explaining why, is shown in the Results chapter). Therefore, we can safely 
assume that the current preparation protocol is fully optimized with the least stress possible on the 
cells to give reproducible results in our experiments. DRGs can be either dissociated by Trypsin 
enzyme or directly seeded onto culture dishes (Horie and Kim, 1984); we chose to dissociate them 
Figure 20 Schematic view of preparation of 
dissociated and explant DRG sensory neuronal 
cultures. 
Source: Expert Opin Drug Discov. 2009 Oct 1; 4(10): 
1035–1045. doi:  10.1517/17460440903266829. 
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(Figure 20) to be able to study exocytosis of LDCVs and SVs at individual cell level. One day 
before the cell culture, coverslips were coated in a 6-well plates with a 3.3 µM aqueous poly D 
lysine solution applied to their center. The 6-well plate is then placed in the incubator. The cell 
culture medium is prepared ahead of time and placed in the incubator so that it adjusts its pH to 
7.4. On the day of cell culture preparation, the Poly-D-Lysine is washed away. PDL, might be toxic 
for the cells if used at high concentrations therefore it should be removed carefully by washing 
each coverslip 2 times with 300 µl Sigma water. Both PDL and Poly-L-Lysine (PLL) promote 
neurite growth in low-density cultures but the D isomer minimizes the aggregation of neurons 
better than the L isomer (Brewer and Cotman, 1989). After washing, the 6-well plate is placed with 
an open lid in the UV chamber for 15 min. The enzymatic digestion solution was prepared with 1 
Figure 21 DRG isolation. 
 Individual DRG are isolated from bony foramen pocket-like structures (gray arrows) and transferred to a Petri dish 
with Lockes solution. The yellow arrow points to the the lumbar section after wich DRG isolation become nearly 
impossible because of their small size it gets. The entire isolation should be carried out within 50 min, to ensure good 
quality of cells. Afterwards DRGs are transferred to a Petri plate with TrypLE Express and incubated for 10 min before 
proceeding with digestion. 
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ml NBA medium that was complemented with 2.31U/mg Unit Liberase and sterile filtered. 
Meanwhile a Petri dish with a 200 µl drop of Locke’s solution and a Petri dish with 200 µl TrypLE 
Express were prepared and placed under the hood. When the UV sterilisation of the coated 
coverslip was over, the remaining water was washed out two times with 50 µl NBA-medium. Later, 
2 ml of cell culture medium were added per well and the plate is placed in the incubator (37°C, 5% 
CO2). Adult mice were sacrificed according to the German Animal Welfare Act
17. Animals were 
placed in transparent glass chamber and CO2 was introduced gradually until the animal was 
unconscious. Unconscious animals were killed by decapitation (adult mice) or cervical dislocation 
(pregnant mice for caesarean-section). After ethanol disinfection, the skin over the spine is 
removed. The tissues surrounding the spine are also removed and the spine is incised at the level 
of the back legs as shown in figure 21. The posterior part of the spine is removed away along with 
the spinal marrow. DRGs are isolated and placed in a Petri dish with Locke’s solution. The entire 
process was completed within 50 min. The DRGs were transferred into the prepared Petri dish with 
TrypLE Express solution to allow slow enzymatic dissociation of the DRG connective tissues 
capsule. DRGs are then transferred into a freshly prepared digestion solution and placed in water 
bath (37 °C) with gentle shaking. The DRG tissue was triturate 10 times with a 1 ml pipette. This 
step was repeated 4 times. In the last step the cells were triturated 15 times. Overall the digestion 
period was 20 to 22 min. Digestion was stopped by adding 100 µl FCS. The cell suspension was 
then centrifuged for 4 min at 3000 rpm. The supernatant is removed and the cells were washed by 
adding 600 µl of DPBS. They were centrifuged again for 4 min at 3000 rpm. The supernant was 
removed and 600 µl of cell culture medium with Pen/Strep were added. The cells were plated onto 
the coverslips and placed in the incubator. 
 
II.2.2 Embryonic DRG Cell-Culture 
All LDCV release experiments were done on adult DRG neurons, with the exception of 
CAPS1 and 2 dKO and CAPS 1 KO mice. Mice lacking either CAPS1 (Speidel et al., 2005) or 
both CAPS1 and 2 are not viable and they die right after birth. Genotypes were verified by PCR 
using primers as described in (Jockusch et al., 2007; Speidel et al., 2005). To study the effect of 
                                                 
17 Adopted in May 25, 1998. Primary citation: Federal Law Gazette I, p. 1094. 
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the absence of both CAPS isoforms on LDCV release as well as synaptic transmission, it was 
necessary to carry out these experiments in embryonic DRGs. Embryonic DRG cell-cultures were 
prepared in very similar fashion to adult and postnatal DRG neurons protocol but with minor 
changes. Pregnant mice were sacrificed according to Animal Welfare Act and babies were removed 
by a C-section. All the cell culture procedures are similar to that of adult culture preparation until 
the isolation step, where 350 µl of TrypLE is directly added onto the Petri dish having the DRGs 
in Lockes solution. After 5 min of incubation, with 1 ml tip pipette, DRGs are transferred into the 
Liberase digestion solution. Trituration is required during the entire digestion process which lasts 
between 2.5 to 3 min, depending on the age of embryo whether its E18 or almost P0 right before 
birth. Digestion is stopped by adding 200 µl FCS. Cells are centrifuged and later washed with PBS 
as described in adult DRG prep. The cells were plated on the center of the coverslip and they were 
given 10 min under sterile hood to settle down. Then 2 ml of NBA with Pen/Strep was added and 
the culture was place in the incubator. 
 
II.2.3 DRG/S neuron Co-Culture 
DRG neurons don’t form synapses on their own in vivo or in cultures (Ransom et al., 1977a; 
Ransom et al., 1977b; Wake et al., 2015) rather, they do form synapses with their natural synapse-
forming partner the dorsal and ventral horn neurons (Joseph et al., 2010). To study synaptic 
transmission, it was necessary to establish the DRG/S neuron co-culture system at our laboratory, 
because they are fundamental to study interactions between cell populations. Cell-cell interactions 
in co-cultures are affected by extracellular surrounding; for cell survival, the culture protocol needs 
to be given careful consideration (Goers et al., 2014). Amy MacDermott and her colleagues were 
among the first to study synaptic properties of DRG/S neuron co-cultures (Gu and MacDermott, 
1997; Labrakakis et al., 2000). Because these co-cultures are very complex to establish, only very 
few laboratories based in New York, Wisconsin, Southern Illinois, London and Taketoyo have 
worked with (Cao et al., 2009; Hendrich et al., 2012; Joseph et al., 2011; Ohshiro et al., 2007; Yu 
et al., 2015). DRG/S neuron co-cultures are prepared in two separate steps. DRG prep was carried 
out as previously described. On the second day, DRG neurons are either transfected with the 
required Lentivirus of interest or not. On the third day, the S neurons were added on the DRG 
neurons and left together 9 DIV before carrying out synaptic transmission experiments. To extract 
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S neurons, P0 to P1 old mice were sacrificed by decapitation. The skin of the mice was sterilized 
with ethanol and the tissues on the back were cleared to expose the upper part of the spinal cord. 
The lower limbs of the pup were cut and a 21 G syringe capillary filled with EBS solution was 
placed on the upper part of the exposed spinal cord and a pressure was applied to eject the spinal 
cord tissue out. The spinal cord tissue was then transferred to a Carbogen-bubbled EBS solution to 
wash away the sucrosefor optimized papaine activity. Later on, the tissue was digested using 
enzymatic solution consisting of 5 ml DMEM, 10 mg L-Cystein, 100 mM CaCl2 0.5 ml, 50 mM 
EDTA and Papain 20 U/ml. The digestion was carried on at 37°C under constant oxygenation for 
30 min. Mechanical dissociation was needed after the enzymatic treatment is over. To do so, 1 ml 
of S neurons cell culture medium was added to stop digestion. The solution was triturated gently 
5 times and with slightly more pressure 2 times using 1 ml tip, then the tube was left upstanding 
for the precipitation of the tissue. Later, 1 ml of medium was added and then a 5 min centrifugation 
at 800 rpm was applied. The supernatant was discarded and 1 ml of filtered 1/1 solution containing 
Dnase, BSA, Trypsin inhibitor and EBSS was added. Trituration was applied 3-4 times and then 
centrifuged again for 5 min at 800 rpm. The previous step was repeated for a second time and the 
tissue was centrifuged again. The supernatant was again discarded the cells were resuspended fresh 
culture medium. The cells were plated on the coverslips (100 µl per well). The 6-well plate was 
placed in CO2 incubator. On the next day, two thirds of the medium in the wells was discarded and 
replaced with a new fresh medium containing FUDR.  
II.2.4 ICC 
Immunocytochemistry is a technique used to localize targets of interest at cellular level. In 
1941, (Coons, 1941) published the first report describing immunofluorescence antibodies and till 
now this technique is widely used across different labs and is  known as ICC. The idea is to use a 
specific primary antibody against the targeted substance and a secondary fluorescently labelled 
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antibody against the primary antibody to visualize it under the microscope (Ooij, 2009). The 
following ICC protocol was optimized for DRG cultures and DRG/S neuron co-cultures. Special 
steps were implemented to enhance the signal to noise ratio. To fix the cells, the medium was 
removed and the coverslips were washed one time with PBS containing 100 mM CaCl2 and 25 mM 
MgCl2 to improve adhesion of the cells to the coverslip. This PBS was used for the rest of the ICC 
procedure. The cells were fixed in 4% ice-cold Paraformaldehyde in PBS of pH 7.4 for 20 min at 
room temperature or overnight at 4°C in the dark. Some experiments needed 2% PFA for 5 min to 
maintain the fragile structures of the fixed target of interest intact (such as synapses). Then the 
coverslips were washed three times with PBS for 2-5 min. All washing steps were done as quickly 
as possible, to prevent the cells on the coverslip from drying out. Samples were quenched with 
50 mM Glycin in PBS for 10 min. Later, the Glycin is washed out with PBS three times for 2-5 
min each. To permeabilize the cells, PBS containing 0.1% Triton-X-100 and 2.5% NGS was added 
for 30 min at room temperature. In an optional step, it is recommended to add 4 drops of iT-FX18 
to decrease background noise. iT-FX eliminates background staining therefore enhancing the 
signal-to-noise ratio of stained cells. It blocks nonspecific interactions of fluorescent dyes with cell 
constituents. I tested it separately to verify how effective it was and it did indeed significantly 
reduce the cell autofluorescence of DRG neurons when excited at 561 nm. Figure 17 shows the 
                                                 
18 Image enhancer from Life Technologies. 
Figure 22 Image iT-FX Signal 
Enhancer effect on auto-
fluorescence.  
DRG culture was prepared from 2 
weeks old WT mouse and cells 
were fixed after 7 DIV with 4% PFA 
for 20 minutes. Fixed DRGs were 
permeabilized with 0.1% Triton 
and stained with secondary 
antibody Alexa 561 and visualized 
at 561 nm wavelength using 
confocal microscopy. (A) DRG cells 
stained the classical way. (B) iT-FX 
Signal Enhancer was added during 
the permeabilization step for 30 
min. 
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autofluorescence of DRG neurons in comparison to DRG neurons that were treated for 30 minutes 
with iT-FX signal enhancer. To block unspecific free epitopes, the coverslips were washed two 
times with PBS/2.5% NGS for 2-5 min. The primary antibody was diluted to the working 
concentration in PBS containing 2.5% NGS. In a wet chamber, 100 µL diluted primary antibody 
solution was placed on a piece of parafilm for each coverslip which was flipped on it with the cell 
side facing the antibody drop. The wet chamber was incubated for 1 h at room temperature or 4 °C 
over night. After the incubation was over, the coverslips were washed with PBS/2.5% NGS/0.1% 
Triton for 2-5 min. The secondary antibody (1:2000 Alexa 405/488/568/633/647-conjugated 
antibody) was diluted in PBS/2.5% NGS and kept in the dark. To avoid background, the diluted 
secondary antibody should be centrifuged at 13000g for 10 min at 4°C. The samples were incubated 
with the secondary antibody for 45 min in dark at room temperature and the cells were washed 
5 times with PBS/2.5% NGS/0.1% Triton for 2-5 min after the incubation period is over. 
Additional 2 times washing steps with PBS is required. Finally, to mount the coverslip to the glass 
slide, 20 µL mounting medium were added on the microscope slide. The coverslips were then 
dipped in distilled water to reduce salts and excess water was removed by gentle touching the 
coverslip to a fine tissue paper. The coverslips were then mounted upside-down whereby the cells 
were embedded in the mounting medium and left to dry for 3 hours at room temperature or 15 min 
at 37 °C while covered with Aluminum foil. The edges of the coverslips were then sealed with nail 
polish to protect the sample from over drying. The sealed samples were stored at -20 °C or 4 °C in 
dark. For all experiments, the samples were imaged at the same day or latest next day in the 
morning to maintain good quality. When 2% PFA fixation for 5 min was applied, the samples were 
exclusively imaged on the fixation and staining day as the samples were fragile and degrade within 
10 to 15 hours. 
 
II.2.5 Double ICC 
To be able to visualize co-distribution of two or more different targets in the same sample 
using primary antibodies raised in the same species, double ICC is needed with an intermediate 
‘blocking’ step. Blocking of the free epitopes of the antibodies is carried out using anti-(against the 
secondary antibody raised in certain species) affinity Fab fragments. This procedure was divided 
into three parts. Part one is to label the first organelle with anti-x antibodies. To fix the cells, the 
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same procedure described in ICC section was performed. The second part involved blocking the 
free epitopes of previous secondary antibody. To do so, cells were incubated with 2.5% NGS in 
PBS for 1 h at room temperature. Three washing steps for 5 min each with PBS were applied. The 
cells were then incubated with anti-x affinity Fab fragments (1:50 dilution in PBS/2.5% NGS) for 
1 h at room temperature, then, carefully washed 3 times for 10 min each with 1X PBS. The third 
part was to label for the second organelle with anti-y antibodies. The same procedure used for first 
organelle labelling was performed. And finally once the second labeling procedure is completed, 
coverslip were mounted on glass slides as described before. The samples were stored at -20 °C 
or 4 °C in dark. 
 
II.2.6 Calcium Phosphate-Lentivirus Production19 
In order to produce Lentiviruses, human embryonic kidney cells (HEK 283FT) are 
transiently transfected with lentiviral transfer vector plasmid, packaging plasmid and envelope 
glycoprotein (Vigna and Naldini, 2000). Following transfection, lentiviral particles are released 
into HEK cells’ culture medium (Tang et al., 2015). These particles are then harvested in Amicon 
Ultra-15 centrifugal filters (100,000 NMWL). This entire process takes 3 to 4 days depending on 
the Lentivirus generation and the size of protein encoded in the viral vector plasmid. The 
production process is divided into three main steps. On the first day in the morning, the medium of 
the HEK cells was changed to incomplete medium (DMEM + Glutamax) to starve and stress them. 
In the afternoon, the transfection procedure was started. Sterile 1.8 ml Sigma water was added to 
15 ml Falcon tube, then the DNA-mix which contains 45 µg DNA of the vector to be produced and 
10 µg of all the Helper Plasmids 12251 pMDLg/pRRE, 12253 pRSC-Rev and 12259 pMD2.G20 
(Dull et al., 1998) was added to the Falcon tube. Afterwards, 200 µL of freshly made calcium 
Chloride 2.5 M was added to the same Falcon tube. The mixture was vortexed. In a second Falcon 
tube, 2 ml HBS solution was added. The DNA solution was then moved from the first Falcon tube 
into the HBS Falcon tube 2 via a glass pipette. The transfer should be slow and in drop-wise manner 
directly into the center of the falcon tube without touching the plastic wall. The mixture is then 
incubated for 15 min at room temperature (up to 30 min) until a cloudy/milky mixture appear. To 
                                                 
19 This procedure should be carried out entirely in S2- Laboratory. Wearing a lab coat is required. 
20 Third generation lentiviral packaging plasmid; Contains Gag and Pol; also requires pRSV-Rev (Addgene#12253) 
and envelope expressing plasmid (Addgene#12259) from AddGene – USA. 
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transfect the HEK cells, a new glass pipette was used and the mixture was carefully transferred in 
a drop wise manner along the entire cell culture flask while moving it in a gentle circular way. One 
to two cell culture flasks can be transfected with this 4 ml DNA/calcium/HBS mixture. Overnight 
incubation (14 – 16 hrs max) at 5% CO2 / 37o C was required. In the second day, the medium was 
removed with a glass pipette. This used medium was discarded in 20% SDS. 8 ml of complete 
DMEM medium (+ Sodium Pyruvate, FCS and NEAA) was added. The flasks were left for 24 to 
48 h in the incubator. NPY-Venus virus production needs 1.5 days incubation while VGLUT-
mNectarin needs 3 days incubation before harvesting. On the third or fourth day, the color of the 
medium was checked, if it changed to yellowish-orange, the cells were inspected under the 
microscope. If clumps and floating cells were visible, the cells were excited with the specific 
wavelength against the fluorescent protein. Once a fluorescent signal was visible, harvesting is 
recommended as longer incubation periods might increase the apoptotic factors and free radicals 
that eventually will drastically affect the quality of cell cultures as well as the efficacy of 
transfection. The medium was then pipetted out from the flasks into a 50 ml falcon tube and 
centrifuged at 1200 rpm speed for 2 min (or up to 5 min). At this moment, it is possible to interrupt 
the procedure for 24 hrs and continue later; for this purpose, the medium was kept at 4o C. The 
harvested solution was poured in the Millipore Centrifugal Filter of 100,000 MWCO Falcon and 
centrifuged for 15 min at 4 o C at 1,800 rpm. Once concentrating was done, the virus suspension 
was aliquoted into cryo-tubes and closed tightly before dipping into liquid Nitrogen for a brief 
while and stored directly at -80 o C. 
II.2.7 RT PCR 
Reverse Transcription-PCR technique was needed to detect whether CAPS1 and 2 were 
found in DRGs at mRNA level. DRGs were isolated from 5 adult mice and 170 mg of DRG tissue 
was collected and stored at -80 °C. The DRG tissues (50 – 100 mg) were transferred to a 50 ml 
Falcon tube containing 1 ml TRIzol reagent. The mixture was centrifuged at 1240 rpm for 10 min 
at 4 °C. The tissues were lysed by repetitive pipetting and grinding and then transferred to 1.5 ml 
Eppendorf tube. The mixture was then centrifuged at 11400 rpm for 10 min at 4 °C, the supernatant 
was transferred into a fresh Eppendorf tube and incubated for 5 min at room temperature. 
Afterwards, 0.2 ml of chloroform was added and the tube was shaken vigorously by hand for 15 s. 
The mixture was then centrifuged at 11400 rpm for 15 min at 4 °C and the resulting aqueous phase 
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was transferred into a new tube. Glycogen (1-5 µl) and Isopropanol (0.5 ml) was added to 
precipitate the sample which was then incubated for 10 min at room temperature. Another 
centrifuging step at 11400 rpm for 10 min at 4 °C was required. The supernatant was removed and 
the remaining was mixed with 1 ml 75% ethanol mixed in Sigma water. The mixture was then 
centrifuged at 8900 rpm for 5 min at 4 °C. The RNA pellet was left briefly to dry and the resulting 
RNA was dissolved in 30 µl Sigma water. In a second step, cDNA is to be produced from the 
resulting RNA whereby 1 µg of RNA was mixed with 1 µl dNTPs, 1 µl random primers, and H2O. 
This mixture was incubated for 5 min at 65 °C and later 4 µl of 5X strand buffer, 2 µl of 0.1 M 
DTT, 1 µl reverse transcriptase and 1 µl  RNAse were added. Then PCR reaction was run and kept 
on hold at 4 °C. In the last step, the produced cDNA is screened with CAPS1 and CAPS2 primers. 
The PCR reaction components included: 1 µl cDNA, 2 µl 10X buffer, forward and reverse 0.2 µl 
each, 1 µl  Taq Polymerase and 15.4 µl Sigma water. The reaction was run for CAPS1 and CAPS2 
separately in DRG cDNA and brain cDNA that was used as a positive control for both CAPS 
isoforms expression and a negative control with water instead of cDNA. The resulting PCR 
products were run in 0.1% agarose buffer with a PCR marker. 
II.2.8 Western Blot 
Samples were collected from E18 and P7 pups and 11 µg of each Sample was diluted with 5X 
sample buffer and homogenization buffer. The samples were then cooked for 5 minutes at 95 °C 
and were loaded into 8% SDS-polyacrylamide gel. The gel was run for 20 min at 100 V and then 
for 50 min at 160 V. The gels were blotted onto nitrocellulose membranes (wet blot 320 mA for 
2 h) and blocked using 5% milk in TBST for 1 h. Membranes were then incubated with primary 
antibodies either against CAPS1 (1:500) or CAPS2 (1:3000) diluted in 1% milk TBST overnight. 
The membranes were washed the next day with 1% milk TBST 3 times for 15 min each. The 
secondary goat anti-rabbit antibody was used for both primary antibodies at a dilution 1:3000 in 
1% milk plus TBST and was incubated for 1 h. Membranes were washed 3 times for 15 min each 
with TBST. They were then incubated in ECL detection reagent for 5 min and detected by 
FluorChem M system (Protein Simple). ß-actin labelling was also performed to correct for the 
loading of the samples using a primary antibody (1:5000) and a secondary goat anti-mouse 
antibody (1:1000). Quantification of CAPS1 and CAPS2 protein signal in Western blot results were 
based on β-actin as a standard and normalized to protein expression level at P7. 
MATERIALS AND METHODS 
 
54 
 
II.2.9 iB4 Staining  
Staining against Isolectin GS-iB4 from Griffonia simplicifolia
21 coupled to Alexa Fluor 568 is 
used to mark the non-peptidergic unmyelinated DRG neurons. It is a common way as described in 
literature to differentiate between peptidergic myelinated DRG neurons and non-peptidergic 
neurons (Kubo et al., 2012). The advantage of using iB4 over other markers like the NF200 
antibody, is its ability to stain living cells without harming them. It’s a perfect marker for live 
imaging while the NF200 is best optimized for fixed cells in ICC experiments. When iB4 is applied, 
the non-peptidergic neurons are stained. To label the cultured DRG neurons, 5 µl (1 mg/ml) of iB4 
conjugated to Alexa-568 was added to 2 ml extra-cellular solution warmed chamber and incubated 
at 37 °C for 20 min. The coverslip was then dipped into another chamber that contains 4 ml of 
extra-cellular solution and later washed for 10 min with continuous extracellular solution 
perfusion. Neurons with bright red cell membrane staining when excited at 561 nm were defined 
as iB4-positive non-peptidergic neurons. 
                                                 
21 Woody climbing shrub native to Central and West Africa. Isolectin GS-iB4 is isolated from the seeds of this plant. 
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II.2.10  Cloning 
II.2.10.1 CAPS2b-mTFP 
The existing CAPS viral Semliki 
Forest constructs in the laboratory were 
all tagged with eGFP. Since we had to 
co-express each CAPS isoform with 
NPY-Venus to examine the effect of 
CAPS overexpression on LDCV 
secretion, we had to change pSFV1-
CAPS2b-IRES-eGFP to pSFV1-
CAPS2b-IRES-mTFP. It was nearly 
impossible to distinguish between DRG 
neurons co-expressing eGFP and Venus 
and those expressing either construct 
separately (or in isolation). This 
difficulty lies in the close spectral 
overlap of eGFP and Venus. Teal was 
our choice because of its reduced spectral 
overlap with Venus (Figure 23). The 
cloning strategy aimed at replacing the 
existing eGFP with Teal, but since there 
was no convenient direct restriction sites 
up and down-stream of eGFP, a more 
complex cloning strategy was developed 
utilizing non-unique cutter enzymes. The strategy involved cutting the vector backbone with - 
several restriction reactions - into three fragments, main vector backbone, eGFP fragment to be 
replaced by PCR mTFP product and a downstream smaller vector backbone fragment. The first cut 
involved ClaI and SpeI restriction enzymes to generate the vector backbone (fragment A). The 
second independent cut involves XhoI and SpeI to generate the second small vector backbone 
Figure 23 Spectral mixing of mTFP, eGFP and Venus. 
(A) Normalized intensity of excitation wavelength of mTFP, eGFP 
and Venus. (B) Normalized intensity of emission of mTFP, eGFP 
and Venus. 
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fragment B. The third 
fragment (C) was a 
synthesized PCR mTFP 
product with unique 
inserted restriction sites. 
fragment A was 
generated by cutting 2 µl 
CAPS2b vector22 with 
2 µl of each ClaI and 
SpeI restriction enzymes 
and 5 µl of Buffer 4 
mixed with 39 µl HPLC 
water. The digestion mixture was incubated for 3 hrs at 37 °C and 1 µl SAP was added and 
incubated at 37 °C for another 1 hr. Heat inactivation followed the phosphorylation for 15 min at 
75 °C. The product was then kept on ice. Fragment B was produced by adding 2 µl of CAPS2b 
vector DNA digested with 2 µl of each XhoI and SpeI restriction enzymes. Buffer 4 was convenient 
for both enzymes and 39 µl HPLC water was added to this reaction. The mixture was incubated at 
37 °C for 3 hrs. Fragment C was produced by a PCR reaction whereby 0.3 µl of mTFP DNA23 was 
mixed with 0.5 µl FW primer with ClaI Restriction site 5’AAAAAT^CGATGTGAGCAA 
GGGCG3’ and 0.5 µl RV primer with XhoI Restriction site 5’AAAAC^TCGAGCTTG 
TACAGCTC3’, 1 µl dNTPs, 1.2 µl Red Taq polymerase, 5 µl 10X PCR Buffer from Sigma and 
51.5 µl of HPLC water. The PCR program started with 94 °C for 5 min followed by 25 cycles of 
94 °C for 45 s, 60 °C for 45 s, 72 °C for 30 s and 72 °C for 7 min and kept on hold at 4 °C. 
Analytical gel with 1% agarose was used to estimate the amount of DNA to be used in the ligation 
reaction (Figure 24). Samples were extracted from gel using QIAquick Gel Extraction kit according 
to the protocol provided by the company24. According to the following formula: (Vector ng/ 
Vector bp x Insert bp = Insert ng for 1:1 ratio), it was estimated that the concentration of the vector 
is 60 ng/µl, 6 ng/µl for fragment B and 7 ng for fragment C. The ligation reaction was followed 
                                                 
22 Lab reference number #284. 
23 Lab reference number #718. 
24 www.qiagen.com/handbooks - Cat. Nos. 28704 and 28706 - Protocol of September 2010 
Figure 24 ZraI check-digest. 
(A) CAPS2b-eGFP digestion 
pattern. (B) CAPS2b-mTFP 
digestion pattern. (C) Samples 
were run on 1% agarose gel to 
identify the correct clones. 
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according to ratio 1:3:4-4.5 (V:I:P) which included 0.5 µl 
of fragment A, 1 µl of fragment B and 1 µl of fragment C 
mixed with 2 µl T4 ligation buffer and 2 µl of T4 Ligase. 
Water up to 20 µl was added to dilute the glycerol content 
that was used to preserve the enzyme. The ligation control 
included the same components of the ligation reaction but 
without fragment B and C. Both the ligation reaction tube 
and the control tube content were separately transformed 
in DH5α bacterial cells. Ring transformation was carried 
out by thawing the 100 µl bacteria slowly on ice for 20 
min, and the 20 µl of the ligation reaction mixture was 
added and incubated on ice for 30 min. The mixture is 
then transferred to 37 °C and then back on ice for 10 min 
to shock the bacteria. Afterwards 300 µl of LB-medium 
is added and the entire mixture is kept at 37 °C with gentle 
shaking at 300 rpm. The 
content is then streaked on a 
pre-warmed agar Petri dish 
near fire source and incubated 
at 37 °C for 12 to 16 hrs. 
Colonies were picked and 
amplified overnight in the 
presence of Ampicillin. DNA 
was extracted using QIAprep 
Spin Miniprep kit25. To 
quickly verify whether the 
cloning reaction worked, 
check-digest reaction was 
carried out with ZraI 
restriction enzyme for its 
                                                 
25 www.qiagen.com/handbooks - Cat. Nos. 27104 and 27106 - Protocol of October 2011 
Figure 25 1% Agarose analytical gel. 
Fragment A (1 µl) was mixed with 1 µl LB + 3 
µl water. Fragment B (2.5 µl) was mixed with 
1 µl LB + 1.5 water. Fragment C (3 µl) was 
mixed with 1 µl LB mixed with 1 µl water. The 
sample was run at 80 mV for 60 min. 
Figure 26 pSFV-mCAPS2b-IRES-mTFP vector map. 
The construct was added to the lab DNA and assigned a reference #294. 
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unique cutting site in eGFP and two cutting sites in mTFP. The resulting DNA (10 µl) from the 
minipreps was digested with 1 µl ZraI in the presence of 2 µl Buffer 4, 2 µl BSA and 5 µl water. 
The reaction was allowed to proceed for 2 hrs at 37 °C and then the samples were loaded along 
with LB at 1% agarose gel and run for 85 min at 80 mV (see Figure 25). The clones with the correct 
digestion patter were sequenced using mTFP primers to eliminate the possibility of mutations 
during the PCR reaction. Once the sequencing results showed that the sequence is correct (Figure 
26), Maxiprep was performed. The virus was later produced and tested on DRG neurons to verify 
whether it’s functional and to check whether overexpressing it together with Lentivirus encoding 
for NPY-Venus is viable. Cells were imaged at 4 hrs of transfection and 4.5 hrs. The transfection 
efficacy was less than 20%. Cells expressing both CAPS2b and NPY-Venus can be clearly 
distinguished from cells expressing one of them (Figure 27). Hence the idea behind switching the 
fluorescent proteins was valid hence the next step was to apply this strategy to CAPS1 vector. 
Figure 27 CAPS2b-mTFP co-expressed with NPY-Venus in DRG neurons. 
(A) Two DRG neurons where one of them was double transfected with CAPS2b-mTFP and NPY-Venus imaged after 
4 h of CAPS2b overexpression. (B) Two DRG neurons where both of them are overexpressing CAPS2b-mTFP and 
only the lower one is transfected with NPY-Venus imaged after 4.5 h of CAPS2b overexpression. 
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II.2.10.2 CAPS1-mTFP 
CAPS1 cloning was a 
more straight forward 
strategy. It involved replacing 
the recently cloned CAPS2b 
in pSFV1-mCAPS2b-IRES-
mTFP with CAPS1. The 
mCAPS2b-IRES segment 
was cut out from pSFV1-
mCAPS2b-IRES-mTFP by 
adding 2 µl of ClaI and 2 µl of 
BamHI mixed with 5 µl 
Buffer 4, 2.5 µl vector DNA 
and 39 µl HPLC water. The 
reaction was allowed for 3 h 
at 37 °C and SAP was added 
for 1 h at 37 °C. Later on, the reaction was heat inactivated for 15 min at 75 °C. To produce the 
CAPS1 insert, mCAPS1-IRES was cut out from pSFV1-CAPS1-IRES-eGFP26 using 2 µl of the 
vector DNA mixed with 2 µl of BamHI and 2 µl of ClaI, 5 µl of Buffer 4 was added and HPLC 
water up 50 µl. The reaction took place for 3 hrs at 37 °C. The vector and the insert was ligated in 
                                                 
26 Lab reference number #175. 
Figure 28 pSFV-CAPS1-IRES-mTFP vector map. 
The assigned reference #293. 
Figure 29 CAPS1-mTFP co-expressed with NPY-Venus in DRG neurons. 
Two DRG neurons are transfected with CAPS1-mTFP. The lower left cell is transfect with NPY-Venus as well. No 
spectral mixing between mTFP and Venus was visualized when imaged at 3% 450 nm laser intensity. Upon higher 
laser intensity, Venus would be weakly excited and hence confused by the signal from CAPS-mTFP. Laser intensity 
lower than 3%, was not enough to visualize the mTFP signal because of the high autofluorescence of DRG neurons 
at that wavelength. 
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1:3 ratio and the cloning was validated by using primers for CAPS1 shown in figure 17 and by 
sequencing. The virus was then produced and tested on DRG neurons (Figure 29) after 4.5 hrs of 
transfection. The transfection efficacy was about 20%. 
II.2.10.3 CAPS1-TagRFP-T 
To measure syna-
ptic activity, it was nece-
ssary at some point to co-
express CAPS1 together 
with SypHy. This comb-
ination of TFP with 
pHluorin nm was not 
doable, hence we decided 
to switch the mTFP with 
Tag-RFP-T27. Roger 
Tsien developed a highly 
photostable Tag-RFP 
which is a monomeric 
derivative of eqFP578 
from Entacmaea quadri-
color which is very stable. 
This fluor-escent protein maintain most of the beneficial qualities of the original proteins and 
perform as reliably as Aequorea victoria GFP derivatives in fusion constructs (Shaner et al., 2008). 
The construct pSFV1-CAPS1-IRES-eGFP was used for exchange of eGFP with Tag-RFP. The 
eGFP was removed out by ClaI and PspXI restriction enzymes and the vector backbone was 
subjected to SAP to prevent the re-ligation on its own. TagRFP was synthesized by PCR to insert 
the ClaI and PspXI restriction sites using FW primer 5’TAGCAT^CGATCCTAGGCACC 
ATGGTGTCTAAGGGCGAAGAG3’ with ClaI site and RV primer 5’TTACCC^TCGA 
GCGGCCGCTTTACTTGTACAGCTCGTCCATG3’ with PspXI site. The FW primer had 
additional restriction site for AvrII that would be used to verify the exchange of fluorescent 
                                                 
27 Lab reference number #1623. 
Figure 30 pSFV-CAPS1-IRES-Tag RFP-T vector map. 
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proteins. The PCR reaction was carried out at 20 cycles to decrease the probability of generating 
mutations. The ligation reaction was carried with a 1:3 ratio and the transformation and DNA 
purification was made as previously described. Resulting samples were digested with BamHI and 
AvrII. Selected clones showed two bands corresponding to the vector backbone and CAPS1-IRES 
fragment. Further verification was performed with sequencing and the virus was produced and 
tested. 
II.2.10.4 VGLUT-mNectarin cloning  
VGLUT-pHluorin obtained from T. A. Ryan could not be used with NPY-Venus because 
both are excited at 488 nm. For this reason, we replaced the fluorescent protein with mNectarine28 
enabling us to study both LDCV and SV exocytosis at the same time. The red fluorescent pH 
biosensor mNectarine was first describe by (Johnson et al., 2009) and its spectral characteristics 
were tested in HEK 293 cells. It was proven to be pH-sensitive with highest fluorescence at 
                                                 
28 pH-sensitive monomeric mNectarine red fluorescent protein. GenBank ID: FJ439505. 
Figure 31 Cloning strategy of vGlut-mNectarine. 
Splicing by overlap extension PCR removed out pHluorin and replaced it with mNectarine. Later VGLUT-mNectarine 
was cloned into second generation Lentivirus. 
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pH = 7.5. The most convenient way to clone mNectarine into the luminal part of VGLUT was to 
remove pHluorin with splicing it out by overlap extension PCR (Figure 31). The strategy involves 
constructing inner primers that bridge different pieces together. These primers should have close 
annealing temperatures for successful PCR. Two end primers with specific restriction enzymes are 
needed to insert the product in the viral vector of interest. The first step is to do the extension PCR 
by which the fragments are separately amplified. In this case its VGLUTi, mNectarine and VGLUT 
ii (see figure 21). Two sequential overlap fusion PCRs are carried on the purified PCR products of 
extension PCR. A final purification PCR is required and the product is then digested with the 
enzymes is extracted and digested with the specific enzymes and hence its read to be inserted into 
the vector. 
 
 
 
 
three independent extension PCR reactions were carried out in order to get the 3 different 
fragments. Fragment VGLUTi was produced by adding FW primer 5’CGTGT^CTAGA 
GCCACCATG GAGTTCCGGCAGG with XbaI restriction site, RV overlap I primer 5’CCTTGC 
TCCACCTGTCCCGC CGCTTC3’, VGLUT-pHluorin 1.3 µl, dNTPs1 µl, Red Taq polymerase 
1.2 µl, PCR buffer 5 µl and Sigma water 41 µl. Fragment mNectarine with the overlaps was 
produced by adding FW overlap I primer 5’GGGACAGGTGGAGTGAGCAAGG 
GCGAGGAG3’, RV overlap II primer 5’TGCCTCCGCTCTTGTACAGCTCGTCCATGC3’, 
mNectarine 1 µl, dNTPs1 µl, Red Taq polymerase 1.2 µl, PCR buffer 5 µl and Sigma water 41 µl. 
The third fragment VGLUTii PCR was done by adding FW overlap II primer 5’3 
GAGCTGTACAAGAG CGGAGGCACAGGTGGC’, RV primer 5’AGGCA^CGCGTTCAGT 
AGTCCCGGACAGGG GGTG3’ with MluI restriction site, VGLUT-pHluorin 1.3 µl, dNTPs1 µl, 
Red Taq polymerase 1.2 µl, PCR buffer 5 µl and Sigma water 41 µl (see Figure 33a). Once the 
Link: http://openwetware.org/wiki/PCR_Overlap_Extension 
 
Figure 32 Splicing by Overlap 
Extension. 
The procedure involves designing 
overlapping primers and two end 
primers with restriction site each. Using 
the proofreading Polymerase, 
‘Extension PCR’ amplifies the segments 
of interest at the right annealing 
temperature. The resulting PCR 
products are used in ‘Overlap PCR’ 
reaction, whereby the template will act 
as primers for each other. To finalize the 
PCR product, use the end primers with 
the restriction sites for ‘Purification 
PCR’. The correct size fragments are 
extracted and cloned into the vector.  
Source: Modified from OpenWetWare 
website, Michael A. Speer, September 
2011.  
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products were purified, a first fusion PCR was applied to the first two fragments. Gradient PCR 
was the choice because we were not certain at which temperature we should carry this reaction, we 
chose 53, 56 ad 58 °C. It turned out all were as efficient (Figure 33 B). Fragment VGLUTi PCR 
product 0.5 µl was mixed with mNectarine PCR product 0.5 µl together with FW primer, RV 
overlap II primer, dNTPs1 µl, Red Taq polymerase 1.2 µl, PCR buffer 5 µl and Sigma water 40 µl. 
The PCR product was purified (Figure 33 C) and extracted. The VGLUTi-mNectarine (0.5 µl) 
product was then used in a second fusion PCR reaction mixed with VGLUTii PCR product 1 µl, 
dNTPs1 µl, Red Taq polymerase 1.2 µl, PCR buffer 5 µl and Sigma water 40 µl. At this step, no 
primers were added and the PCR was run for 10 cycles at 40 °C to allow the fragments to anneal. 
Figure 33 vGlut-mNectarine cloning. 
(A) vGlut I, mNectarine and vGlut ii are produced with extension PCR. The produced products have overlapping ends. 
(B) First fusion gradient-PCR with 3 different extension temperatures whereby vGlut I is fused to mNectarine. (C) The 
correct fragment size was purified and part of it was loaded on a control gel. (D) Second fusion PCR between vGluti-
mNectarine and vGlut ii fragment. The expected size approximately 2600 bp. (E) Analytical estimation of the insert 
and the vector backbone in order to estimate the DNA ligation ratio. (F) The resulting clone’s DNA from the ligation 
reaction were digested with XbaI and MluI. The insert was cut out in clone 1, 2, 4, 9 and 11, indicating that these 
were the correct clones. All gels were 1% agarose gel. Samples were run at 80 mV for 60 min. 
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Later, 0.5 µl of FW primer and RV primer each were added and the PCR was run for 20 cycles at 
60 °C (Figure 33 D). The obtained fusion PCR product was then purified and digested with XbaI 
and MluI. Analytical gel was performed to estimate the amount of products needed for successful 
ligation reaction (Figure 33 E). The ligation reaction involved 0.5 µl of vector, 2 µl insert, 2 µl T4 
buffer, T4 ligase, and 13.5 µl water. A control reaction involved the same components but without 
insert. The first DNA transformation was carried in DH5α cells. We failed to produce correct 
clones. To overcome this problem, different antibiotic concentrations, the agar quality and bacteria 
used (Tiscornia et al., 2006) were separately tested and none managed to produce successful 
resistant clones. (Bichara et al., 2000; Kang and Cox, 1996) Multiple direct repeats in Lentiviral 
vectors cause problems when transformed into DH5α. On the contrary, instability-prone Lentiviral 
vectors are remarkably stable when cloned in Escherichia coli Stbl3 (Faisal A. Al-Allaf, 2012). 
Invitrogen Stbl3 is a chemically stable competent bacteria that reduce the frequency of homologous 
recombination of LTRs in big expression vectors. The company reported that the yielded DNA is 
ten-fold higher than that of DH5α. Unlike DH5α, Stbl3 can be harmful and cause irritation if it 
touches the skin. The transformation carried out in stbl3 worked from the first time and 5 out of 11 
clones showed correct DNA once digested with MluI and XbaI (Figure 33 F). One of the clones 
Figure 34 Tile confocal images showing overexpression of vGlut-mNectarine in DRG-S neurons co-culture. 
DRG culture was transfected with the Lentivirus encoding for vGlut-mNectarine and then S neurons were later added 
and left together for 5 DIV. The cells were then fixed with 4% PFA and excited at 561 nm and acquired in tiles. The 
resulting images were overlaid with bright field. The transfection efficacy was around 60%. 
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was successfully sequenced and the Lentivirus was produced. The virus was effectively tested in 
DRG/S neuron co-culture (Figure 34). 
II.2.11 Analysis 
ICC experiments performed on SIM microscopes were processed using previously mentioned 
ZEN software. The background was subtracted and co-localization was performed using JACoP 
plugin on ImageJ to get Manders’ coefficient (Bolte and Cordelieres, 2006). ICC experiments 
performed on confocal microscope and the data was analyzed in ImageJ v1.49i, the background 
was subtracted and the mean gray value was quantified to compare the true signal with that of 
control. Manders’ coefficient was also calculated through ImageJ. LDCV secretion graphs were 
displayed as cumulative increase of released vesicles normalized to the surface area of individual 
cells. To analyze exocytosis, LDCV secretion was counted as fast disappearance of vesicles within 
200 ms time while slower disappearance indicates that the vesicles are leaving the plasma 
membrane. The figure below is a representative classical example that demonstrates LDCV 
secretion where a vesicle approaches the membrane and fuses completely with it (Figure 35). The 
graph in figure 35 E depicts fluorescence intensity time course of the vesicle approaches the 
membrane, and hence its fluorescence is increased and then fuses inducing a fast disappearance of 
the signal. We also included all other forms of LDCV secretion that encompass kiss and run, kiss 
and stay and these vesicles that are docked at the membrane and fuses, inducing an increase 
Figure 35 Representative example of classical LDCV secretion. 
Cultured DRG neurons were transfect with a Lentivirus encoding for NPY-Venus and left to stay in culture for 7 days.  The cells 
were then transferred to a special metal holder and are incubated with Tobias physiological solution and placed on the TIRFM 
setup. The field electrode is placed next to the cells as shown in (A) and images were acquired in bright field (D.), epifluorescence 
(C) as well as TIRF (D.). (E) Exemplary fluorescence intensity trace during fusion. 
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fluorescence intensity and fast disappearance of the signal because of the dispersion of the NPY-
Venus cargo (Bost et al., 2017). Acquired data was analysed with ImageJ and secretion events were 
documented with specific regions of interest (ROIs). The LDCV secretion curves were displayed 
as average cumulative curves whereby individual cells were normalized to their own surface area 
and multiplied by the average area of all cells. In order to analyze synaptic formation, synapses 
were marked by ROIs and counted via special ImageJ macro written by Dr. Ralf Mohrmann who 
also wrote a second macro to measure distances between individual synapses and neurons. Mature 
synapses were defined by the co-localization of Bassoon, PDS95 and Synaptobrevin (SybKI). The 
number of synapses were normalized to the area of the acquisition, hence the displayed numbers 
in the graph represent synapse per unit of area. The synaptic transmission experiments were 
analyzed through ImageJ. Synapses were defined as SypHy labelled structures and responded to 
the 4 V at 10 Hz electrical stimulus. The background was subtracted by using a macro which 
calculated the average mean grey value over an ROI that selected an empty part of the coverslip 
and subtracted the value frame by frame for the entire acquisition. Synapses were marked by ROIs 
and the mean gray value was measured as a function of time. The displayed graphs were normalized 
to the maximum signal upon NH4Cl application. The time at which maximum fluorescence was 
reached was different between recordings due to the manual application of NH4Cl. For display 
purpose, I corrected for this shift. For each recording, the row contains the maximum values as 
determined and an index offset correction was applied. This offset function shifted the cells 
automatically in such a way that all maximums started at the same time point, before normalizing 
to it. Error bars were standard error of mean and were calculated through Excel or by SigmaPlot. 
Mann Whitney, t-test, one way ANOVA and two way ANOVA were calculated with SigmaPlot 
13. Graphs were generated by SigmaPlot and rarely by Igor or Excel. The graphs were formatted 
with CorelDRAW X6.
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III. Results 
  Since the description of p145 aka CAPS1 in 1992 by Thomas Martin (Walent et al., 1992) 
and the discovery of the second isoform CAPS2 by Nils Brose (Speidel et al., 2003), there has been 
controversy concerning their function. contradicting roles of these isoforms are ever growing in 
the  literature. The two isoforms and the splice variants of CAPS2 with their different domains as 
well as their developmental expression over time add several layers of complexity. We chose DRG 
and DRG/S neuronal culture and co-culture, respectively to address the role of CAPS in LDCVs 
and SVs in in one system. This neuronal culture enables us to study LDCV and SV release either 
individually or simultaneously. The first experiments investigated whether CAPS isoforms are 
found in DRG neurons at the mRNA and protein developmental expression levels as well as its 
localization at the cellular level. 
III.1  CAPS Localization 
CAPS1 and CAPS2 are distributed among various tissues and cell types in mice. For 
instance, CAPS1 and CAPS2 were shown to be widespread in mouse at mRNA level (Sadakata et 
al., 2004; Speidel et al., 2003). The cellular distribution was well examined by (Sadakata et al., 
2006), whereby he showed that CAPS1 and CAPS2 were complementarily expressed in embryonic 
nervous system. CAPS1 was distributed at different levels while CAPS2 was localized to distinct 
cell types and fibers in various brain regions including olfactory bulb, cerebrum, hippocampal 
formation, thalamus, mesencephalic tegmentum, cerebellum, medulla and spinal cord. Using IHC 
experiments on spinal cord splices, the authors found that while CAPS1 was distributed in all 
DRGs, CAPS2 was in subpopulation only. Though this study gave us a hint about CAPS 
distribution in PNS neurons but it lacked the percentages at which each isoform was distributed 
and it was not providing the distribution of these isoforms at the level of different DRG neuron 
subtypes. 
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III.1.1 CAPS Localization at mRNA Level 
We sought to identify the presence of CAPS 
by using Reverse transcription-PCR on complete 
DRGs.  RT-PCR semi-quantitative results indicate 
that CAPS1 and to lesser extent CAPS2 isoforms are 
found in DRGs isolated from 2 weeks old mice. This 
finding fits well with the previous findings described 
by (Sadakata et al., 2006). We next wanted to 
investigate the expression of CAPS isoforms at 
protein level and during development. This was of 
particular importance because some experiments in 
this work were carried out with adult WT or 
CAPS2 KO mice while others were made with 
CAPS dKO mice at embryonic day 18 because they 
dye at birth (Speidel et al., 2008). 
III.1.2 CAPS Localization at Protein Level 
To investigate the presence of CAPS isoforms at the protein level in DRG neurons, WT 
DRGs were isolated from 12 mice separately and Western blot29 was carried out. To validate the 
specificity of the antibodies we used, dKO mice were used. The age of the mice from which the 
DRGs were isolated was E18 and P7. We chose P7 old mice because for imaging experiments on 
CAPS dKO cells, we waited for the Lentivirus expressing NPY-Venus 7 days before measuring 
                                                 
29 The Western blot was carried out by Mr. Ahmed M. Shaaban. 
Figure 36 RT-PCR from 2 weeks old mice. 
mRNA was produced from 5 adult mice (170 mg of 
tissue) and converted to cDNA by PCR reaction.. In 
a second PCR reaction, screening for CAPS1 and 
CAPS2 was mediated by primers specific against 
each isoform. Cerebellum was used as a positive 
control for both isoforms (Sadakata et al., 2006; 
Sadakata et al., 2007a). 
Figure 37 CAPS developmental protein expression levels. 
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LDCV exocytosis. Both CAPS1 and CAPS2 isoforms were found at the protein level in E18 pups 
(Figure 37 A). To correct for sample loading errors, ß-actin labelling was also performed. 
Interestingly, CAPS1 expression levels doubled as pups grew older. CAPS2 embryonic expression 
levels were high compared to that of CAPS1. While RT-PCR and Western blot experiments 
confirmed the existence of CAPS isoforms in DRGs, they also contain cells other than neurons 
such as astrogial cells and fibroblasts. Therefore, we screened for CAPS at the cellular level to 
exclude the possibility that CAPS was localized to cells other than our neurons. 
III.1.3 CAPS Localization at Cellular Level 
ICC experiments to localize CAPS in DRG 
neurons involves primary antibodies against CAPS 
isoforms that are detected through secondary 
antibodies coupled to IgG Alexa Fluorophore. To 
make sure that the signal from such experiments is 
correct, control samples are essential to prove that 
the primary antibody is specific to the antigen, the 
secondary antibody is specific to the used primary 
antibody and the obtained signal is a result of the 
added label and not due to endogenous 
autofluorescence (Burry, 2011). Furthermore, we 
investigated the autofluorescence profile of these 
cells in order to be able to distinguish the real signal 
from noise that usually arises from cell components 
and free radicals and to choose the appropriate 
fluorophore of the secondary antibody. To do so, an 
adult DRG cell culture was fixed with 4% PFA at 
1, 7 and 14 DIV. The cells were excited with 405, 
458, 488, 514, 561 and 633 nm lasers and the 
Figure 38 DRG neurons autofluorescence profile. 
DRG neurons were fixed with 4% PFA for 20 min and 
images were acquired using confocal microscope. (A) 
Autofluorescence emission intensity was measured 
upon exciting with different wavelengths in 1 day old 
DRG culture, and 7 days old culture in (B.). 
Continuing Figure 37… (A) CAPS developmental protein expression levels was examined by western blot. DRGs were 
isolated from WT and CAPS dKO E18, and WT P7 old mice and the samples were run. Actin was used to standardize 
the protein expression levels. (B) The graph shows actin-based corrected protein expression levels normalized to 
the signal from P7. Results indicate that both CAPS1 and CAPS2 proteins are present prenatal mice and the 
expression levels is elevated in postnatal mice. 
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emission spectrum was plotted in figure 31. We found that one day old fixed DRG neurons exhibits 
autofluorescence at 405, 458 and 488 nm and very low autofluorescence at 561 and 633 nm 
(Figure 31 A).  The longer the neurons stay in culture the stronger the autofluorescence got. The 
autofluorescence was highest with excitation at 458 nm (Figure 31 B). Living DRG neurons 
showed a milder but similar autofluorescence pattern compared to fixed cells. Taking into 
consideration this autofluorescence pattern of DRG neurons both in living cultures and fixed preps, 
all upcoming experiments were optimised accordingly. 
Thus, to localize CAPS isoforms, E18 DRG neurons of WT and CAPS dKO genotype were 
separately produced and left to stay in culture for seven30 days. Then the cells were fixed according 
to the previously described protocols and CAPS isoforms where screened using home produced 
antibodies in collaboration with Dr. Martin Jung. To detect both CAPS isoforms, a 1347/48 – serum 
831 was used. Results indicate that CAPS1 and CAPS2 are found in DRG neurons in both diffuse 
cytoplasmic and punctate staining (Figure 32). It was possible to purify from this serum the 
antibodies that recognize CAPS2 only. Several purified serums were produced, I tested 1403b – 
serum 4, 6 and 10 to finally use serum 6. Controls that ensured the specificity of serum 6 were 
carried out in CAPS2 KO background, to rule out any cross-reactivity with CAPS1 isoform 
(Appendix VI.1). We took advantage of this newly generated serum to perform double 
immunostaining together with serum 8 which recognizes both isoforms and managed to determine 
the distribution of individual isoforms. The results showed that half of the cells were positive for 
CAPS2 (Figure 39) which means that rest of the signal comes either entirely from coexistence of 
CAPS1 in all cells and CAPS2 in half of the population or by random distribution of each isoform 
                                                 
30 DRG neurons are transfected with a Lenti-virus encoding for NPY-Venus to label LDCVs to monitor exocytosis. 
The virus is incubated for seven days in order to achieve a bright labeling of LDCVs. 
31 1347/48 – serum 8 was produced by injecting the full length CAPS2e protein into the rabbit and due to the high 
similarity between CAPS1 and CAPS2 isoforms, this serum can detect both isoforms. 
 
Figure 39 CAPS isoforms are found in DRG 
neurons. 
Adult DRG neurons were fixed with 4 % PFA 
for 20 min and stained with serum 8 
against CAPS1 and CAPS2. Alexa 561 goat 
anti-rabbit secondary antibody was used. 
The fluorescence intensity of serum 8 was 
quantified in WT DRG neurons and 
compared to that of CAPS1 and CAPS2 dKO. 
 
N = 2 mice, n = 37 WT cell, n = 29 dKO cell. Mann Whitney significance test was applied, ** p < 0.01. 
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and not necessarily being expressed together. However, the second possibility is unlikely because 
previous data indicates that CAPS1 is found in all DRG neurons while CAPS2 in a subpopulation 
(Sadakata et al., 2006). CAPS2 staining was remarkably diffuse, suggesting that the punctate 
staining from serum 8 comes from CAPS1. We were also interested to know the subcellular 
localization of CAPS to get a hint about its function, whether it is localized to synapses, in order 
to test its possible effect on SV secretion, using the advantage from DRG/S neuron co-culture 
system. We used serum 8 and carried out double ICC together with anti-synaptophysin antibody in 
DRG/S neuron co-culture. Results showed that CAPS fluorescence signal was intensified at 
synapses between DRG neurons and spinal neurons (Figure 41). Manders’ coefficient of 0.8 ± 0.02 
from synaptophysin to CAPS suggests that the majority of synapses have either CAPS1 or 2 or 
both isoforms, while the lower Manders’ coefficient of 0.6 ± 0.03 from CAPS to synaptophysin 
suggests that CAPS is also found in processes and not just at the synapses. Further analysis of the 
position of synapses indicates that 40% of synapses were found between DRG processes and 
S neurons cell body and about 60% of the synapses were between processes of these neurons. This 
shows that CAPS is indeed found at synapses and confirms that the DRG/S neuron co-culture can 
be used to study the possible differential roles of CAPS isoforms in secretion of LDCVs and SVs. 
However, DRG neurons are silent in culture (Ransom et al., 1977b) and synapses don’t exist 
Figure 40 CAPS1/2 and CAPS2 
double-immunostaining. 
Adult DRG neurons were fixed 
and stained with serum 8 
against CAPS1 and CAPS2. Alexa 
561 goat anti-rabbit was used 
as secondary antibody was. Fab 
fragments were used to block 
serum 8 active sites before 
carrying out the second staining 
with purified serum 6 against 
CAPS2. Alexa 488 goat anti-
rabbit secondary antibody was 
applied against purified serum 
6. The images were acquired by 
confocal microscope and the 
signal from WT DRG neurons 
was compared to dKO neurons. 
(A) Bright field and confocal 
images acquired at, 561 and 
488 nm of WT DRG neurons 488 nm of DRG neurons were compared to dKO cells. (B) Graph displaying the fluorescence intensity of serum 8 and 
serum 6 compared to dKO signal. (C) Distribution of CAPS isoform among cells in percentage. N = 2 adult mice, n = 
28 WT and n = 94 dKO cell. Mann Whitney significance test was applied, *** p < 0.001. 
RESULTS 
 
72 
 
between 
DRG 
subpopulations (Joseph et al., 2010; Wake et al., 2015), so it was a prerequisite to establish and 
optimize and stimulation protocol to induce secretion of both LDCVs and SVs in DRG and 
DRG/S neuron cultures, respectively. 
 
III.2 Stimulus Protocol 
Stimulating LDCV and SV secretion was carried out the previously described field electrode 
but at different frequencies. The concept was to pick the mildest stimulus that can induce the 
highest number of cells responding to the stimulus. 
III.2.1 Stimulating DRG Neurons 
The electrical stimulus of four Volts at hundred Hertz to induce LDCV secretion was 
applied via a custom-made bipolar Platinum-Iridium field electrode. The establishment and the 
concept behind the field electrode is explained in details in the Materials and Methods chapter. 
Figure 41 CAPS isoforms localization to synapses in DRG/S neuron co-culture. 
Adult WT DRG neurons were co-cultured with dKO S neurons for five days and were fixed with 4 % PFA for 20 min 
and marked with serum 8 against CAPS1 and CAPS2 which was labelled with Alexa 561 goat anti-rabbit secondary 
antibody was used against serum 8. Fab fragments were used to block serum 8 antibodies active sites before 
carrying out the second staining against synaptophysin. Alexa 488 goat anti-rabbit secondary antibody was used 
against synaptophysin. The images were acquired using confocal microscope.  They were subjected to uniform 
threshold to compute Manders’ coefficients that are shown in the adjacent graph. M1 = Fraction of synaptophysin 
overlaying with CAPS isoforms, M2 = Fraction of CAPS isoforms overlaying with synaptophysin.  N = 2 animals for 
DRG neuronal preparation, N = 8 P0 pups for S neurons preparation, n = 82 cell. 
P
ro
c
e
s
s
e
s
 
M
an
d
e
rs
’ c
o
e
ff
ic
ie
n
ts
 
RESULTS 
 
73 
 
III.2.1.1 Stimulus optimization 
To test and optimize the electrical stimulus, cultured DRG neurons were incubated with the 
fluorescent calcium sensor Fluo 4 AM32 for 15 min and then washed. Several voltage intensities at 
different frequencies were tested and fluorescence intensity change was recorded. Results showed 
that a minimum stimulus of 2.5 V induced a slight increase in intracellular calcium, while at 4 V 
about 70% of DRG neurons displayed a strong increase in intracellular calcium (Figure 42), going 
below 2.5 V or above 4 V did not change the percentage of responding cells (data not shown), 
hence we picked 4 V at 100 Hz. The frequency of 100 Hz was chosen because it was shown that 
BDNF release from LDCVs in hippocampal neurons was not evoked at stimulus lower than 50 Hz 
                                                 
32 Fluo 4 AM from ThermoFisher is a fluorescent calcium assay. Upon binding calcium, its structure is modified 
inducing an increased fluorescence once excited at 488 nm. 
Figure 42 Electrical stimulus for DRG neurons. 
 DRG neurons were loaded with Fluo 4 AM dye for 20 min before recording. The cells were stimulated by custom-
made bipolar Platinum-Iridium field electrode at different voltages and the increase of Fluo 4 fluorescence intensity 
was imaged in epifluorescence mode. (A) Representative four DRG neurons are shown in bright field (left), 
epifluorescence at 488 nm before the electrical stimulus (middle) and upon the electrical stimulus (right). Three cells 
showed an increase in fluorescence intensity while the fluorescence in DRG number 4 didn’t change, hence this cell 
didn’t respond to the stimulus. ROIs marked the individual neurons and the fluorescence curves were plotted as a 
function of time in the lower graphs. (B) The graph shows the fluorescence intensity normalized to the baseline of 
individual DRG neurons subjected to 30 seconds stimulus of 2.5 V at 100 Hz as a function of time. (C) DRG neurons 
were stimulated with 4 V at 100 Hz and the fluorescence intensity was plotted against time. 
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(Gartner and Staiger, 2002). It was notable that DRG neurons didn’t exhibit
measurable calcium signal before the stimulus, supporting the argument that these cells are silent 
in culture and needs stimulus in order to secrete. The field electrode was entirely renewed every 
six month and calcium measurements were carried out every 3 months to ensure the consistency 
and efficacy of the electrical stimulus. 
III.2.1.2 LDCV Secretion 
To visualize secretion, DRG neurons were transfected with NPY-Venus. Venus was tagged 
to NPY to ensure its localization into LDCVs. NPY-Venus was driven by a Lentiviral expression 
system, it was essential to test if NPY-Venus was sorted correctly into LDCVs although 
Lentiviruses are gentle on cells and ensure a high survival rate after infection (Mao et al., 2015). 
NPY-Venus expressing DRG neurons were fixed and stained against Chromogranin A, a marker 
for LDCVs. Colocalization analysis showed that overexpressed NPY-Venus is loaded correctly 
into LDCVs (see Appendix VI.3). 
III.2.2 Stimulating Hippocampal Neurons 
To further verify the efficacy of the stimulus, we tried to stimulate hippocampal neurons 
with 10 Hz according to what is described in the literature (Balkowiec and Katz, 2002; Jacobs and 
Meyer, 1997). Eight days old hippocampal neurons33 were loaded with Fluo 4 AM and stimulated 
with 4 V at 10 Hz and 4 V at 100 Hz. The recordings showed that both stimuli had similar effect 
of about 70% of the neurons exhibited an increase in intracellular calcium (see Appendix VI.1 A. & 
B.), proving the efficacy of the customized field electrode. Unlike DRG neurons, hippocampal 
neurons were active before the stimulus which is normal for neurons that form active synapses in 
culture (Basarsky et al., 1994; Fletcher et al., 1994). This activity was evident in the first thirty 
seconds before the stimulus, as fluctuations of calcium concentration were visible. This, was not 
the case in DRG neurons calcium recordings (see Appendix VI.1 B.). 
                                                 
33 Hippocampal neuronal cultures were kindly provided by Mr. Ali Harb. 
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III.2.3 Stimulating DRG/S neuron co-cultures 
To study the effect of CAPS on SV 
secretion, we tested which stimulation frequency 
should be used to evoke reliable SV exocytosis. 
DRG neurons were infected with synaptophysin-
pHluorin one day before adding the S neurons. Co-
cultured neurons remained 9 days in culture to give 
enough time for synapses to form. Results showed 
that a 10 Hz stimulus was enough to evoke SV 
secretion at synapses. A 100 Hz stimulus 
following the first 10 Hz didn’t evoke further SV 
release, and one 100 Hz stimulus alone didn’t 
managed to evoke higher SV secretion as 
compared to 10 Hz (Figure 43 A, B & C). 
Consistent with hippocampal neurons results, a 10 
Hz stimuli is enough to evoke SV secretion. Now 
that the stimulus protocols to evoke SV and LDCV 
release were established, we could start studying 
the effect of CAPS on the exocytosis machinery. 
III.3 CAPS Isoforms Effect on LDCV 
Secretion 
Unlike central nervous system neurons, the 
exocytosis machinery in DRG neurons is not 
thoroughly studied. For instance it is known that 
exocytosis from the somata of DRGs is calcium- 
(Huang and Neher, 1996) and voltage-dependent 
(Liu et al., 2011) but how it is regulated at the 
molecular level remains poorly understood. Based 
on the differential localization of CAPS in DRG 
Figure 43 Electrical stimulus for DRG/S neuron co-
cultures. 
(A) DRG/S neuron co-cultured neurons were 
transfected with synaptophysin pHluorin and 
stimulated at 10 Hz. Fluorescence intensity was 
quantified as a function of time. A stronger stimulus 
was applied in (B) at 100 Hz and a 10 Hz stimulus 
followed by a 100 Hz stimulus was tested in (C.). 
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neurons (see Figure 40 & 41), we speculated that CAPS isoforms might play a role in the secretion 
machinery of LDCVs and SVs. To test this hypothesis, we prepared DRG neuron cultures from 
CAPS1 and CAPS2 dKO E18 mice, monitoring their LDCV release and compared it to neurons of 
WT E18 mice. 
III.3.1 CAPS Absence Hinders LDCV Secretion 
DRG neuronal cultures of CAPS1 and CAPS2 dKO mice were made at E18 because these 
mice were not viable and died at birth. LDCV secretion was measured in dKO and WT neurons 
that were prepared simultaneously and measured on the same day. The cumulative normalized 
secretion to individual cell surface area in WT cells was in average two vesicles per cell. This was 
significantly decreased to an average of one vesicle being secreted in dKO cells (Figure 44 A). To 
test whether CAPS1 and CAPS2 dKO had an effect on tethering of LDCVs to the plasma 
membrane, the vesicles in the TIRF plane were counted in WT and compared to dKO condition. 
No significant difference was measured (Figure 39 B& C). These results suggest that CAPS has a 
role in LDCV secretion in DRG neurons through priming but not tethering. 
III.3.2 CAPS Rescues LDCV Secretion in CAPS dKO Neurons 
Rescue experiments were performed to test whether the dKO secretion phenotype can be 
reversed by CAPS expression. Both CAPS1 and CAPS2 isoforms were able to restore LDCV 
secretion in CAPS dKO DRG neurons exceeding the WT level. CAPS dKO DRG neurons 
transfected with CAPS1 secreted in average 3.3 ± 0.8 LDCVs in the time of the recording 
comparable to neurons transfected with CAPS2 that secreted in average 3.9 ± 0.3 LDCVs, but 
significantly more than in dKO DRG neurons (Figure 40 A). The number of tethered vesicles were 
significance test was applied, ** p < 0.01 and ns p > 0.05.  
Figure 44 CAPS1 and CAPS2 dKO effect on 
LDCV secretion. 
(A) Cumulative secretion of LDCVs normalized 
to cell surface area in WT compared to CAPS1 
and CAPS2 dKO neurons. (N = 11 E18 pups, n = 
29 for WT and 74 for dKO). (B) Vesicles in the 
TIRF field were counted in both WT and CAPS1 
and CAPS2 dKO neurons and depicted in the 
graph. (C) Representative TIRF image of WT 
neurons and CAPS1 and CAPS2 dKO neurons 
expressing NPY-Venus. Scale bar is equal to 5 
µm. All error bars are SEM, Mann Whitney 
significance test was 
RESULTS 
 
77 
 
not different in dKO cells as compared to those that 
overexpress either CAPS1 or CAPS2 with no evident significant change (Figure 40 B & C). These 
data indicate that the reduction of secretion in CAPS1 and 2 dKO neurons is solely due to the 
deletion of the protein and not to some downstream series of effects. 
III.3.3 CAPS Overexpression Increases LDCV Secretion 
 CAPS dKO neurons rescued with either CAPS isoform secreted more LDCV than WT 
neurons. In chromaffin cells, however, LDCV secretion of CAPS dKO cells is rescued by CAPS2 
transfection only to WT level and in WT cells CAPS1 or 2 overexpression failed to increase LDCV 
exocytosis (Liu et al., 2010). Thus we tested if CAPS overexpression in WT DRG neurons would 
affect the LDCV secretion. First, CAPS1 was overexpressed and secretion was compared to WT 
cells. CAPS1 overexpressing neurons secreted 3.6 ± 0.4 LDCVs while control neurons secreted 
1.4 ± 0.3 LDCVs (Figure 46 A) without affecting the number of vesicles tethered to the plasma 
membrane (Figure 46 B & C). This suggests that CAPS1 has no function at the level of tethering 
of vesicles and the effect on secretion is rather due to enhanced LDCV priming. In similar fashion, 
CAPS2 overexpression increased secretion till 3.9 ± 0.3 LDCVs compared to 2.1 ± 0.4 LDCVs in 
WT condition (Figure 47 A) without affecting the overall number of tethered vesicles to the plasma 
Figure 45 CAPS1 and CAPS2 overexpression in 
dKO effect on LDCV secretion. 
(A) LDCV secretion in dKO neurons compared to 
dKO neurons either overexpressing CAPS1 or 
CAPS2b (N = 10 E18 pups, n =25 for dKO, 12 for 
dKO+CAPS1 and 9 for dKO+CAPS2b). (B) The 
number of and the vesicles in TIRF field were 
quantified for every condition. (C) 
Representative TIRF images for dKO, 
dKO + CAPS1 and dKO + CAPS2. All error bars 
are SEM, One Way ANOVA Dunn’s post 
significance test was applied, * p < 0.05, ** p < 
0.01 and ns > 0.05. Scale bar is equal to 5 µm. 
 
(A) Shows averaged normalized cumulative 
secretion of LDCVs to cell surface area in WT 
neurons compared to WT neurons 
overexpressing CAPS2b (N = 7 adult mice, n = 40 
for WT and 28 for WT + CAPS2b). (B) Bar 
diagram of the number of LDCV in the TIRF field 
in both WT and WT + CAPS 1. (C) Representative 
TIRF image of WT neurons and WT neurons 
overexpressing CAPS2b. Scale bar is equal to 5 
µm. All error bars are SEM, Mann Whitney 
Whitney significance test was applied, ** p < 0.01 and ns p > 0.05.  
Figure 46 CAPS2 overexpression effect 
on LDCV secretion in DRG neurons. 
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membrane (Figure 47 B & C). Altogether, this data indicates that CAPS isoforms can affect LDCV 
secretion through priming and not tethering. 
III.4 Half of DRG Neurons Secrete LDCVs 
The secretion from dKO 
neurons was intriguing, as we 
noticed while doing the 
experiments that only a very small 
population secreted from the entire 
measured cells. Further analysis of 
the data showed that half of the 
neurons would respond to the 
stimulus and secrete LDCVs in 
WT system while this percentage 
is significantly decreased to 30% 
in CAPS1 and CAPS2 dKO 
system. Upon overexpressing of either CAPS isoform in WT cells, there was a tendency to have 
more cells that secreted LDCVs. This data emphasize the strong effect of CAPS by showing that 
CAPS not only affects the number of secreted LDCVs but also the number of secreting cells.  
We were also puzzled by the fact that whatever electrical stimulus we applied even with 
higher voltage (data not shown), the number of secreting cells in WT was not changed. Therefore, 
we investigated whether stimulated LDCV secretion is limited to a certain subset of DRG neurons. 
Figure 48 Percentage of secreting cells. 
Percentage of secreting cells was counted in CAPS1 and CAPS2 dKO, 
CAPS1 overexpressing and CAPS2 overexpressing neurons and compared 
to those of WT neurons. Mann Whitney significance test was 
applied, * p < 0.05. 
 (A) Normalized cumulative secretion of LDCVs to 
cell surface area in WT neurons compared to WT 
neurons overexpressing CAPS1 (N = 5 adult mice, 
n = 50 for WT and 33 for WT + CAPS1). (B) 
Vesicles in the TIRF field were counted in both 
WT and WT + CAPS1 neurons and depicted in the 
graph. (C) Representative TIRF image of WT 
neurons and WT neurons overexpressing CAPS1. 
Scale bar is equal to 5 µm. All error bars are SEM, 
Mann Whitney significance test was applied, ** Mann Whitney significance test was applied, ** p < 0.01 and ns p > 0.05. 
Figure 47 CAPS1 overexpression effect on 
LDCV secretion in DRG neurons. 
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III.5 Peptidergic and Non-Peptidergic DRG Neurons  
DRG neurons con-
stitute a very heterogeneous 
population depending on 
their sensory input or 
morphological characteris-
tics. Despite this diversity, 
they can be classified into 
two main categories, the 
peptidergic myelinated 
neurons and the non-
peptidergic un-myelinated 
neurons (Saeed and Ribeiro-
da-Silva, 2012). Peptidergic 
neurons can be marked by 
anti-CGRP antibody 
(Barabas et al., 2012), anti-
NK-1r34 (McLeod et al., 
1998; Takeda et al., 1991; 
Todd et al., 2002), 
anti-Chromogranin A 
(Adams et al., 1993; Schafer 
et al., 2010) and anti-
TRKB35 receptor (Dykes et 
al., 2010; Scott et al., 2011). 
Often, NF-20036 is used as a 
                                                 
34 Neurokinin-1 receptor for substance P, is a G protein coupled receptor that is a product of TACR1 gene and found 
in CNS and PNS (Takeda et al., 1991). 
35 Tyrosine Kinase B receptor that has high specificity to BDNF. 
36 Neurofilament-200 is anti-heavy neurofilaments of around 200-220 kDa that are major component of neuronal 
cytoskeleton. 
Figure 49 Percentage of peptidergic and non-peptidergic DRG neurons. 
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global marker to label all 
peptidergic neurons 
(Ishikawa et al., 2005; 
Pierce et al., 2006; Segond 
von Banchet et al., 2002). 
Non-peptidergic neurons 
are collectively labelled by 
isolectin B4 (Hunt and 
Mantyh, 2001; Molliver et al., 1997; Stucky and Lewin, 1999; Wang and Zylka, 2009; Woolf and 
Ma, 2007) according to the protocol that was described by Kubo et al. (2012). Because iB4 can be 
applied to living cells, we chose this method to identify different neuron subtypes while carrying 
out physiological experiments. To characterize DRG neuronal populations, two adult mice 
preparations were fixed after 7 DIV with 4% PFA and stained with iB4. Extensive washing steps 
were applied with the addition of iT-FX image enhancer. To account for the high diversity of 
neuronal populations, about 436 cells were imaged using confocal microscope. The acquisition 
parameters were set in such a way to increase the signal-to-noise ratio with 1 AU pinhole, low 
digital gain and 2% laser power. Results showed that 49% of the DRG neurons in culture are 
peptidergic neurons and 51% are non-peptidergic neurons. The peptidergic neurons were mainly 
of medium, large and extra-large sized population while non-peptidergic neurons were of medium 
and small size (Figure 49 A & B). The two subtypes were grouped according to size (Figure 44 C). 
We further investigated whether there is a correlation between the strength of iB4 and the size of 
DRG neurons. The fluorescence intensity of iB4-positive cells were plotted against the size in 
Figure 44 D, and the results suggest that there is no correlation. Now that we were able to group 
these cells according to peptidergic and non-peptidergic classes, we screened for CAPS isoforms 
among these two subpopulations and checked whether they have a preferential localization. 
III.6 CAPS Isoforms Localization in DRG Neuron Subtypes 
CAPS isoforms were localized to DRG neurons subtypes using ICC experiments involving 
primary antibodies against CAPS1 and CAPS2. 
Continuing figure 49… (A). Cultured WT DRG neurons were fixed with 4% PFA 
and stained against Isolectin receptor using GS-iB4 coupled to Alexa-561 and 
incubated for 1 hr. Fixed cells were imaged using confocal microscopy and cells 
were counted and screened against positive and negative staining. Positively 
stained cells are non-peptidergic neurons and the unstained cells are the 
peptidergic DRG neurons. N = 436 cells were imaged from two DRG neuron 
cultures. (B) Representative images showing in the upper panel two positively 
medium-sized stained non-peptidergic neurons imaged at 561 nm laser and in 
the lower panel, one larger DRG peptidergic neuron that is not stained. (C) 
Occurrence of DRG neuronal subpopulations versus neuron surface area. (D) 
Plot of the signal intensity of iB4 positive neurons against their surface area, 
N = 226. 
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III.6.1 CAPS1 Isoform Localization into DRG Subtypes 
To localize CAPS1, experiments to ensure the specificity of a new commercial anti-
CAPS137 antibody were carried out involving WT cells that were compared to CAPS1 KO cells 
(Appendix VI.2). WT DRG neurons were fixed with 4% PFA for 20 min and stained against CAPS1 
together with iB4 labelling. Image stacks were acquired using a confocal microscope with 2% laser 
intensity for both 488 and 561 nm wavelength and 500 digital gain. Taking a stack helps in judging 
whether the neuron is peptidergic or not, because some red processes from non-peptidergic neurons 
were wrapped around the base of other neurons, falsifying the identification. A non-peptidergic 
neuron should be entirely outlined with the red signal from the base to its top. CAPS1 fluorescence 
intensity was analysed in iB4 positive and negative neurons. Results indicate that CAPS1 is 
distributed randomly across peptidergic and non-peptidergic neurons. Nevertheless, some 
peptidergic DRG neurons showed brighter CAPS1 fluorescence but it didn’t impact significantly 
the average fluorescence when compared to the non-peptidergic neurons (Figure 50). To further 
characterize CAPS1 localization in peptidergic neurons subtypes, we stained DRG neurons against 
NK-1r and TRKB receptor together with anti-CAPS1. The fluorescence intensity of CAPS1 was 
quantified and we compared it between cells that expressed NK-1r or not. CAPS1 expression was 
                                                 
37 Polyclonal rabbit anti-CADPS1 antibody from Synaptic Systems, cat. no. 262 013 
Figure 50 CAPS1 with iB4 staining. 
Embryonic WT DRG neurons were fixed with 4% PFA for 20 min then stained against CAPS1 (1:1000) and iB4-Alexa 
561. The left panel shows confocal images of DRG neurons in bright field, 561, 488 nm and all 3 channels merged. 
The graph to the right shows CAPS1 fluorescence intensity in peptidergic and non-peptidergic DRG neurons. N = 2 
animals. N = 118 cell. Mann Whitney significance test was applied, ns p > 0.05. All error bars are SEM. 
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significantly higher in NK-1r positive cells (Figure 51 A). The same analysis was done for TRKB 
positive cells and there was no significant preferential localization of CAPS1 to this subtype of 
peptidergic neurons (Figure 51 B). About 22.7%38 of adult DRG neurons are NK-1r positive (Hall 
et al., 1997; Tuchscherer and Seybold, 1985), this probably explains why there is no significant 
difference of CAPS1 expression levels among peptidergic and non-peptidergic neurons. Next we 
examined CAPS2 distribution among different DRG subtypes. 
                                                 
38 13.5% ± 1.9 SEM of all E19.5 DRG neurons express substance P, this fraction gets bigger as the mice develop in 
age (Hall et al., 1997). 
Figure 51 CAPS1 localization into peptidergic neurons. 
Embryonic WT DRG neurons were fixed with 4% PFA for 20 min then stained against CAPS1 and stained either 
against TAC-1 , which is an antibody recognizing NK-1 receptors, or TRKB. (A) The left panel shows confocal images 
for DRG neurons in bright field, 488, 561 nm and all 3 merged channels of CAPS1 and TAC-1 staining. N= 2 animals, 
n = 92 cells. The graph to the right quantifies CAPS1 fluorescence intensity in TAC-1 positive and negative neurons. 
(B) The right panel shows confocal images of DRG neurons in bright field, 488 nm, 561 nm and all 3 channels merged. 
The graph to the right shows CAPS1 fluorescence intensity in TRKB positive neurons compared to TRKB negative 
neurons. N = 2 animals, n = 34 cells. Mann Whitney significance test was applied, ns p > 0.05. * p < 0.05. All error 
bars are SEM. 
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III.6.2 CAPS2 Isoform Localization into DRG Subtypes 
DRG neurons were co-stained against CAPS2 and iB4. Images were acquired in similar 
fashion as the previous experiment. There was a striking difference in CAPS2 localization, for 
instance, its fluorescence signal was four times higher in peptidergic neurons compared to non-
peptidergic neurons (Figure 52). Almost 80% of peptidergic neurons expressed CAPS2. Based on 
our previous data that indicate that CAPS2 is found in half of DRG neurons, this experiment 
accordingly states that this 50% are the peptidergic neurons. To further verify and strengthen these 
findings, we co-stained neurons against CAPS2 and anti-NK-1r or anti-TRKB. The percentage of 
NK-1r expressing cells in vitro was ~25% ± 0.5 SEM (Figure 53 A), which was very close to the 
endogenous in vivo expression levels (Hall et al., 1997). Of those neurons that were positive for 
NK-1r, 60% expressed CAPS2 (Figure 53 B). About 60% of peptidergic neurons were TRKB 
positive (Figure 53 A) of which 80% expressed CAPS2 (Figure 53 B). This data set reinforces the 
idea that CAPS2 expression is restricted to peptidergic neurons and led us to hypothesize that the 
50% LDCV stimulated secretion profile observed in WT neurons might be regulated by CAPS2 
that is found in ~50% of DRG neurons. The next experiments were designed to investigate this 
possibility. 
Figure 52 CAPS2 with iB4 staining. 
Embryonic WT DRG neurons were fixed with 4% PFA for 20 min then stained against CAPS2 and iB4-Alexa 561. Alexa 
488 secondary goat anti-rabbit antibody was used against CAPS2 antibody. The left panel shows confocal acquired 
images of DRG neurons in bright field, 561, 488 nm and merged channels. The graph to the right shows CAPS2 
fluorescence signal distribution among peptidergic and non-peptidergic DRG neurons. N = 2 animals, n = 57 cells. 
Mann Whitney significance test was applied, n*** p < 0.001. All error bars are SEM 
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III.7 LDCV Secretion in Peptidergic and Non-Peptidergic Neurons 
To verify our hypothesis we assessed which neuron subtype can secrete LDCVs. We took 
advantage of the fact that iB4 stains living cells without affecting their physiological properties and 
measured LDCV release from peptidergic and non-peptidergic neurons. 
Figure 53 CAPS2 localization into peptidergic subtypes neurons. 
Embryonic WT DRG neurons were fixed with 4% PFA for 20 min then stained against CAPS2 and stained either against 
TAC-1 or TRKB. (A) The left panel shows confocal images for DRG neurons in bright field, 488, 561 nm and all 3 channels 
merged of CAPS2 and TAC-1 staining. The graph on the upper right shows the percentages of DRG neurons that are 
either TAC-1 or TRKB positive neurons. N= 2 animals, n = 156 cells for TAC-1 and n = 95 cells for TRKB. (B) The lower 
left panel shows confocal images for DRG neurons in bright field, 488, 561 nm and all 3 channels merged of CAPS2 
and TRKB staining. The graph on the lower right shows the percentage of CAPS2 positive neurons of TAC-1 or TRKB 
subtype. N = 2 animals, n = 34 for TAC-1 and n = 53 cells for TRKB. All error bars are SEM. 
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III.7.1 CAPS2 Mediates LDCV Secretion 
DRG neurons from two week old WT mice were transfected with NPY-Venus and labelled 
with iB4 according to the previously described protocol (Figure 54 A). Cells were washed with 
warmed extracellular solution at 34 °C. LDCV secretion was recorded in TIRFM dual-view setting 
which was necessary to eliminate spectral overlaps coming from the bright signal of Alexa-561 
Figure 54 Examining secretion in peptidergic and non-peptidergic DRG neuron subpopulations. 
(A) Schematic diagram explaining iB4-Alexa 568 staining of DRG neurons. Cells are incubated in extracellular solution 
in the presence of 1 mg.ml-1 of iB4-Alexa 568 for 20 min at 37 °C then washed for 10 min with continual perfusion. 
iB4+ neurons were visualized with 561 nm laser. (B) Imaging of iB4 positive non-peptidergic unmyelinated DRG 
neurons. The top panels show a non-peptidergic DRG neuron transfected with NPY-Venus while the middle panels 
show a peptidergic neuron, outlined with white dotted line, the white arrow points out an adjacent non-peptidergic 
DRG neuron. The bottom panel shows a non-peptidergic DRG neuron co-expressing NPY-Venus and CAPS2b-mTFP. 
(C) Average LDCV secretion in iB4+ non-peptidergic neurons (N = 4, n = 34) compared to iB4- peptidergic neurons (N= 
4, n = 30). (D) Average LDCV secretion of iB4 non-peptidergic DRG neurons overexpressing CAPS2b (N = 3, n = 20) 
compared to iB4+ non-peptidergic (N = 3 n = 19) and iB4- peptidergic neurons (N = 3, n = 14). (E) Percentage of iB4 
non-peptidergic DRG neurons overexpressing CAPS2b secreting cells compared to iB4- iB4+ DRG neurons. 2 weeks 
old mice were used for these experiments. Error bars in (C, D & E) are SEM and ***p < 0.001 Mann Whitney test; 
***p < 0.001 one way ANOVA; ***p <0.001 one way ANOVA, respectively. 
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that is coupled to the isolectin product. Measurements from four cultures showed that LDCV 
secretion occurs almost exclusively in peptidergic neurons. Out of 34 non-peptidergic recorded 
neurons only 2 cells secreted. We then overexpressed CAPS2b in WT adult DRG neurons and 
repeated the previous experiment and we measured LDCV secretion from non-peptidergic 
transfected neurons. All of the sudden, these silent cells started to secrete (Figure 54 D) and the 
percentage of secreting cells elevates from almost nil to 60% (Figure 54 E). Although, non-
peptidergic neurons express CAPS1, it seems the presence of this isoform is not sufficient to allow 
LDCV secretion. Therefore, CAPS2 is required for the priming of LDCV secretion from the soma 
of WT DRG neurons. 
 
III.8 Establishing DRG/S neuron Co-Culture 
In order to assess the function of CAPS isoforms in mediating synaptic transmission, we 
established DRG/S neuron co-culture. DRG neurons do not form autaptic synapses, neither in vivo 
nor in cultures (Ransom et al., 1977a). DRG neurons that are located outside the spinal cord, form 
synapses with S neurons by extending their axons mainly to the dorsal horn neurons (Barber and 
Vaughn, 1986; Zeilhofer et al., 2012) and to lesser extent the large axons are extended to the ventral 
horn neurons (Molander and Grant, 1987). The establishment of this sophisticated co-cultures 
involved extensive optimization to enhance cell survival and synapse formation rate in vitro. 
III.8.1 DRG/S neuron Survival in Vitro  
The first challenge was to maintain S neurons living in culture along with DRG neurons. 
Initially it was difficult to keep S neurons in culture for longer than four days but changes in the 
culture conditions helped keep S neurons alive for at least nine days in vitro (Figure 55). Neurons 
grew processes which was an indication that they are in good health condition. We then tested 
whether these neurons form synapses in vitro under these culture preparation conditions. 
RESULTS 
 
87 
 
III.8.2 Synapses Form between DRG and S neurons39 
To check whether synapses do form in 
vitro, Mr. Ali Harb performed preliminary 
experiments in which DRG neurons were co-
cultured with S neurons and kept in culture for 
four days. The co-cultured neurons were fixed 
with 4% PFA and stained against MAP-2 to 
mark neurons (Caceres et al., 1986; Fischer et 
al., 1986) and synaptophysin to mark synapses 
between neurons (Jahn et al., 1985; Regnier-
Vigouroux et al., 1991; Wiedenmann et al., 
1985). The red spots opposing the S neuron 
suggest that synapses start forming between the 
two types of neurons at day four in vitro 
(Figure 56). This experiment confirmed that 
synapses form but whether these synapses are 
functional remained unknown. 
                                                 
39 This experiment was carried out by Mr. Ali Harb during his Masters II. 
Figure 55 DRG/S neuron co-cultured neurons morphology over time. 
WT DRG neurons were co-cultured with WT S neurons in culture. Morphology and health state of these cells were 
monitored at DIV 3. 5. 7 and 9 using confocal microscope. 
Figure 56 Marking synapses between DRG neurons and 
S neurons. 
WT DRG/S neuron culture were fixed with 4% PFA and 
stained as MAP-2 (1:1000) shown in blue and against 
synaptophysin (1:1000) shown in red. The upper two 
arrows on the bright field image indicate a DRG neuron 
while the lower arrow points to S neuron. The red dotted 
staining on the S neuron soma and neurite are synapses 
formed between DRG and spinal neurons. 
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III.8.3 Synapses are Functionally Connected40 
To investigate synapse 
functionality, field electrode 
stimulation was ruled out as it would 
stimulate all cells in proximity. Taking 
advantage that some DRG neurons are 
touch sensitive through specialized 
mechanoreceptors (Abraira and Ginty, 
2013; Lumpkin and Bautista, 2005); 
co-cultured DRG/S neuron were loaded 
with Fluo 4 AM and DRG neurons 
were mechanically stimulated in hope 
that they would have mechanoreceptors 
which respond to the stimulus. After 
several trials, we were able to find one 
DRG neuron that responded first steep increase in Fluo 4 fluorescence. In contrast, the S neurons 
displayed a delayed answer to the stimuli indicating that they were not directly activated by the 
touch but instead received their input over synaptic transmission from the DRG neurons (Figure 
57). Attempts to directly mechanically stimulate S neurons were unsuccessful (data not shown). 
Therefore we conclude that DRG neurons form functional synapses with S neurons in our culture 
conditions. To further understand the development of the synapses, we did an extensive study 
involving hundreds of cells and counting thousands of synapses to understand when these synapses 
start to form in our co-culture conditions. 
III.8.4 Characterizing Synapses over Time 
DRG neurons of Synpatobrevin-mRFP knockin (Matti et al., 2013) were co/cultured with 
WT S neurons and fixed with 4% PFA for ten minutes instead of the usual twenty minutes to 
maintain the synapses integrity. The SybKI signal allowed tracing of the processes back to DRG 
neurons and distinguish them from S neurons. The co-cultured neurons were stained against 
bassoon to label presynapses (Brandstatter et al., 1999; Richter et al., 1999; tom Dieck et al., 1998) 
                                                 
40 This experiment was carried out by Dr. Ute Becherer. 
Figure 57 DRG/S neuron Synapses are functional. 
DRG/S neuron co-cultured cells were loaded with Fluo 4 AM. One 
DRG neuron was poked with glass pipette to depolarize the cells 
and induce an increase of the intracellular calcium concentration. 
The bright field image shows One DRG neuron and next to it our 
smaller dorsal horn neurons (DHN). The graph on the right displays 
the change in Fluo4 fluorescence intensity over time. 
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and PSD9541 to label postsynapses (Cho et al., 1992; Hunt et al., 1996). Co-cultured neurons were 
fixed and stained at different time point and synapses were counted (Figure 58 A). We counted two 
types of synapses, those that we called mature synapses that included all three signals from SybKI, 
Bassoon and PSD95 and non-active synapses that encompass the signal of bassoon and PSD95 
near a process that is labelled with SybKI signal. Analysing thousands of synapses, showed that 
mature synapses start to form at day three in vitro and increase as they stay longer while immature 
synapses number remain the same. As the cells grow older in culture, DRG neurons tend to survive 
but S neurons number declines (Figure 58 B). Next, we wanted to understand where these synapses 
are located. In automated fashion, we measured the distances from individual synapses on 
processes back to DRG neurons and S neurons (Figure 58 C). Synapses form in significantly closer 
proximity to S neurons compared to DRG neurons. Thus, TIRFM recordings should be performed 
closer to S neurons to pick up synaptic activity (Figure 58 D). To further ensure a good quality of 
the culture, we made sure that the density of astrocytes remained consistent. This experiment 
enabled us to firmly control the parameters of establishing synapses between DRG and S neurons. 
To achieve a count of 80 synapses per 0.5 mm2, an average number of 3.5 DRG neurons, 5 
S neurons and 3.6 astrocytes are needed per 0.5 mm2 that should be maintained in culture for 9 
DIV. Now that synapses between DRG and S neurons are fully controlled in our co-culture settings, 
studying CAPS isoforms effect on synaptic transmission became feasible. 
 
 
                                                 
41 Post synaptic density 95 
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Figure 58 Synapse formation over time. 
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III.9 CAPS1 Localization at Synapses 
CAPS2 is present in half of the DRG neuronal population and is responsible for the 
secretion of LDCVs in these neurons. We speculated that CAPS1 play an essential role in mediating 
synaptic transmission. If CAPS1 is involved in synaptic transmission by promoting priming of 
synaptic vesicles in DRG neurons then CAPS1 should be localized to synapses. To test this 
hypothesis, we performed an immunostaining of the DRG/S neuron co-culture with anti CAPS1 
antibody and anti synaptophysin which is specifically localized to synapses (Jahn et al., 1985; 
Regnier-Vigouroux et al., 1991; Wiedenmann et al., 1985). To avoid confounding results, the 
culture included DRG neurons that were isolated from WT mice and S neurons that were isolated 
from CAPS dKO mice (Figure 59 E). With this configuration a co-localisation of both proteins can 
only occur at heterologous synapses formed between DRG and S neurons and not at inter S neuron 
synapses. Figure 59 A shows that CAPS1 is aggregating at discrete spots along the neurites partially 
co-localizing with synaptophysin. The co-localization analysis with Manders coefficient showed 
that a large fraction of CAPS1 is not localized to synapses (Figure 59 B) but rather that it was 
spread along the neurites. Additionally, only about 40% of synaptophysin is localized to CAPS1 
because more than 60% of synapses were formed in between S neurons inherently devoid of 
Continuing Figure 58… Co-cultured Synaptobrevin-mRFP Knock-In (SybKI) DRG neurons with WT S neurons were 
fixed with 4% PFA at DIV 03, 05, 07, 09 and 11. To identify fully functional synapses, neurons were stained against 
presynaptic marker Bassoon and postsynaptic marker PSD-95. Synaptobrevin-mRFP in DRG neurons allowed the 
identification of heterotypic synapses that were formed between DRG and S neurons and not homotypic synapses 
in between two S neurons. 
(A) From top to bottom bright field and confocal images of Bassoon (cyan), PSD-95 (yellow) and SybKI (magenta) 
labelling. The fifth row of images corresponds to the overlay of all 4 channels. White arrows point at S neurons and 
yellow arrows indicate synapses in which Bassoon, PSD-95 and SybKI signals co-localize. The last row is a magnified 
portion of the images row 5 delineated by a stippled line. (B) Synapses in which Bassoon, PSD-95 and SybKI signal 
co-localized (top), as well as DRG and S neurons (bottom) were counted manually and plotted against the number 
of DIV. The data was normalized to the acquired surface area. (C) Schematic representation of the analysis method 
used to measure the distance from each heterotypic synapse to the nearest DRG and S neuron cell body of neurons 
that were maintained for 9 days in co-culture. (D) Box plot of the distance between heterotypic synapses and 
neuronal cell bodies at DIV 9. Pink and black lines in the box correspond to the average and median distances, 
respectively. Note that heterotypic synapses were preferentially formed closer to S neurons than to DRG neurons. 
The data originated from two separated cultures. In total DRG neurons were isolated from 2 adult mice while S 
neurons were isolated from 12 P0 mice. Several DRG and S neurons were analyzed and hundreds of synapses were 
counted: DIV 03, nDRG neurons = 75, nS neurons = 139 and nsynapses = 286; DIV 05, nDRG neurons = 84, nS neurons = 157 and 
nsynapses = 258; DIV 07, nDRG neurons = 82, nS neurons = 109 and nsynapses = 845; DIV 09, nDRG neurons = 62, nS neurons = 73 and 
nsynapses = 1401 and DIV 11, nDRG neurons = 31, nS neurons = 58 and nsynapses = 1120. A total of 343 DRG neurons, 536 
S neurons and 4704 synapse were counted. 
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CAPS (Figure 59 C). This indicates that nearly all synapses between DRG and S neuron contained 
CAPS1. Furthermore, CAPS1 fluorescence signal was 2.5 fold higher at synapses in comparison 
to extra synaptic regions (Figure 59 D, F). Therefore, CAPS1 is not only localized to but also 
enriched at synapses suggesting a possible role in synaptic transmission. 
Figure 59 CAPS1 colocalization 
at synapses in co-cultured 
DRG/S neuron. 
(A) Co-cultured P0 WT DRG 
neurons with E18 CAPS dKO 
S neurons that were fixed with 
4% paraformaldehyde at DIV 7 
and stained with antibodies 
directed against CAPS1 and 
synaptophysin. This culture 
condition ensured that CAPS1 
labelling would be exclusively 
localized to DRG and not 
S neurons.  (A) From left to right 
bright field, and confocal 
maximal intensity projected 
images (MIP) of CAPS1 (green) 
and synaptophysin (red) labeling. 
The last panel depicts the overlay 
of both confocal channels. (B) 
Graph showing Manders’ 
coefficients of CAPS1 positive 
pixels co-localizing with 
synaptophysin or of 
synaptophysin positive pixel 
co-localizing with CAPS1 in green 
and red, respectively. (C) 
Percentage of heterotypic 
synapses between DRG/S 
neurons compared to homotypic 
S/S neurons. A total of 1178 
synapse were analyzed, 412 
where heterotypic while 766 
were homotypic. (D) Average 
fluorescence intensity of CAPS1 
labeling measured at 144 
synapse and 135 nearby 
positions on the DRG neuron 
neurites. (E) Schematic 
representation of representation of the experimental design. Yellow dots indicate merged anti CAPS1 and synapt physin labeling, 
which were localized exclusively to heterotypic synapses by experimental design. (F) Profile diagram of the 
fluorescence intensity of CAPS1 (green line) and synaptophysin (red line) labelling along a DRG neurite shown in 
A right panel. Error bars in (B & D) are SEM and ***p < 0.001 Mann Whitney test for (D). 
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III.10 Measuring Synaptic Transmission via V-GLUT mNectarine 
We initially decided to 
measure synaptic transmission by 
tagging VGLUT with a pH sensitive 
fluorescent protein. Fusion of 
fluorescent protein with synaptic 
vesicle associated proteins like, 
synaptophysin, Synaptobrevin, 
synaptotagmin and VGLUT is a 
common procedure to measure 
synaptic vesicle fusion 
(Miesenbock et al., 1998; 
Sankaranarayanan and Ryan, 2000). 
We were limited in the choice of the 
options of fluorescent proteins 
because CAPS was tagged with 
mTFP and NPY with Venus so we 
selected the pH sensitive m-
Nectarine (Johnson et al., 2009). 
The mNectarine was cloned to the 
N-terminal part of VGLUT so that it 
faces the luminal side of the vesicle 
(See Appendix VI.4). Because of its 
pH sensitive characteristics, 
mNectarine signal was not visible at 
all in acidic environment of 
vesicles. This was one major 
disadvantage, because we would not 
know which cells were transfected. 
Measurements would be carried 
blindly, hoping that the cell was 
Figure 60 Measuring synaptic transmission with vGlut-mNectarine. 
(A) Vesicles that are labelled with vGlut-mNectarine shows no 
fluorescence but once secretion is induced, pH elevates pushing the 
mNectarine to fluoresce. Upon NH4Cl application, NH3 goes inside 
vesicles chelating proton ions and elevating pH inside the vesicles 
which pushes mNectarine to fluoresce serving as a method to reveal 
all synapses in transfected cells. (B) The first panel shows vGlut-
mNectarine signal imaged at 561 nm laser and the second panel 
shows an overlay of the red channel with the bright field. (C) 
Measuring synaptic transmission in transfected cells after inducing 
secretion with 4 V at 10 Hz electrical stimulus. The graph displays the 
fluorescence intensity as a function of time. 
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transfected. Then at the end of the experiment the cells were superfused with NH4Cl to deprotonate 
the content of vesicles and reveal the transfected cells and synapses (Figure 60 A). The production 
of this virus passed through a year of optimization to enhance its transfection efficacy. It required 
a special bacteria to produce the DNA without unwanted genetic recombination. Stbl3 a chemically 
competent E. coli were designed for cloning huge plasmid DNA with direct repeats found in 
lentiviral expression vectors. This bacteria is used to reduce the frequency of homologous 
recombination of long LTRs and often yield ten folds higher DNA compared to the conventional 
DH5α cells. Once transfected it was almost impossible to see the signal in transfected cells and it 
required high laser power which also increase autofluorescence (Figure 60 B). Cells were randomly 
stimulated and no clear response was evident as the noise was very high which made this 
measurements very complicated (Figure 60 C). One layer of complexity was unintentionally added 
to this set of experiments as we were trying to measure synaptic transmission at 5 DIV. We didn’t 
know at that time the optimal time point to measure synaptic transmission. We eventually decided 
to drop this method and replace it by the well-
established synaptophysin-pHluorin lentiviral 
driven expression system. 
III.11 Measuring Synaptic Transmission 
via Synaptophysin-pHluorin 
SypHy held a major advantage over 
VGLUT-mNectarine because the signal is slightly 
visible in transfected cells (Royle et al., 2008). 
Upon vesicle fusion or NH4Cl application and 
therefore pH elevation, an increase in fluorescence 
is recorded (Figure 61). SypHy has been 
established as a powerful tool to record synaptic 
transmission, as it has an excellent signal to noise 
ratio and high transfection efficacy42. Furthermore, 
                                                 
42 The transfection efficacy was about 70% in conventional means of virus production and this percentage is increased 
till +90% in ultra-centrifuged viral batches. 
Figure 61 NH4Cl mode of action on SypHy. 
SypHy is slightly fluorescent at acidic pH, once the 
vesicle fuse with the membrane, the pH elevates 
which increase the fluorescent of SypHy. Upon NH4Cl 
application, the NH3 diffuses into the membrane and 
deprotonates the lumen of vesicles by binding the H+ 
ions inside hence achieving maximal SypHy 
fluorescence intensity. 
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its specificity of marking synaptic vesicles was well documented in the literature (Granseth et al., 
2006; Kwon and Chapman, 2011; Li et al., 2011; Miesenbock et al., 1998; Royle et al., 2008). 
Stimulation protocols were extensively tested (see Materials and Methods chapter) and adjusted to 
evoke robust SV secretion with minimal possible stress to cells. We then used this methodology to 
test the effect of CAPS isoforms on synaptic transmission. We hypothesized that CAPS1 is 
preferentially localized to synapses because it is a priming factor of SV secretion. 
III.11.1 CAPS1 Mediates SV Secretion in DRG/S neuron Co-Culture 
DRG neurons of WT, CAPS1 and 2 dKO, CAPS1 KO and CAPS2 KO genotypes were 
transfected with SypHy, co-cultured with WT S neurons and measured as previously described. 
Raw data of the exemplary measurements are displayed in figure 62. Individual synapses exhibited 
different maximal responses upon NH4Cl application as shown in figure 57 B. For this reason we 
Figure 62 Exemplary traces of averaged synapses from individual recordings of DRG/S neuron co-cultures. 
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normalized all the synapses to their individual maximal response upon 40 mM NH4Cl application 
(Figure 62). Figure 63 shows that the response to 10 Hz depolarization train was maximal in WT 
neurons and reduced to 38.5% in dKO neurons. Similarly, deletion of CAPS1 reduced the peak 
SypHy response to 58%. In contrary, deletion of CAPS2 had little effect on the maximum increase 
of SypHy fluorescence. Hence, in 
DRG neurons synaptic transmission 
appears to be promoted exclusively by 
CAPS1 while CAPS2 seems to be 
responsible for LDCV release. We 
noticed that the average time course of 
SypHy fluorescence intensity change 
of many cells elicited by field 
electrode stimulation was different 
depending on the genotype. The 
question was then whether CAPS2 
might have an indirect effect on 
synaptic transmission. 
III.11.2 A Role for CAPS2 in Synaptic Transmission? 
The average time course of fluorescence intensity change can be influenced by two 
parameters: the fluorescence intensity change of each individual synapse due to spontaneous 
activity or the time point at which they react in delayed fashion within the stimulus range. In the 
latter case, the unsynchronized response to a stimulus would result in a reduced but broader average 
peak. To investigate whether CAPS isoform had an effect on the synchronization of synaptic 
transmission to the stimulus, we measured the delay between the stimulus and the change of 
fluorescence intensity at each synapse. We pooled all synapses that responded with a fluorescence 
increase during immediately upon stimulation. In WT control DRG neurons they represent 80% of 
Figure 63 Synaptic transmission in DRG/S neuron co-culture. 
This graph shows the normalized to individual maximal intensity 
averaged synapses of WT DRG/WT S neurons (black trace), dKO 
DRG-WT S neurons (red trace), 1KO DRG-WT S neurons (light blue 
trace) and 2KO DRG-WT S neurons (navy blue trace). WT set: N = 32 
cell, n = 209 synapse, dKO set: N = 35 cell, n = 252 synapse, 1KO set: 
N = 38 cell, n = 270 synapse and 2KO set: N = 155 synapse. SEM were 
too small to be displayed. 
Continuing Figure 62… (A) Embryonic DRG neurons of WT, dKO, 1KO or 2KO were co-cultured with WT S neurons. 
The first column consists of bright field images of the different co-cultures, the second column shows semi-TIRF 
images before applying the stimulus and the third column display the same cells after the stimulus. The forth column 
shows the application of NH4Cl. (B) Shows the averaged traces from all synapses per one recording. Error bars 
are SEM. 
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all synapses (Figure 64). In CAPS2 
KO neurons the proportion of 
synapses that were synchronous with 
the stimulus decreased slightly to 70% 
while in CAPS dKO and in CAPS2 
KO neurons the percentage of 
synchronous synapses raised 
significantly to more than 90%. In WT 
control neurons the unsynchronized 
released occurred not only with a 
delay after the onset off stimulus but 
also and to a similar extent before the 
stimulus. This finding is intriguing 
because DRG neurons in co-culture 
with S neurons are not spontaneously 
active in vitro (Ransom et al., 1977a). 
Ca2+ concentration measurements 
performed to test the field electrodes show virtually no calcium variation prior field electrode 
stimulation (Figure 42). The asynchronous synaptic transmission prior stimulus was not changed 
in CAPS1 KO neurons when compared to WT neurons. However, SV exocytosis ensuing after the 
onset of stimulus was increased from 11% in WT neurons to 18% in CAPS1 KO neurons. In 
contrast,  in CAPS dKO and CAPS2 KO cells, the unsynchronized response was reduced to less 
than 5% whether the response occurred prior to or after stimulation. Taken together synaptic 
transmission in WT and in CAPS1 KO neurons was considerably more unsynchronized in 
comparison to transmission in CAPS dKO and CAPS2 KO neurons. We hypothesize that 
stimulation of peptidergic DRG neurons, which expressed CAPS2 (Figure 52), induced the release 
of a variety of neuropeptides, which in turn activated their respective presynaptic receptors 
inducing asynchronous synaptic activity. 
Figure 64 Synaptic transmission synchronicity. 
The graph shows synaptic responses synchronicity in different sets 
plotted against time. Synaptic activity was divided into three groups 
that includes the synapses that responded before the stimulus, the 
synapses that responded at the stimulus and the synapses that 
responded in delayed fashion. WT set: N = 32 cell, n = 209 synapse, 
dKO set: N = 35 cell, n = 252 synapse, 1KO set: N = 38 cell, n = 270 
synapse and 2KO set: N = 155 synapse. Error bars are SEM and Mann 
Whitney test significance test was applied, ns non-significant, * p < 
0.5, ** p < 0.01 and ***p < 0.001. 
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III.12 CAPS2 Indirectly Modulates Synapses 
 To test whether CAPS2-mediated secretion peptides affects synaptic transmission, three 
peptide antagonists were used to block the major peptides secreted by peptidergic neurons (Figure 
65). We selected the antagonists based on their selective characteristics reported in the literature. 
We chose the most effective and specific blockers available. For instance, the potent and selective 
TRKB inhibitor Cyclotraxin B was used at 10 µM to alter BDNF related physiological processes 
such as neuronal differentiation and synaptic plasticity (Cazorla et al., 2010; Thibault et al., 2014). 
L-703,606 oxalate salt hydrate was used as a non-peptide NK-1 tachykinin receptor antagonist at 
10 µM (Cascieri et al., 1992; Fong et al., 1992; Greenwood-Van Meerveld et al., 2014; Martinez 
et al., 2015). The third peptide antagonist was Olcegepant to block the binding of CGRP to its 
receptor (Dasgupta et al., 2014; Russo et al., 2009). Olcegepant is known to be not stable for long 
in aqueous solution and can be toxic for cells if incubated with for more than 50 min, for these 
reasons, it was incubated for shorter amount of time at a low concentration (10 nM) (Doods et al., 
2000; Nitzan-Luques et al., 2013) (Figure 65). The three peptide blockers were also added to the 
extracellular solution and the cells were continually perfused during the experiment to ensure 
Figure 65 Blocking CGRP, substance P and BDNF. 
The non-peptides antagonists Olcegepant and oxalate salt hydrate were used to block CGRP and substance P binding 
to their receptors. The peptide antagonist Cyclotraxin B was used to block the binding of BDNF to TRKB receptors. 
The cells were pre-incubated with Cyclotraxin B and oxalate salt hydrate at 10 µM for 2 hrs. Olcegepant was incubated 
for shorter time, about 15 min prior to measurements. During the experiment, the cells were continuously perfused 
with extracellular solution containing the three antagonists to ensure effective blocking of the receptors of interest. 
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effective blocking. Synaptic transmission was measured in WT with or without peptide blocker 
treatment. We were expecting to see more synchronized synaptic activity coupled to the stimulus 
but the results were far more surprising. Figure 8A shows two exemplary recordings in which WT 
neurons were treated or not (control) by the antagonists. The images are overlays of two successive 
DRG neurites pictures acquired during field electrode stimulation (white) and during 40 mM 
Figure 66 Peptides antagonists reduce active synapses and synchronize them. 
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NH4
+ application that renders all synapses visible (red). In control neurons a large majority of 
synaptic sites were active as can be recognized by the large overlap off red and white pixels. In 
contrary, in neurons treated with inhibitors only few red synaptic sites were also marked white. 
This reveals that only few synapses were active upon depolarization. Overall, nearly 5 times less 
treated synapses responded to the stimulus as in control (Figure 66 B). For responding synapses 
the change in fluorescence intensity of SypHy was nearly identical whether the cells were treated 
or not (Figure 66 C). This indicates that the number of released SV at responding synapse was 
independent of the treatment. More importantly, exocytosis of SV was significantly better 
synchronized to the stimulus upon peptide antagonist treatment when compared to untreated 
control cells (Figure 66 D). In control neurons only 73% of synapses exhibited fluorescence upon 
depolarization whereas in treated neurons this percentage immediately rose to 86% (** p < 0.01). 
Synchronization of synaptic response was essentially due to reduction by a factor greater than 2 of 
the percentage of synapses that were active before the stimulus when comparing control and treated 
neurons (*** p < 0.001). In summary, blocking the effect of CGRP, substance P and BDNF via 
antagonist treatment, reproduced the effect of CAPS2 deletion on unsynchronized synaptic activity. 
Therefore, we can conclude that while CAPS1 directly promotes SV exocytosis, CAPS2 indirectly 
modulates synaptic transmission via control of neuropeptide release contained in LDCVs. 
Continuing Figure 66… Synaptic transmission was measured in WT DRG/S neurons co-culture that were pre-
incubated or not (control) with a cocktail of peptide antagonists containing 10 nM Olcegepant to block CGRP 
receptors, 10 µM L-703,606 oxalate salt hydrate as a non-peptide NK-1 tachykinin receptor antagonist and 1 µM 
Cyclotraxin B to inhibit BDNF binding to TRKB. Cells were stimulated via field electrode at 10 Hz for 1 min and after a 
period of recovery they were superfused with NH4Cl like in Figure 7. Co-cultures were made with 2 adult mice for 
DRG neurons and 12 P0 mice for S neurons. Number of cells was 29 and 50 for control and peptide block, respectively. 
Total number of counted synapses was 241 and 101 for control and for peptides blocking condition, respectively. 
Error bars are SEM and Mann Whitney significance test was applied, ns non-significant, * p < 0.5, ** p < 0.01 and 
*** p < 0.001. (A) Representative overlay of the maximum intensity projection of SypHy epifluorescence images of 
DRG/S neurons acquired prior to (white) and during superfusion with NH4Cl (red). The white image reveals only active 
synapses while the red image depicts all SypHy labeled synapses. Control condition is displayed on the left while cells 
pre-incubated with the blockers are shown on the right. Yellow arrows indicate the synapses that were synchronized 
with the initiation of the stimulus. White arrows point to uncoupled synapses responding before or after stimulus. 
The associated numbers correspond to the delay in seconds. (B) Peptide antagonist pretreatment (grey) reduces the 
average number of active synapses in comparison to control (black). (C) Average synaptic SypHy responses 
normalized to SypHy fluorescence upon NH4Cl application in control compared to cells treated with peptides 
antagonist reveals that the number of SV secreted at each active synapse was not affected by the antagonists. (D) 
Similarly to the deletion of CAPS2, peptide blocker treatment synchronizes the synaptic activity to the stimulus. 
Density dot plot showing the time point of activity and the percentage of synapses that were either synchronized to 
the stimulus or that responded before or after the stimulus. The time point of response of each asynchronized 
synapse is shown by individual symbol whereas all the synchronized synapses are shown as one orange circle. Orange 
dash are the average time point of asynchronized response ± SEM. (E) Model of CAPS1 and CAPS2 function in DRG 
neurons. Our data indicates that SV exocytosis is promoted by CAPS1 and LDCVs are primed by CAPS2. Peptidergic 
cargo released by LDCVs indirectly affects synaptic transmission through binding to their receptors which might 
activate Ca2+ channels or other proteins leading to [Ca2+]i increase and finally SV fusion. 
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IV. Discussion 
Regulation of vesicle release literature had a strong boost in the late 1980s when SNARE 
proteins were first introduced as major elements in regulating membrane fusion (Brunger, 2005; 
Fasshauer, 2003; Hong, 2005; Jahn and Scheller, 2006; Trimble et al., 1988; Wilson et al., 1989). 
It is widely accepted that alterations in the components of the SNARE machinery hinders or even 
abolish vesicle secretion. Many proteins interact with SNARE proteins either prior or subsequent 
to the formation of SNARE complexes (Fiebig et al., 1999; Nicholson et al., 1998) mediating 
together membrane fusion. Accumulating evidence proposes that CAPS regulates the release 
machinery. CAPS is well conserved in evolution. One CAPS isoform (UNC-31) exists in 
C. elegans, whereas two isoforms, CAPS1 and CAPS2 are expressed in vertebrates. CAPS is 
believed to mediate exocytosis in an ATP-dependent step by binding to the vesicle membrane and 
cell membrane (Grishanin et al., 2004). More recent findings indicated that CAPS affects fusion 
pore formation (Eckenstaler et al., 2016). It is well known that mutations in CAPS disturb the 
function of the nervous system, reinforcing the importance of this key player in vesicle fusion. For 
instance, CAPS1 deletion is lethal (Speidel et al., 2003), while CAPS2 deletion is not lethal but 
mutations are often associated with autism (Bonora et al., 2014; Sadakata et al., 2007a). Reviewing 
twenty years of literature concerning CAPS isoforms adds enough complexity about the nature of 
the now-accepted different functions of this protein (Table 3). We aimed to evaluate separately the 
two isoforms, investigate their localization and test their effect on LDCV and SV secretion 
machinery. We believe this is the first time someone has approached the function of CAPS isoforms 
through suggesting that the different localization of both isoforms in brain and DRG tissues 
(Speidel, D. et al., 2003; Sadakata et al., 2006) might imply different functions. Through the course 
of this discussion we will provide compelling arguments showing that CAPS isoforms play 
differential roles in mediating secretion of LDCVs and SVs in DRG neurons. The first experiments 
aimed to identify whether CAPS is found and later to localize CAPS into DRG neurons subtypes. 
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IV.1 CAPS1 is Localized to all DRG Neurons while CAPS2 is Localized to the 
Peptidergic Subtypes 
Localizing CAPS into DRG neurons was not easy, as no good commercial anti-CAPS1 or 
CAPS2 antibodies were not available at the time I started my work. It was necessary to identify 
whether these isoforms were present in DRGs, for this purpose, we made RT-PCR as a first 
approach to address this issue. The presence of glial cells and fibroblast in complete DRGs 
contaminates the observed signal and limits the significance of the conclusions. Nevertheless, RT-
PCR remains a common practice to screen for mRNAs in complete glands. For example full adrenal 
glands have been used to investigate the content of chromaffin cells (Bruder et al., 2007; Nguyen 
Truong et al., 2014); although they contain other cell types such as fibroblasts (Kirshner et al., 
1989; O'Connor et al., 2007) and endothelial cells (Banerjee et al., 1985). A more precise method 
would ultimately be single cell PCR on individual DRG neurons. Previous single cell PCR and 
RNA sequencing showed that these cells are highly heterogeneous (Usoskin et al., 2015) and it is 
therefore very difficult to screen for proteins at individual cell level. Because using RT-PCR was 
a quick and a more convenient approach, we used it to investigate the presence of CAPS isoforms 
at the mRNA level in DRG neurons. RT-PCR semi-quantitative results showed that CAPS1 is 
highly expressed at the mRNA level in DRGs and to lesser extent CAPS2 which was consistent 
with what was previously described (Sadakata et al., 2006). Next we wanted to verify the existence 
of CAPS at the protein level, to show that the detected mRNA is being translated into protein. We 
also wanted to check the developmental expression of CAPS isoforms through time. For this 
reason, we isolated DRGs from embryonic and adult mice. Results showed that both isoforms are 
present in embryonic DRG neurons. These isoforms were differentially regulated during 
development. CAPS1 expression level tripled between the E18 and P7 while CAPS2 levels merely 
increased over this time period. This was not surprising if we took into consideration our later 
findings that show CAPS1 is preferentially localized at synapses and the fact that synapses between 
DRG neurons and spinal neurons start to form at P5-P6 and continues maturation over a period of 
time extending up to P40 in mice (Ashrafi et al., 2014; Betley et al., 2009). Our findings were 
consistent with what was shown of CAPS developmental expression in brain (Speidel et al., 2005). 
With new commercially available CAPS1 antibody and in house made CAPS2 antibody, we were 
able to investigate the cellular and subcellular localisation of CAPS isoform. ICC experiment 
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showed that CAPS1 and/or 2 were present in all DRG neurons. Later on, it was possible to purify 
antibodies specific against CAPS2 from the previous serum. Double ICC experiments showed that 
CAPS1 is found in all DRG neurons while CAPS2 in 45% of the population. This data confirmed 
the immunohistochemistry results of Sadakata et al., (2007). They also agree with findings in other 
regions of the nervous system where it has been shown that CAPS1 was almost expressed in all 
brain cells while CAPS2 was expressed in sub-regions like cerebellum, cortex, hippocampus and 
olfactory bulb (Speidel et al., 2003). Further, using various markers (iB4, anti TRKB, anti NK-1r, 
anti CAPS1 and anti CAPS2) we were able to differentiate between peptidergic and not peptidergic 
neurons. We found that CAPS1 was uniformly localized between the two types while CAPS2 was 
almost localized to all peptidergic medium and large neurons (Figure 67). To further verify this 
finding, we stained against peptidergic subtypes like NK-1r and TRKB and found that CAPS2 
Figure 67 CAPS localization into peptidergic and non-peptidergic neurons. 
DRG neurons were classified according to peptidergic and on-peptidergic neurons using iB4 labeling. Peptidergic 
neurons were exclusively large and extra-large in size and some were of medium sized cells. Non-peptidergic neurons 
on the other hand were either exclusively small sized cells or of medium size. CAPS2 was localized to peptidergic 
neurons while CAPS1 was expressed randomly among peptidergic and non-peptidergic neurons. 
Image courtesy: This image was generated together with the help of Mr. Abed Shaib. 
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localizes to these neurons. This confirms that CAPS2 indeed is localized to peptidergic neurons. 
Interestingly, CAPS2 had a remarkable subcellular cytoplasmic localization, which we failed to 
identify due to time constraints (see Appendix VI.6). Additionally, CAPS1 distribution was not 
uniform among different DRG neurons. Some cells exhibited a stronger CAPS1 fluorescence signal 
compared to other cells. We tried to identify which subtype of these cells had higher CAPS1 
endogenous expression levels. CAPS1 didn’t preferentially localize to cells that were positive with 
TRKB, rather some NK-1r positive neurons exhibited high CAPS1 expression. We showed that 
peptide secretion of WT neurons is not modulated by CAPS1. The elevation of CAPS1 isoform in 
a fraction of peptidergic NK-1r subtype could be explained by the fact that upon nerve injury, some 
larger neurons start to secret substance P that usually do not produce it (Lee et al., 1985; Szucs et 
al., 1999; Weissner et al., 2006). In vivo, substance P secreting neurons represent 13.5% ± 1.9 of 
DRG population (Hall et al., 1997), and this percentage increases to 25% in our DRG neuron 
culture. These newly-secreting substance P stressed neurons need to transmit this information to 
the higher order of CNS dorsal horn neurons (Swett and Woolf, 1985; Yoon et al., 1996). To do 
so, CAPS1 might be upregulated to mediate SV secretion which is in line of our working model. 
After the adequate input, the spinal neurons in return will trigger central sensitization (Khasabov 
et al., 2002). 
IV.2 CAPS2 is the Priming Factor for LDCV Secretion 
Our data showed that CAPS2 and not CAPS1 is responsible for priming LDCVs in DRG 
neurons. It is well documented that CAPS1 is essential for calcium-mediated LDCV exocytosis 
(Ann et al., 1997; Berwin et al., 1998; Grishanin et al., 2004; Renden et al., 2001; Speese et al., 
2007; Tandon et al., 1998). Similarly, CAPS2 has been shown to have a priming function and that 
its function is redundant with CAPS1; for instance, both CAPS1 (Liu et al., 2008) and CAPS2 
primes LDCV secretion in chromaffin cells (Liu et al., 2011). Similarly, CAPS1 (Eckenstaler et 
al., 2016; Farina et al., 2015; Sadakata et al., 2013) as well as CAPS2 (Sadakata and Furuichi, 
2009; Shinoda et al., 2011) can prime LDCV secretion in hippocampal neurons. Consistently, both 
CAPS isoforms have similar function in regulating LDCV release in cerebellum (Sadakata and 
Furuichi, 2009). Unlike the previously cited cell types, in DRG neurons CAPS isoforms not only 
exert distinct functions but also their subcellular localization was different. CAPS2 and not CAPS1 
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is intensely localized to the cytoplasm where it primes LDCVs, while CAPS1 is localized to 
synapses where it primes SVs. The question is whether the differential function of CAPS isoforms 
is due to specific interaction with the two organelles or whether the localization is dictating the 
function of the isoform. We showed that LDCV release is promoted to a similar extent upon 
overexpressing either isoform in WT neurons; it appears that support priming. Moreover, our data 
shows that both isoforms can rescue the CAPS1 and 2 dKO secretion phenotype. We think that 
flooding the cells with viral-driven overexpression overcomes the specific localisation of both 
isoforms and thereby evens their function. In consistence, and while keeping in mind that CAPS1 
is in all DRG neurons, overexpressing CAPS2 in non-peptidergic non-secreting CAPS2-missing 
neurons, secretion is induced (see Figure 54). In line with these findings, CAPS 2 KO DRG 
peptidergic neurons exhibited no LDCV secretion (data not shown). Munc13 exhibits a similar 
phenotype to CAPS1, for example it does not prime LDCV release in chromaffin cells but upon 
Figure 68 CAPS2 primes LDCV release. 
DRG peptidergic neurons endogenously expressing CAPS2 can secrete LDCVs upon stimulating with 4 V at 100 Hz 
while non-peptidergic neurons cannot secrete LDCVs using the same stimulus. This phenotype can be reversed 
upon overexpressing CAPS2 in non-peptidergic neurons driving them to secrete LDCVs. 
Image courtesy: This image was generated together with the help of Mr. Abed Shaib. 
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over expressing it, the secretion is increased (Man et al., 2015). Therefore, we hypothesize that 
both isoforms can prime LDCVs but that due to its somatic localization, CAPS2 is conferring to 
the DRG neurons the ability to secrete LDCVs. Our CAPS priming model allows the possibility of 
extending it to other cell types. For instance, Farina et al., (2015) showed that CAPS1 primes 
LDCV fusion at synapses in hippocampal neurons. They also showed that CAPS1 was localized to 
synapses while CAPS2 was merely present. This fits well our theory that both CAPS isoforms can 
prime LDCVs, it depends on the availability. An important question remains unsolved as how 
would CAPS2 switch the non-peptidergic non-secreting DRG neurons into peptidergic secreting 
neurons? Or simply, CAPS2 derives secretion from non-peptidergic neurons without affecting the 
nature of these cells. 
IV.3 CAPS1 Primes SV Secretion 
To study CAPS effect on synaptic transmission we extensively studied the synapse formation 
between the co-cultured neurons to ensure optimal close-to-physiological conditions for the 
experiments. DRG neurons can be grown with other cell types like skin cells (Koizumi et al., 2004; 
Malin et al., 2007; Reynolds et al., 1997; Taherzadeh et al., 2003) and higher order CNS neurons 
(Gu and MacDermott, 1997; Shepherd et al., 1997). We co-cultured DRG neurons with S neurons 
allowing them to form synapses (Joseph et al., 2010). This co-culture system has been used by only 
very few groups (Cao et al., 2009; Hendrich et al., 2012; Joseph et al., 2011; Ohshiro et al., 2007; 
Yu et al., 2015) and to the best of my knowledge none were using neurons from mice. It was 
important to focus on the synapses that form between DRG neurons and S neurons and exclude all 
the synapses between S neurons. To do so, we initially infected the DRG neurons with adenovirus 
encoding for Life Act-Ruby and added later the S neurons. The processes originating from infected 
DRG neurons were nicely labelled with red and can be differentiated from S neurons processes 
(see Appendix VI.7). But this approach was limited by the transfection efficacy of the adenovirus 
whereby not all DRG neurons would be transfected and therefore excluding some synapses 
between DRG neurons and S neurons. For this reason, we decided to use the SybKI mice (Matti et 
al., 2013) to prepare the DRG neurons co-cultured with WT S neurons. This way, all DRG 
processes were labelled and we could study exclusively the synapses between DRGs and 
S neurons. Through these co-cultures, we confirmed that synapses do form between these neurons. 
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We successfully quantified synapse formation and established the best culture settings, achieving 
Figure 69 CAPS differential role model. 
CAPS2 is localized to peptidergic DRG neurons and is responsible for priming LDCV secretion. CAPS1 is found at all 
DRG neurons and primes SV secretion at synapses with spinal neurons. Our data also indicate that CAPS regulates 
the intravesicular pH by making it more acidic probably by interacting with the proton pumps. 
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high number of synapses with good cell quality suitable for electrophysiological experiments. 
Further, we also confirmed that these synapses are not only linked but also active. We loaded the 
cells with calcium sensitive dye and we stimulated single DRG neuron neighboring S neurons and 
monitored the fluorescence intensity. We did not use the field electrode stimulation as it will 
stimulate all cell simultaneously; rather we took advantage from the fact that cultured DRG neurons 
maintain the ability to sense thermal (Cesare and McNaughton, 1996; Reid and Flonta, 2001), 
chemical (Jordt et al., 2004; Peier et al., 2002) and mechanical stimuli (McCarter et al., 1999). We 
proved that these synapses were functionally connected after trying out several different chemical 
and mechanical stimulating methods. In these well-adjusted co-culture conditions we measured SV 
fusion using the SypHy based imaging technique. We compared exocytosis from WT with CAPS1 
KO, CAPS2 KO or CAPS dKO DRG neurons. Unlike peptide release, measurement of SV fusion 
showed that CAPS1 and not CAPS2 mediates neurotransmitter release (Figure 69). Knocking out 
both CAPS isoforms dramatically reduced SV fusion as compared to WT. While CAPS2 KO didn’t 
have any effect on the scale of SV fusion, CAPS1 KO induced a strong decrease in SV fusion. This 
data is consistent with our ICC experiments where we showed that CAPS2 was concentrated in 
DRG cell bodies while CAPS1 was localized to synapses. This idea is partially supported by a 
recent paper published by Farina et al. (2015) where they show that CAPS1 is present at synapses 
in hippocampal neurons and that CAPS1 primes LDCVs there. Our findings contradict with an 
older paper that showed synaptic vesicles secretion in hippocampal neurons requires both CAPS1 
and CAPS2 (Jockusch et al., 2007). This notion gets puzzling when combined with the fact that 
CAPS2 is weakly present at synapses. Together with the LDCV secretion results, these data also 
indicate that priming can be fulfilled by either isoform in our system, depending on the isoform 
availability and since CAPS1 is localized to synapses, it simply primes SVs. 
IV.4 CAPS2 Indirectly Affects Synaptic Transmission through Peptide Release 
An interesting phenomena was evident while acquiring the synaptic transmission data 
whereby some synapses showed unsynchronized synaptic activity, while the activity of other 
synapses were tightly coupled to the stimulus. In depth analysis showed that synaptic activity in 
dKO DRG neurons was less coupled to the stimulus when compared to the WT genotype. 
Complementary to this, DRG neurons of CAPS2 KO genotype showed a very similar behavior of 
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unsynchronized synaptic activity to dKO DRG neurons. Conversely, CAPS1 KO DRG neurons 
showed synaptic activity that was precisely synchronised to the stimulus as described in WT DRG 
neurons. Altogether, this data infers that CAPS2 is somehow affecting indirectly synaptic 
transmission. Our LDCV secretion data shows that LDCV secretion occurs at a low rate when the 
neurons were stimulated at 10 Hz frequency. Secreted peptides at the cell body or synapses (De 
Camilli and Jahn, 1990; Navone et al., 1989; Scarfone et al., 1988) find their way to peptides 
receptors on the presynaptic membrane, inducing an autocrine feedback on synaptic transmission 
(Figure 70). For instance, it was shown that CGRP receptors are present in CGRP containing nerve 
terminals (Nuki et al., 1994). In hippocampal neurons BDNF does not act on TRKB receptors 
postsynaptically, rather presynaptically modulating long term potentiation (Xu et al., 2000). In 
accordance, NPY was described to have presynaptic activity through multiple NPY receptors that 
Figure 70 CAPS2 indirect effect on synaptic transmission model. 
The electrical stimulation used to induce SV secretion is strong enough to induce LDCV secretion as well. The secreted 
peptides at or near the synaptic cleft find their way to the peptide-receptor on presynapses. Therefore depolarizing 
the membrane to the level of inducing later SV secretion. This model explains the asynchronous synaptic transmission 
that is less coupled to the main stimulus. While CAPS1 regulates SV exocytosis, CAPS2 is responsible for regulating 
LDCV exocytosis. The cargo released from LDCVs affects SV secretion, hence CAPS2 indirectly affects synaptic 
transmission. 
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coexist on pre- and postsynapses (Chen and van den Pol, 1996; Obrietan and van den Pol, 1996). 
Once the peptides are released, their effect is reported to be slower than small sized 
neurotransmitters such as GABA, glutamate and acetylcholine (Schlicker and Kathmann, 2008). 
Perhaps, this could explain the delayed asynchronous synaptic responses. To provide more cues 
elucidating any possible indirect role of CAPS2, we decided to use a cocktail of non-peptide and 
peptide antagonists for the major peptides secreted by DRG neurons. Blocking the effect of CGRP, 
substance P and BDNF induced a synchronization of the synapses with the stimulus suggesting 
that there were no or little other exterior effectors to the synaptic transmission. This evidence 
supports the idea that CAPS2 can regulate the synaptic activity through the secretion of peptide 
contained in LDCVs. The effect of these peptides antagonists was even more pronounced on the 
number of active synapses in control compared to the condition in which the neurons were treated 
with peptide antagonists as their number was significantly reduced from 20 ± 4 to 5 ± 0.3 synapse 
per 0.05 mm2 area. This lasting decrease in synaptic transmission could be due to the fact that the 
absence of these peptides led to an alteration of calcium concentration, subsequently generating 
long term depression (Malenka and Nicoll, 1999). Retrograde signalling involving peptides, 
messengers, conventional transmitters and lipid messengers in neurons often regulates presynaptic 
plasticity (Regehr et al., 2009). These substances can be either released from the neuron cell bodies 
or processes targeting presynaptic structures leading to the modification of synaptic transmission 
in the form of a long-lasting effect (Castillo, 2012; Regehr et al., 2009; Tao and Poo, 2001). Even 
though there is a wide agreement that these messengers trigger LTD and/or LTP, the mechanisms 
and main effectors underlying such changes are unknown (Futai et al., 2007; Gottmann, 2008). 
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V. Conclusion and Perspectives 
CAPS is a complex multi-domain protein that is known to be a strong priming factor in 
several species. Recent evidence indicates that CAPS might be implicated in several functions with 
contradicting roles among different species and within the same species in different cells (Ann et 
al., 1997; Berwin et al., 1998; Eckenstaler et al., 2016; Elhamdani et al., 1999; Farina et al., 2015; 
Grishanin et al., 2004; Jockusch et al., 2007; Liu et al., 2011; Liu et al., 2008; Renden et al., 2001; 
Sadakata and Furuichi, 2009; Sadakata et al., 2013; Shinoda et al., 2011; Speese et al., 2007; 
Speidel et al., 2005; Tandon et al., 1998; Vogl et al., 2015). Through this thesis, we managed to 
demonstrate that CAPS isoforms play differential role in regulating secretion of LDCVs and SVs 
in murine DRG neurons. We showed that CAPS2 is localized to peptidergic neurons and is the 
priming factor for LDCVs while CAPS1 has no function in LDCV exocytosis from DRG neuron 
somata. We also showed that CAPS1 is localized to synapses and is responsible for mediating 
synaptic transmission by direct priming of SVs while CAPS2 had no direct effect. Finally, we 
produced evidence indicating that CAPS2 indirectly affects synaptic transmission by regulating 
peptide release near synapses. 
Our findings provides a probable understanding of pain generation in DRG neurons by 
suggesting a molecular switch for pain synthesis. We propose that CAPS2 might be the molecular 
switch that converts non-peptidergic DRG neurons into neurons that are capable of neuropeptide 
release. By overexpressing the ‘absent’ CAPS2 in non-peptidergic neurons, they start to release 
peptides. It is known that in response to chronic pain injury, the number of peptidergic neurons is 
increased. We speculate that CAPS2 expression in these neurons is activated hence pushing these 
non-peptidergic neurons to secrete. It is unclear though what triggers the change of non-peptidergic 
neurons to peptidergic neurons. To address this important issue, an experiment should be carried 
out by which one would overexpress CAPS2b and stain with iB4 together with CGRP, BDNF, NK-
1r and chromogranin A. The idea is to find a non-peptidergic neuron overexpressing CAPS2 and 
check whether it has any of the peptides inside LDCVs. In order to conduct this experiment 
properly, CAPS2b should be overexpressed slowly using a Lentiviral system to give the cells the 
necessary time for all the possible molecular changes that CAPS2 might induce. In addition to the 
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expression speed, additional complexity lies in the transfection efficacy of CAPS-Semileki Forest 
virus in DRG neurons which was as low as 20%. It would be very difficult to find a fixed 
transfected cell that would be stained with iB4 and the other peptidergic subtypes. 
Collectively, we can conclude that CAPS isoforms play differential roles due to its differential 
localization. A lot of questions were answered during this thesis† and a lot of answers still wait to 
be uncovered. For instance, the localization signal that sends CAPS1 to synapses and keeps CAPS2 
in somata of DRG neurons, remains unknown43. It is still unclear whether CAPS2 pushes non-
peptidergic neurons to become peptidergic neurons hence the secretion, or it only derives secretion 
of LDCVs in non-peptidergic neurons once expressed. Furthermore, it is interesting to investigate 
the expression of CAPS2 upon nerve constriction and chronic pain generation in vivo models.  
 
 
 
 
 
 
 
 
                                                 
43 Experiments that attempt to provide evidence about the localization signal of CAPS isoforms were performed but 
are not covered in the course of this book. 
†NB: This thesis book did not include the identification of Munc13 isoforms. Dr. Benjamin Cooper kindly provided 
us with Munc13-eGFP KI mice. We identified two isoforms of Munc13 expressed in DRG neurons, munc13-2 and 
munc13-3. We also investigated the region that is responsible for CAPS1 localization to synapses. Primary results 
favored our speculated region of interest which is also found in munc13-1. Data was not included in this thesis 
awaiting further experiments to support our initial conclusions and other functional experiments. 
It is worth mentioning that with the help of Mr. Ali Harb, we managed to patch adult DRG neurons and induce 
secretion by depolarizing single cells. 
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VI.1 Stimulating Hippocampal Neurons 
Hippocampal neurons were loaded with Fluo 4 AM and were incubated for 20 min before 
recording. The cells were washed by continual perfusion at 37 °C. Hippocampal neurons were 
stimulated through the field electrode with different frequencies while measuring fluorescence 
intensity in epifluorescence at 488 nm. (A) Top graph shows the response of neurons to the 
application of a stimulus of 4 V at 10 Hz, n = 69 cells were stimulated out of which 55 cells 
responded. The lower graph shows the average of Fluo 4 fluorescence intensities. (B) The upper 
graph shows the application of 4 V at 100 Hz stimulus response curves, n = 38 cells were stimulated 
out of which 29 cells responded. The lower graph shows the average of Fluo 4 fluorescence 
intensities. (C) The upper graph shows the fluorescence intensity fluctuations without any 
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stimulation serving as a control. The lower graphs shows the averaging of Fluo 4 fluorescence 
intensities. 
VI.2 CAPS2 Negative Control 
 Anti-CAPS2 Serum 6 was tested with CAPS2 KO control to ensure there is no cross 
reactivity with CAPS1. Embryonic WT DRG neurons were stained against CAPS2 (1:1000) and 
the signal was revealed via staining with goat anti-rabbit secondary antibody coupled to Alexa 488. 
The cells fluorescence was measured via confocal microscopy. Results showed staining in WT 
cells while absence of the signal was evident in CAPS2 KO cells. It is worth to note that anti-
CAPS2 serum 6 staining always had some background noise in CAPS2 KO cells, even with higher 
dilutions, but the signal in WT was significantly higher exhibiting staining pattern in subcellular 
compartments. 
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VI.3 CAPS1 Negative Control 
Similar control involving CAPS1 KO cells were performed to ensure the specificity of 
SynapticSystems anti-CAPS1 antibody (1:1000) and no cross-reactivity with CAPS2. The results 
below shows total absence of punctae staining in CAPS1 KO cells (lower panel in the figure 
below). 
 
VI.4 NPY-Venus is loaded correctly into LDCVs 
NPY-Venus is commonly used for labeling LDCVs with a pH-sensitive fluorescent protein 
(Ramamoorthy et al., 2011). NPY-Venus was cloned into a second generation 
pRRl.sin.cPPT.CMV.WPRE Lentiviral vector in order to drive its expression in DRG neurons. 
Although, Lentiviruses are gentle and express slowly the encoded protein for long term without 
stressing the cells and ensure high survival rate after transfection (Dull et al., 1998; Vigna and 
Naldini, 2000), it was critical to test if NPY-Venus is loaded correctly into LDCVs upon a viral 
overexpression in DRG neurons. To do so, DRG neurons were transfected with the Lentivirus 
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encoding for NPY-Venus and left for 7 days in culture, then fixed with 4% PFA and permeabilized 
with 0.2% triton for 1 h to ensure that LDCV membranes are permeabilized. The primary 
polyclonal antibody against Chromogranin A (ab15160) from Abcam was used in dilution 1/200 
and incubated overnight. Goat anti Rabbit coupled to Alexa 561 was used against the primary 
antibody in dilution 1/2000 and stacks of confocal images were acquired. (A) This panel includes 
a bright field image showing single DRG neuron, NPY-Venus imaged at 514 and assigned to a 
false green color, Chromogranin A signal imaged at 561 nm in red and the merger of the channels. 
(B) Percentage of Chromogranin A positive cells. (C) Manders’ coefficient showing the 
colocalization from NPY to Chromogranin A and the opposite. (D) Line scan analysis to show 
colocalization of NPY with Chromogranin A at individual vesicles. N = 2 adult mice and n = 46 
cells. 
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VI.5 VGLUT-mNectarine structure 
VGLUT-mNectarine was cloned into a second generation Lentivirus pLenti2g-VGLUT-
mNectarine. The mNectarine was inserted near the N-terminal part of VGLUT towards the lumen 
of the vesicle. 
 
VI.6 LDCV Size in Peptidergic and Non-Peptidergic Neurons – STED 
To test if NPY-Venus is loaded in similar vesicles in peptidergic and non-peptidergic neurons 
we decided to measure their size with STED microscopy (Ms Angelina Staudt made the staining 
of the cultures and Dr. Ute Becherer acquired and analysed the STED images). NPY-Venus 
transfected DRG neurons were stained with iB4–Alexa641 to identify peptidergic and non 
peptidergic neurons (see Figure 3). Because STED beam bleaches Venus extremely fast, we fixed 
the DRG neurons with 4% PFA at DIV 7 and performed an immuno-labelling against Venus with 
anti GFP antibody (Life Technology,G10362, at a dilution of 1:20) and anti-rabbit secondary 
antibody (Abberior STAR red). We acquired first a stack of 5 images in confocal mode at 561 nm 
to visualize the IB4 signal (top row: maximum intensity projection). Then we visualized the LDCVs 
in a single section of the cells at 647 nm in confocal (middle row) and STED (bottom row). STED 
allowed us to clearly identify individual vesicles as can be seen on the enlarged portion of the 
images. 
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(A) Vesicles labeled with NPY-Venus had a diameter of 103 ± 2 nm in both DRG neuron subtypes. 
Individual vesicle images were cut out of the image of the cell (top picture), imported in Igor 
(Wavemetrics) and fitted by equation 1 where A is the amplitude, cor the cross-correlation term 
that lays between -1 and 1, xo, yo are the center coordinates and xwidth, ywidth are the x and y half 
width at half maximum of the vesicle displayed in (B). 
(1) 𝑓(𝑥) = 𝐴 ∙ 𝑒𝑥𝑝 [
−1
2(1−𝑐𝑜𝑟2)
((
𝑥−𝑥𝑜
𝑥𝑤𝑖𝑑𝑡ℎ
)
2
+ (
𝑦−𝑦𝑜
𝑦𝑤𝑖𝑑𝑡ℎ
)
2
−
2∙𝑐𝑜𝑟∙(𝑥−𝑥𝑜)(𝑦−𝑦𝑜)
𝑥𝑤𝑖𝑑𝑡ℎ∙𝑦𝑤𝑖𝑑𝑡ℎ
)] 
In the graph we displayed the X and Y full width at half maximum of vesicles from peptidergic 
and non-peptidergic neurons. To insure that we had the resolution to be able to distinguish 
variations in vesicle size we imaged 40 nm large crimson red beads (Invitrogen, bottom picture) 
with the same STED settings as the used to image DRG neurons. Their apparent size was 55.6 ± 1.1 
nm well below the size of NPY-Venus labelled vesicles (n = 10). 
(C) The size distribution of NPY-Venus labeled vesicles show that they represent one population 
whether in peptidergic or non-peptidergic neurons. nneurons = 7 and 6, nLDCVs = 135 and 105 for 
peptidergic and non-peptidergic, respectively. 
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VI.7 Golgi Staining 
In the hopeful efforts to determine CAPS2 subcellular localization, we co-stained with 
CAPS2 purified serum 6 antibody and with anti-GM130 antibody, a cis-Golgi marker from Abcam 
(ab52649). Results showed there is no correlation between CAPS2 signal and cis-Golgi 
compartments. Further staining against other Golgi compartments were not successful. 
Unfortunately, it remains unknown at what subcellular compartment CAPS2 signal is enriched. 
 
 
VI.8 Life Act-Ruby Experiment 
DRG neurons were double transfected by an Adenovirus that was kindly provided by 
Prof. Peter Lipp, encoding for Life Act tagged to Ruby fluorescent protein and a Lentivirus 
encoding for NPY-Venus. S neurons were added on the second day and images were acquired after 
16 hrs using confocal microscope. (A) Bright field image composed of four stitched images with 
12% overlap. (B) NPY-Venus signal imaged at 514 nm. (C) Life Act-Ruby imaged at 561 nm 
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wavelength. (D) Merged image that is magnified in (E.), the white arrows point to a process that 
originates from S neurons. Scale bar is 20 µm. 
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VI.9  List of Antibodies 
Antibody Host Immunogen Manufacturer & 
catalog no. 
Working 
dilution 
  Primary antibody 
CAPS1 Rabbit Recombinant protein (aa 18-
107 of mouse CAPS 1) 
Synaptic systems 
(No 262 013) 
1:1000 
CAPS2 Rabbit Exon 1 of CAPS2e Provided by 
M. Jung 
1:1500 
Synaptophysin1 
(monoclonal)  
 
Mouse Clone 7.2 Synaptic systems 
(No. 101 011) 
1:1000 
 
Bassoon Rabbit Recombinant protein aa 330 
– C terminal (rat) 
Synaptic systems 
(No 141 003) 
1:300 
PSD95 
(monoclonal) 
Mouse Fusion protein aa 77-299 
(human)  
NeuroMab 
(Clone K28/43) 
1:500 
eGFP Rabbit Full length protein Life technologies 
(G10362) 
1:20 
Chromogranin A Rabbit Recombinant fragment from 
the C-terminal (human)  
Abcam 
(ab15160) 
1:1000 
Β-actin Mouse Monoclonal, clone AC-15 Sigma Aldrich 
(A1978) 
1:5000 
 Secondary antibody - Life Technologies, Invitrogen 
Alexa 488  goat anti-mouse A-11001 1:2000 
Alexa 647   goat anti- mouse A-21235 1:2000 
Alexa 488   goat anti-rabbit A-11008 1:2000 
Alexa 647   goat anti-rabbit A-21244 1:2000 
Fab fragments  goat anti-mouse (IgG H&L) Biomol: 
Rockland, 
(810-1102) 
1:50 
STAR Red  goat anti-rabbit (IgG) Abberior 
(2-0012-011-9) 
1:100 
 Table 4 List of used antibodies. 
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Publications 
CAPS2 primes regulated peptide release while CAPS1 directly promotes synaptic 
transmission in murine dorsal root ganglion neurons 
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